SESSION 1 SCHEDULE
Tuesday
SESSION 1: PROGRESS IN TRANSCATHETER HEART VALVES AND NEW APPROACHES TO ASCENDING AORTIC DISEASE
x
6:45 AM - 6:49 AM Opening Remarks
  Presenter(s):Frank J. Veith, MD  
  View Slides in PDF      
6:50 AM - 6:55 AM Valve-In-Valve Transcatheter Aortic Valve Implantation (TAVI) And Mitral Valve-In-Valve Endovascular Repair: How Well Do They Work
  Presenter(s):Dietmar H. Koschyk, MD  
  View Slides in PDF      
6:56 AM - 7:01 AM Current Status Of Transcatheter Mitral Valve Repair: New Technology And Techniques
  Presenter(s):Ted Feldman, MD  
  View Slides in PDF      
7:02 AM - 7:07 AM Current Status And Future Prospects For TAVI: A Cardiac Surgeon’s Perspective
  Presenter(s):Allan Stewart, MD  
  View Slides in PDF      
7:08 AM - 7:13 AM Current Status And Future Prospects For TAVI: An Interventional Cardiologist’s Perspective
  Presenter(s):Ted Feldman, MD  
  View Slides in PDF      
ASCENDING AORTIC ENDOGRAFTING
7:14 AM - 7:19 AM Ascending Aortic Endografting: Where Are We And What Are The Issues
  Presenter(s):Ralf R. Kolvenbach, MD  
  View Slides in PDF      
7:20 AM - 7:25 AM Endograft Repair Of Ascending Aortic Lesions And Type A Dissections With A Physician Sponsored IDE (PSIDE) For A Modified Valiant Device: Lessons Learned And What Are The Prospects For An Endograft-Valve Combined Device
  Presenter(s):Carlos E. Donayre, MD / Rodney A. White, MD  
  View Slides in PDF      
7:26 AM - 7:31 AM Ascending Aortic Endografting: Lessons Learned, Present Status And Future Potential: From A PSIDE Experience
  Presenter(s):Rodney A. White, MD / Ali Khoynezhad, MD, PhD  
  View Slides in PDF      
7:32 AM - 7:37 AM Access Routes And Off-The-Shelf Devices For Ascending Aortic Endovascular Repair
  Presenter(s):Grayson H. Wheatley, MD  
  View Slides in PDF      
7:38 AM - 7:43 AM Panel Discussion
END OF SESSION 1
 
SESSION 2 SCHEDULE
Tuesday
SESSION 2: NEW DEVELOPMENTS IN TREATMENT OF AORTIC ARCH LESIONS AND DISSECTIONS
x
7:44 AM - 7:49 AM Aortic Arch Hybrid Repair With Supra-Aortic Trunks Re-routing: Current Indications, Long-Term Results And Complication Management In Patients With Degenerative Aneurysms And Dissections
  Presenter(s):Yamume Tshomba, MD / Roberto Chiesa, MD / Germano Melissano, MD  
  View Slides in PDF      
7:50 AM - 7:55 AM Current Management Of Aortic Arch Lesions With Hybrid Procedures: What Are Key Details And Precautions
  Presenter(s):Eric E. Roselli, MD  
  View Slides in PDF      
7:56 AM - 8:01 AM Redo Procedures For Aortic Arch Lesions: When Open; When Endo
  Presenter(s):Michael J. Jacobs, MD  
  View Slides in PDF      
8:02 AM - 8:07 AM Update On Endovascular Repair Of Arch Aneurysms Using The Internally Branched Endograft (Cook): Advantages, Limitations And 3-Center Midterm Results
  Presenter(s):Stephan Haulon, MD  
  View Slides in PDF      
8:08 AM - 8:13 AM What Are The Best Endovascular Techniques For Managing Arch Lesions – Including Branched Endografts And In Situ Fenestration
  Presenter(s):Timothy A. Resch, MD, PhD / Bjõrn Sonesson, MD, PhD / Martin Malina, MD, PhD  
  View Slides in PDF      
8:14 AM - 8:19 AM Status Of Sandwich (Parallel) Grafts For Total Endovascular Arch Replacement
  Presenter(s):Armando C. Lobato, MD, PhD  
  View Slides in PDF      
8:20 AM - 8:25 AM Parallel Grafts (Chimney And Periscope Grafts) For Arch Lesions: Advantages And Limitations
  Presenter(s):Ralf R. Kolvenbach, MD  
  View Slides in PDF      
8:26 AM - 8:31 AM What Is The Future For Endovascular Repair Of Aortic Arch Lesions: Advantages And Limitations Of Two Different Techniques Of Endograft Repair
  Presenter(s):Tilo Kölbel, MD, PhD  
  View Slides in PDF      
8:32 AM - 8:37 AM Update On Advantages Of Custom-Made Precurved Fenestrated Endograft (Naguta) For Arch Lesions: Durable Long-Term Results Are Better Than With Other Endo Techniques
  Presenter(s):Yoshihiko Yokoi, MD  
  View Slides in PDF      
8:38 AM - 8:43 AM Value And 3-Year Results With Branched Endograft From Bolton For Treating Complex Arch Lesions
  Presenter(s):Toru Kuratani, MD, PhD  
  View Slides in PDF      
8:44 AM - 8:49 AM Branched Endograft vs. Chimney Techniques For Treating Complex Arch Lesions: Which Is Best: When And Why
  Presenter(s):Qingsheng Lu, MD / Zaiping Jing, MD  
  View Slides in PDF      
8:50 AM - 8:58 AM Panel Discussion
END OF SESSION 2
 
SESSION 3 SCHEDULE
Tuesday
SESSION 3: TYPE B AORTIC DISSECTIONS (TBADs) AND THEIR TREATMENT: THORACIC AORTIC
x
8:58 AM - 9:03 AM What Do We Know About Intensive Medical Treatment For Acute TBADs: How Well Does It Work
  Presenter(s):Frank A. Lederle, MD  
  View Slides in PDF      
9:04 AM - 9:09 AM Natural History Of TBAD Patients Treated Medically: Predictors Of Deterioration And Which TBAD Patients Benefit Most From TEVAR (Based On 5-Year Results)
  Presenter(s):Mark Conrad, MD, MMSc  
  View Slides in PDF      
9:10 AM - 9:15 AM 4D Magnetic Resonance Imaging (MRI) In TBADs: Will It Enable Prediction Of Behavior (Aneurysm Formation, Etc.), Individualization Of Treatment And Assessment Of Its Effectiveness
  Presenter(s):Rachel E. Clough, MD, PhD  
  View Slides in PDF      
9:16 AM - 9:21 AM With Uncomplicated Acute TBAD Patients, What Factors Point To Deterioration On Medical Treatment And The Need For TEVAR: When Should TEVAR Be Performed: Based On New Data From The IRAD Registry
  Presenter(s):Santi Trimarchi, MD, PhD / Christoph A. Nienaber, MD, PhD  
  View Slides in PDF      
9:22 AM - 9:27 AM Optimal Management Of Malperfusion Syndrome From TBADs: What To Do When TEVAR Is Not Enough
  Presenter(s):Weiguo Fu, MD  
  View Slides in PDF      
9:28 AM - 9:33 AM Early Predictors Of Late Complications Including Aneurysm Formation In Patients With Acute TBADs
  Presenter(s):Jean-Marc Alsac, MD, PhD  
  View Slides in PDF      
9:34 AM - 9:39 AM Management Of Complications Of TBADs Before And After TEVAR: Intestinal, Spinal Cord And/Or Limb Ischemia
  Presenter(s):Xin Li, MD / Chang Shu, MD  
  View Slides in PDF      
9:40 AM - 9:45 AM False Lumen Occlusion Techniques With TBADs: When Are They Needed, How Are They Done, What Are The Complications: What Is The World Experience
  Presenter(s):Tilo Kölbel, MD, PhD  
  View Slides in PDF      
9:46 AM - 9:51 AM Strategies And Devices For Eliminating False Lumen Flows With TBADs And When Are They Needed
  Presenter(s):Eric E. Roselli, MD  
  View Slides in PDF      
9:52 AM - 9:58 AM Panel Discussion
9:58 AM - 10:10 AM Break – Visit Exhibits And Pavilions (2nd and 3rd Floors)
END OF SESSION 3
 
SESSION 4 SCHEDULE
Tuesday
SESSION 4: MORE NEW DEVELOPMENTS IN TEVAR, THE AORTA AND MANAGING TBAD PATIENTS
x
10:10 AM - 10:15 AM Status Of Brain Embolic Protection Devices For TEVAR And TAVI: How Effective Are The Embrella, Sentinel And Triguard Neuroprotection Devices
  Presenter(s):Jeffrey P. Carpenter, MD  
  View Slides in PDF      
10:16 AM - 10:21 AM Effect Of TEVAR Timing On Freedom From Aortic Events And The Need For Reinterventions In TBADs: TEVAR Before 6 Months Is Better
  Presenter(s):Toru Kuratani, MD, PhD  
  View Slides in PDF      
10:22 AM - 10:27 AM A New Classification System For Aortic Dissections: DISSECT - Duration, Intimal Tear, Size Of Aorta, Segmental Extent, Complications, Thrombosis In False Lumen
  Presenter(s):Michael D. Dake, MD / Christoph A. Nienaber, MD, PhD  
  View Slides in PDF      
10:28 AM - 10:33 AM Correlation Between False Lumen Remodeling And Patent Intercostal Arteries
  Presenter(s):Wei Guo, MD  
  View Slides in PDF      
10:34 AM - 10:39 AM How The Petticoat Technique (Proximal Covered Stent And Distal Bare Stent) Is Better Than Standard TEVAR For TBAD Patients: Update On The STABLE I And II Trials
  Presenter(s):Joseph V. Lombardi, MD  
  View Slides in PDF      
10:40 AM - 10:45 AM Long-Term Results Of Medical Treatment And TEVAR For TBAD: False Lumen Thrombosis Is Not The End Of The Story: Thus The Need For Long-Term Surveillance And Late Reinterventions
  Presenter(s):Götz M. Richter, MD, PhD  
  View Slides in PDF      
10:46 AM - 10:53 AM Panel Discussion
Moderator(s): Michael D. Dake, MD / Frank J. Veith, MD  
10:53 AM - 10:58 AM What Defines Chronic TBAD: When And How Should It Be Treated Conservatively; By Endo Repair; By Open Repair
  Presenter(s):Joseph E. Bavaria, MD  
  View Slides in PDF      
10:59 AM - 11:04 AM Fenestrated And Branched EVAR (F/B EVAR) Is The Best Treatment For Thoracoabdominal Aneurysms (TAAAs) After TBADs – Especially Chronic TBADs: Advantages And Limitations
  Presenter(s):Eric L.G. Verhoeven, MD, PhD  
  View Slides in PDF      
11:05 AM - 11:10 AM Current Optimal Treatment Of Patients With Chronic TBADs And Associated Complications And Aneurysms From Them
  Presenter(s):Gustavo S. Oderich, MD, FACS  
  View Slides in PDF      
11:11 AM - 11:16 AM Comparison Of Endovascular And Open Repair Of Degenerative And Dissecting Thoracic Aneurysmal Lesions In Patients Who Are Candidates For Both Types Of Repairs
  Presenter(s):Yamume Tshomba, MD / Germano Melissano, MD / Roberto Chiesa, MD  
  View Slides in PDF      
11:17 AM - 11:22 AM Secondary Interventions After TEVAR: Indications, Techniques And Results
  Presenter(s):Mark K. Eskandari, MD  
  View Slides in PDF      
11:23 AM - 11:28 AM Size (Diameter) And Normal Growth Rates Of The Aorta From Top To Bottom: At What Thoracic Aortic Size Is There A Real Risk Of Rupture
  Presenter(s):John A. Elefteriades, MD  
  View Slides in PDF      
11:29 AM - 11:34 AM The Mechanics Of TEVAR Device Conformability To Aortic And Arch Anatomy: How Do The Various Devices Compare
  Presenter(s):Ludovic Canaud, MD, PhD  
  View Slides in PDF      
11:35 AM - 11:40 AM True Lumen Volume/False Lumen Volume Ratio (<.8) On CT Can Predict The Need For TEVAR In Uncomplicated Acute TBAD
  Presenter(s):Jean M. Panneton, MD  
  View Slides in PDF      
11:41 AM - 11:46 AM Long-Term Results After TEVAR Are Not So Great: Some Notes Of Caution
  Presenter(s):Dittmar Boeckler, MD  
  View Slides in PDF      
11:47 AM - 11:52 AM Antegrade Delivery Of A Stent-Graft Into The Descending Aorta During Open Repair Of A Type A Aortic Dissection With Arch Involvement: A “Frozen Elephant Trunk”: How To Do It
  Presenter(s):Joseph S. Coselli, MD / Ourania Preventza, MD  
  View Slides in PDF      
11:52 AM - 12:00 PM Panel Discussion
12:00 PM - 1:00 PM Lunch Break – 2nd Floor Promenade
Visit Exhibits And Pavilions (2nd and 3rd Floors)

END OF SESSION 4
 
SESSION 5 SCHEDULE
Tuesday
SESSION 5: NEW KEY DEVELOPMENTS IN THE MANAGEMENT OF PATIENTS WITH CAROTID DISEASE
x
1:00 PM - 1:05 PM Update On The ACT I Trial Comparing CAS And CEA In Patients With High-Grade Asymptomatic Carotid Stenosis (ACS)
  Presenter(s):Jon S. Matsumura, MD  
1:06 PM - 1:11 PM CAS Is Equivalent To CEA In Many Circumstances
  Presenter(s):William A. Gray, MD  
  View Slides in PDF      
1:12 PM - 1:17 PM DEBATE: Not So: Lessons Learned From US Datasets On Outcomes After CEA And CAS Show CAS Results Are Substantially Worse Than In CREST: The Brighter The Light The Darker The Shadow
  Presenter(s):Ross Naylor, MD, FRCS  
  View Slides in PDF      
TWO-WAY DEBATE
1:18 PM - 1:23 PM DEBATE: Late Results Of ICSS Trial Show CAS And CEA To Be Equivalent In Patients With Symptomatic Carotid Stenosis
  Presenter(s):Jonathan D. Beard, ChM, MEd, FRCS / Martin M. Brown, MD  
  View Slides in PDF      
1:24 PM - 1:29 PM DEBATE: Late Results Of ICSS Do Not Show Equivalence Of CAS And CEA: CEA Still Wins For Symptomatic Carotid Stenosis
  Presenter(s):Anne L. Abbott, MD, PhD, FRACP  
  View Slides in PDF      
1:30 PM - 1:35 PM Stroke And Death Rates (Early And Late) After CAS Are Higher Than The Randomized Controlled Trials (RCTs) Would Indicate: Therefore, We Should Be Less Aggressive With Our Use Of CAS – Especially In The Elderly And Asymptomatic Patients
  Presenter(s):J. David Spence, MD  
  View Slides in PDF      
1:36 PM - 1:41 PM Asymptomatic Carotid Stenosis (ACS) Up To 80% Is Benign: What About Those Stenoses Over 85% - Especially When Associated With A Contralateral Occlusion: Which ACS Patients Should Be Treated Invasively And How
  Presenter(s):Russell H. Samson, MD, RVT, FACS  
  View Slides in PDF      
1:42 PM - 1:47 PM Long-Term Results Of The SAMMPRIS (Intracranial Stenting) Trial In Patients With Intracranial Stenoses: What Does It Tell Us About Best Medical Treatment (BMRx); Compliance And Long-Term Benefits: The Recent VISSIT Trial Confirms The Negative Effects Of Intracranial Stenting
  Presenter(s):Colin P. Derdeyn, MD  
  View Slides in PDF      
1:48 PM - 1:54 PM Panel Discussion
Moderator(s): Wesley S. Moore, MD / Thomas S. Riles, MD  
1:55 PM - 2:00 PM Why Transcranial Doppler (TCD) Is Essential Before, During And After CAS, CEA And TAVI
  Presenter(s):Zsolt Garami, MD  
2:01 PM - 2:06 PM Status Of Endovascular Treatment Of Total Carotid Occlusions: Advantages, Technique, Complications And How To Avoid Them
  Presenter(s):Paul H.L. Kao, MD  
  View Slides in PDF      
2:07 PM - 2:12 PM Diaphragm Of The Internal Carotid Artery: An Underdiagnosed Cause Of Stroke
  Presenter(s):Emmanuel M. Houdart, MD  
  View Slides in PDF      
2:13 PM - 2:18 PM DEBATE: Carotid Plaque Morphology Is Only Important In Symptomatic Patients
  Presenter(s):Henrik Sillesen, MD, DMSc  
  View Slides in PDF      
2:19 PM - 2:24 PM DEBATE: Not So: Carotid Plaque Morphology Is Helpful (With Other Criteria) In Predicting Stroke Risk In ACS Patients: What Percent Of ACS Patients Are High Risk And Justifiably Need CEA Or CAS
  Presenter(s):Andrew N. Nicolaides, MS, FRCS / Stavros Kakkos, MD, PhD  
  View Slides in PDF      
2:25 PM - 2:30 PM Risk Stratification Of Patients With Carotid Stenosis: How To Quantify: An Aging Brain Is More Important Than Plaque Characteristics – And Even Symptom Status
  Presenter(s):Thomas G. Brott, MD  
  View Slides in PDF      
2:31 PM - 2:36 PM Importance Of Preoperative And Perioperative Statin Dosage In Patients With Carotid Stenosis: Can They Change And Shrink Plaque: How Often
  Presenter(s):Andrew N. Nicolaides, MS, FRCS / Stavros Kakkos, MD, PhD  
  View Slides in PDF      
2:37 PM - 2:42 PM What Is New In The Effects Of Carotid Disease And Carotid Treatments (CEA And CAS) On Cognitive Function: Are There Differences Between CEA And CAS
  Presenter(s):Wei Zhou, MD  
  View Slides in PDF      
2:43 PM - 2:48 PM Tips And Tricks For Obtaining Distal Exposure Of The Internal Carotid Artery – To The Skull Base: Your ENT Surgeon Colleagues Can Help
  Presenter(s):Ross Naylor, MD, FRCS  
  View Slides in PDF      
2:49 PM - 2:55 PM Panel Discussion
2:55 PM - 3:05 PM Break – Visit Exhibits And Pavilions (2nd and 3rd Floors)
END OF SESSION 5
 
SESSION 6 SCHEDULE
Tuesday
SESSION 6: EXCITING PROGRESS IN THE TREATMENT OF ACUTE STROKES
x
3:05 PM - 3:10 PM Urgent CEA And CAS Are Safe And Without A Bleeding Risk After A Small-To-Moderate Sized Stroke Is Treated By Thrombolysis
  Presenter(s):Hernan Bazan, MD, FACS  
  View Slides in PDF      
3:11 PM - 3:16 PM Carotid Interventions (CEA/CAS) In Acute Stroke Patients: Which Procedure On Which Patient And When
  Presenter(s):R. Clement Darling III, MD  
  View Slides in PDF      
3:17 PM - 3:22 PM Emergency CEA For Stroke In Evolution: When Is It Indicated And How Should It Be Done
  Presenter(s):Hans-Henning Eckstein, MD, PhD  
  View Slides in PDF      
3:23 PM - 3:28 PM Recent Progress In Endovascular Intracranial Treatment Of Acute Ischemic Strokes: Dramatic Positive Results Of ESCAPE, SWIFT-PRIME, EXTEND – IA, REVASCAT And MR CLEAN Trials: Why Are These Trials Positive And When Should Patients Be Treated And When Not
  Presenter(s):L. Nelson Hopkins, MD  
  View Slides in PDF      
3:29 PM - 3:34 PM Results And Techniques Of The ADAPT-FAST Trial Of A Newer Better Thrombus Removal Method For Treating Acute Strokes
  Presenter(s):Alejandro M. Spiotta, MD  
  View Slides in PDF      
3:35 PM - 3:40 PM New Developments In The Treatment Of Acute Strokes: It Is A New Treatment Horizon: Tips, Tricks, And Precautions And The Importance Of Balloon Tipped Guide Catheters To Decrease Prograde Flow During Clot Removal
  Presenter(s):Klaus D. Mathias, MD  
  View Slides in PDF      
3:41 PM - 3:46 PM Critical Elements In Stroke Interventions And Who Should Be In The Game
  Presenter(s):Colin P. Derdeyn, MD  
  View Slides in PDF      
3:47 PM - 3:52 PM Comments On Acute Stroke Treatment From A Pioneer: Why Others Than Neurointerventionists Must Be Involved And How Can They Be Trained
  Presenter(s):Horst Sievert, MD  
  View Slides in PDF      
3:53 PM - 3:59 PM Panel Discussion
END OF SESSION 6
 
SESSION 7 SCHEDULE
Tuesday
SESSION 7: MORE ABOUT TBADs, THORACIC ANEURYSMS AND TEVAR
x
4:00 PM - 4:05 PM DEBATE: Stent-Grafts And Endovascular Repair Are Usually A Poor Option For Treating Aneurysm Patients With Connective Tissue Disorders
  Presenter(s):Michael J. Jacobs, MD  
  View Slides in PDF      
4:06 PM - 4:11 PM DEBATE: Stent-Grafts And Endovascular Repair Can Be A Reasonable Option For Treating Aneurysm Patients With Connective Tissue Disorders And Ehlers-Danlos Syndrome
  Presenter(s):Vicente Riambau, MD, PhD  
  View Slides in PDF      
4:12 PM - 4:17 PM How To Fix Endoleaks From 2° Intimal Tears At The Celiac Axis And SMA After Remote TEVAR For TBADs
  Presenter(s):Ronald M. Fairman, MD  
  View Slides in PDF      
4:18 PM - 4:23 PM F/B EVAR To Treat Thoracoabdominal Dissections And Post Dissection TAAAs: Indications, Contraindications And Pitfalls
  Presenter(s):Stephan Haulon, MD  
  View Slides in PDF      
4:24 PM - 4:29 PM Saccular vs. Fusiform Configurations In Thoracic Aortic Aneurysms (TAAs): Does It Matter
  Presenter(s):Frank J. Criado, MD, FACS, FSVM  
  View Slides in PDF      
4:30 PM - 4:35 PM DEBATE: For Arch And Thoracic Aortic Lesions That Are Embolizing, When Anticoagulation, When Bare Stent, When Endograft
  Presenter(s):Ramesh K. Tripathi, MD, FRCS, FRACS  
  View Slides in PDF      
4:36 PM - 4:41 PM DEBATE: For Aortic Lesions That Are Embolizing, Endograft Treatment Is Generally The Best And Most Durable Treatment
  Presenter(s):Michel Makaroun, MD  
  View Slides in PDF      
4:42 PM - 4:48 PM Panel Discussion
END OF SESSION 7
 
SESSION 8 SCHEDULE
Tuesday
SESSION 8: HOW SHOULD MOST PATIENTS WITH UNCOMPLICATED ACUTE TBAD BE TREATED: CONTROVERSY EXISTS AND WILL CONTINUE: THE PROS AND CONS OF EARLY TEVAR
x
FOR EARLY TEVAR
4:48 PM - 4:53 PM Most Patients With Acute/Subacute Uncomplicated TBADs Should Undergo TEVAR: The INSTEAD-XL RCT Shows Better Long-Term Survival With TEVAR Than With Medical Treatment
  Presenter(s):Christoph A. Nienaber, MD, PhD  
  View Slides in PDF      
4:54 PM - 4:59 PM Most Patients With Acute Uncomplicated TBAD Should Receive TEVAR Treatment: I Have Said It Before – Now I Know It Is True And No More Trials Are Needed
  Presenter(s):Rodney A. White, MD  
5:00 PM - 5:05 PM Most Patients With Uncomplicated Acute TBAD Should Be Treated By TEVAR: Some Immediately And Some After A 6-12 Week Delay: How Can They Be Selected For Each Based On Data From The MOTHER Registry
  Presenter(s):Matt M. Thompson, MD  
  View Slides in PDF      
5:06 PM - 5:11 PM With Uncomplicated Acute TBAD There Is A High Risk Group That Should Be Treated By TEVAR: How Can They Be Selected And When Should They Be Treated
  Presenter(s):Michael D. Dake, MD  
  View Slides in PDF      
5:12 PM - 5:17 PM Medical Treatment Is Adequate For Most Patients With Uncomplicated TBAD Based On Current Long-Term Results
  Presenter(s):John A. Elefteriades, MD  
  View Slides in PDF      
5:18 PM - 5:23 PM The ADSORB Trial Tells Us What We Need To Know About Treating Uncomplicated TBADs: We Don’t Need Further Trials
  Presenter(s):Jan S. Brunkwall, MD, PhD  
  View Slides in PDF      
5:24 PM - 5:29 PM We Still Need More Evidence Before We Treat Most Uncomplicated Acute/Subacute TBAD Patients With TEVAR
  Presenter(s):Michel Makaroun, MD  
  View Slides in PDF      
5:30 PM - 5:35 PM Why Wider Use Of TEVAR For Uncomplicated TBADs Right Now May Not Be So Good
  Presenter(s):Frank J. Criado, MD, FACS, FSVM  
  View Slides in PDF      
5:36 PM - 5:41 PM The INTACT-AD RCT Comparing TEVAR With Medical Treatment Will Give The Final Answer About The Best Treatment For Uncomplicated Acute/Subacute TBAD Patients: We Need This International Trial And How Will It Be Structured
  Presenter(s):Firas F. Mussa, MD / Christoph A. Nienaber, MD, PhD  
  View Slides in PDF      
5:42 PM - 5:50 PM Panel Discussion

End of Program A

END OF SESSION 8
 
SESSION 9 SCHEDULE
Tuesday
SESSION 9: NEW DEVELOPMENTS IN AAAs AND EVAR
x
6:40 AM - 6:44 AM Opening Remarks
  Presenter(s):Frank J. Veith, MD  
  View Slides in PDF      
6:45 AM - 6:50 AM Can Anything Besides Smoking Cessation Slow AAA Enlargement
  Presenter(s):Frank A. Lederle, MD  
  View Slides in PDF      
6:51 AM - 6:56 AM Redefining Adverse Neck Morphology With Newer EVAR Devices Which Perform Better In Short, Angulated And Large Diameter Necks And Those With A Thrombus Burden: What Are The Limits: From The ENGAGE Registry
  Presenter(s):Hence J.M. Verhagen, MD, PhD  
  View Slides in PDF      
6:57 AM - 7:02 AM Parallel Grafts To Revascularize Critical IMAs And Ectopic Renal Arteries When They Must Be Preserved: How To Do It
  Presenter(s):Konstantinos P. Donas, MD  
  View Slides in PDF      
7:03 AM - 7:08 AM How Will The Decreased Frequency And Increased Complexity Of Open AAA Repair Affect Vascular Surgery Training: What Can Be Done About It
  Presenter(s):Jeffrey E. Indes, MD  
  View Slides in PDF      
7:09 AM - 7:14 AM World’s Largest AAA Repair: All Large AAAs Do Not Rupture
  Presenter(s):Dainis K. Krievins, MD / Christopher K. Zarins, MD  
  View Slides in PDF      
7:15 AM - 7:20 AM EVAR For All AAA Patients: We Are Going Too Far: Some Large Aneurysms Should Not Be Fixed: Some Should Be Fixed By Open Repair
  Presenter(s):Frank J. Criado, MD, FACS, FSVM  
  View Slides in PDF      
7:21 AM - 7:26 AM Outcomes Of EVAR For Inflammatory AAAs Are Favorable
  Presenter(s):Furuzan Numan, MD  
  View Slides in PDF      
7:27 AM - 7:32 AM Toward 15-Year Results Of The EVAR Trials And Individual Patient Data (IPD) Meta-Analysis With The DREAM, ACE And OVER Trials
  Presenter(s):Roger M. Greenhalgh, MD  
  View Slides in PDF      
7:33 AM - 7:38 AM Long-Term Results Of EVAR Are Better Than We Thought – Particularly With The Newer EVAR Devices
  Presenter(s):Timur P. Sarac, MD  
  View Slides in PDF      
7:39 AM - 7:46 AM Panel Discussion
END OF SESSION 9
 
SESSION 10 SCHEDULE
Tuesday
SESSION 10: NEW DEVELOPMENTS IN THE TREATMENT OF AORTIC BRANCH LESIONS – ESPECIALLY OF THE AORTO-ILIAC SEGMENT - AND TRAUMATIC AORTIC INJURY
x
7:46 AM - 7:51 AM Iliac Artery Endofibrosis In Hardcore Cyclists: Is Endovascular Treatment Ever Effective If They Won’t Give Up Their Sport Or Is Surgery The Only Effective Treatment: What Should The Operative Treatment Be
  Presenter(s):Kenneth J. Cherry, MD  
  View Slides in PDF      
7:52 AM - 7:57 AM Retrograde Open Superior Mesenteric Artery Stenting For Acute Mesenteric Ischemia: Indications, Techniques And Results
  Presenter(s):Richard J. Powell, MD  
  View Slides in PDF      
7:58 AM - 8:03 AM Parallel Grafts For Hypogastric Artery Revascularization During EVAR: Techniques, Advantages And Disadvantages
  Presenter(s):Ronald L. Dalman, MD  
  View Slides in PDF      
8:04 AM - 8:09 AM What Factors Predict When Treatment Of Blunt Traumatic Aortic Injuries Can Safely Be Delayed
  Presenter(s):Robert S. Crawford, MD / Donald G. Harris, MD  
  View Slides in PDF      
8:10 AM - 8:14 AM Panel Discussion
TREATMENT OF AORTO-ILIAC OCCLUSIVE DISEASE
Moderator(s): Barry T. Katzen, MD / Kenneth Ouriel, MD, MBA  
8:14 AM - 8:19 AM In Claudication Due To Aorto-Iliac Disease, Supervised Exercise Is As Effective As Stenting When Added To BMRx: What Can Make Exercise Work And Why It Is Good Treatment: The CLEVER RCT Results
  Presenter(s):Alan T. Hirsch, MD  
  View Slides in PDF      
8:20 AM - 8:25 AM With Juxtarenal Aorto-Iliac Occlusions Open Surgical Treatment Is Best And Safest: What Precautions May Be Needed
  Presenter(s):Giustino Marcucci, MD  
  View Slides in PDF      
8:26 AM - 8:31 AM Most Aorto-Iliac Occlusions Should Be Treated Endovascularly With Stents: But There Are Limits That Require Open Surgery
  Presenter(s):George H. Meier III, MD  
  View Slides in PDF      
8:32 AM - 8:37 AM All Aorto-Iliac Occlusions Can Be Treated Endovascularly By Stents – If Certain Precautions Are Taken To Prevent Renal And Visceral Embolization
  Presenter(s):Sonia Ronchey, MD, PhD / Nicola Mangialardi, MD  
  View Slides in PDF      
8:38 AM - 8:43 AM Complex Juxtarenal Aorto-Iliac Occlusions Can Be Treated Safely And Effectively With Covered Stents (The CERAB Technique) – However Renal Chimney Endografts May Be Required: Technique For Doing Them Without Risking Renal Or Visceral Embolization
  Presenter(s):Peter C.J. Goverde, MD / Michel M.P. Reijnen, MD, PhD  
  View Slides in PDF      
8:44 AM - 8:49 AM The CERAB Technique Using Covered Stents Is Better Treatment For Complex Aorto-Iliac Occlusions Than Bare Stents: Based On Flow Characteristics In An In Vitro Model
  Presenter(s):Michel M.P. Reijnen, MD, PhD / Peter C.J. Goverde, MD  
  View Slides in PDF      
8:50 AM - 8:55 AM Value Of Fusion Imaging To Facilitate Treatment Of Complex Aorto-Iliac Occlusions
  Presenter(s):Klaus M. Overbeck, MD, MPhil  
  View Slides in PDF      
8:56 AM - 9:01 AM Treatment Of TASC C And D Aorto-Iliac Occlusions With A Bifurcated Unibody Endograft (AFX – Endologix) Rather Than Kissing Stents Or Stent-Grafts: Technique And Early Results
  Presenter(s):Thomas S. Maldonado, MD / Michel M.P. Reijnen, MD, PhD  
  View Slides in PDF      
9:02 AM - 9:09 AM Panel Discussion
END OF SESSION 10
 
SESSION 11 SCHEDULE
Tuesday
SESSION 11: VASCULAR LAPAROSCOPY, SOME ROBOTICS AND OPEN SURGERY SKILLS
x
9:09 AM - 9:14 AM The Da Vinci Robot Facilitates Laparoscopic Aorto-Femoral Bypass For Occlusive Disease: Will It Displace Endovascular Techniques
  Presenter(s):Jean-Marc Alsac, MD, PhD / Salma El Batti, MD  
  View Slides in PDF      
9:15 AM - 9:20 AM Status Of Retroperitoneoscopic Techniques In Vascular Surgery: They Have Value But Will They Catch On
  Presenter(s):Bernard J. Segers, MD  
  View Slides in PDF      
9:21 AM - 9:26 AM A Propensity Score Matched Comparison Of Laparoscopic And Open Repair Of AAAs In Poor Candidates For EVAR: Is Laparoscopic Repair Better And Worth Learning
  Presenter(s):Jean-Baptiste Ricco, MD, PhD  
  View Slides in PDF      
9:27 AM - 9:32 AM DEBATE: Laparoscopy And Articulated Robots For Aortic Surgery Is A Failed Experiment
  Presenter(s):Willem Wisselink, MD  
  View Slides in PDF      
9:33 AM - 9:38 AM DEBATE: Laparoscopic Robotic Aortic Surgery Is Not Dead But Has A Bright Future: What Will It Be And What Is The Evidence
  Presenter(s):Fabien Thaveau, MD, PhD  
  View Slides in PDF      
9:39 AM - 9:44 AM Open AAA Repair Is Becoming A Lost Art: Why And What Can Be Done About It: Tips And Tricks For Learning It And For Doing It Well
  Presenter(s):Edward Y. Woo, MD  
  View Slides in PDF      
9:45 AM - 9:51 AM Panel Discussion
9:51 AM - 10:05 AM Break – Visit Exhibits And Pavilions (2nd and 3rd Floors)
END OF SESSION 11
 
SESSION 12 SCHEDULE
Tuesday
SESSION 12: UPDATE ON OPTIMAL TREATMENT METHODS FOR JUXTARENAL AND PARARENAL AAAs: IT IS STILL CONTROVERSIAL AND OTHER NEW DEVELOPMENTS IN TAAA TREATMENT, TEVAR AND TBAD
x
ADVOCACY FOR SEVERAL METHODS OF JUXTA AND PARARENAL AAA REPAIR
10:05 AM - 10:10 AM Open Repair Is The Procedure Of Choice For Juxta- And Pararenal AAAs: By What Approach
  Presenter(s):Michael S. Conte, MD  
  View Slides in PDF      
10:11 AM - 10:16 AM Fenestrated And Branched Grafts With EVAR (F/B EVAR) Is The Best Approach For Juxta- And Pararenal AAAs
  Presenter(s):Timothy A.M. Chuter, DM  
  View Slides in PDF      
10:17 AM - 10:22 AM Endografts With Parallel Grafts (Chimneys Or Periscopes) To The Renovisceral Arteries Are The Best Treatment For Juxta- Or Pararenal AAAs: Tips And Tricks For Doing Them Right
  Presenter(s):Zoran Rancic, MD, PhD / Mario L. Lachat, MD  
  View Slides in PDF      
10:23 AM - 10:28 AM For Juxta- And Pararenal AAAs Sometimes Chimney EVAR Is Best And When; Sometimes Fenestrated EVAR (F/EVAR With Z-Fen Endograft) Is Best And When: The Two Techniques Are Complementary
  Presenter(s):Jason T. Lee, MD  
  View Slides in PDF      
10:29 AM - 10:34 AM Use Of Parallel Grafts With EVAR To Treat Juxta- And Pararenal AAAs: A Simple Safe Technique
  Presenter(s):David J. Minion, MD  
  View Slides in PDF      
10:35 AM - 10:40 AM For Juxta- And Pararenal AAAs And Failed Standard EVARs Chimney EVAR Is Effective Midterm: Technical Tips And Tricks For Performing With Endurant Aortic Endografts: From The PROTAGORAS Registry
  Presenter(s):Konstantinos P. Donas, MD / Giovanni Torsello, MD  
  View Slides in PDF      
10:41 AM - 10:46 AM Late Results Of Parallel Grafts (Chimneys) For Juxta- And Pararenal AAAs Can Be Good If Done Right: Self-Expanding vs. Balloon-Expanding Branch Stents: Which Is Best
  Presenter(s):Ralf R. Kolvenbach, MD  
  View Slides in PDF      
OTHER RELATED TOPICS
10:47 AM - 10:52 AM New Concepts And Improvements In Fenestrated Aortic Endografts And Improvements In Imaging For F/BEVAR With Fusion And IVUS
  Presenter(s):Mark A. Farber, MD  
  View Slides in PDF      
10:53 AM - 10:58 AM Perils Of The Widespread Use Of FEVAR: All Results Are Not Good
  Presenter(s):Christopher J. Abularrage, MD  
  View Slides in PDF      
10:59 AM - 11:04 AM Tips For Decreasing The Learning Curve For Performing F/BEVAR
  Presenter(s):Andres Schanzer, MD  
  View Slides in PDF      
11:05 AM - 11:10 AM Value Of Ultrasound (Duplex) In Surveillance Of Renal Artery Branches After B/FEVAR For Juxta- And Pararenal AAAs
  Presenter(s):Martin R. Back, MD  
  View Slides in PDF      
11:11 AM - 11:19 AM Panel Discussion
TAAA TREATMENT, TEVAR AND TBAD RELATED TOPICS
Moderator(s): Mark A. Farber, MD / James F. McKinsey, MD  
11:20 AM - 11:25 AM Novel Simplified Endograft Device With Off-The-Shelf Potential For Treatment Of TAAAs: The Gore TAMBE Device: How It Works And Early Clinical Results
  Presenter(s):Pierre Galvagni Silveira, MD, PhD  
  View Slides in PDF      
11:26 AM - 11:31 AM Avoiding Pitfalls In Sizing The Diameter Of Endografts For TEVAR: The Timing Of Gated CT Scans Matters
  Presenter(s):Juan C. Parodi, MD  
  View Slides in PDF      
11:32 AM - 11:37 AM Goals Of Treatment For Complicated And Uncomplicated TBAD: Value Of IVUS And Other Tips And Tricks For Getting Good Outcomes: From A Large Single Center Experience
  Presenter(s):Ali Azizzadeh, MD / Hazim J. Safi, MD  
  View Slides in PDF      
11:38 AM - 11:43 AM Value Of Chimney Grafts In Aortic Arch Repairs For Dissections And For Aneurysms: Pros And Cons
  Presenter(s):Jan S. Brunkwall, MD, PhD  
  View Slides in PDF      
11:44 AM - 11:49 AM Open And Endovascular Treatment Of Lusorian Artery (Ectopic Right SCA) And Associated Aneurysms (Kommerell’s Diverticulum)
  Presenter(s):Michael J. Jacobs, MD  
  View Slides in PDF      
11:50 AM - 12:00 PM Panel Discussion
Visit Exhibits And Pavilions (2nd and 3rd Floors)

12:00 PM - 1:00 PM Lunch Break – 2nd Floor Promenade
Visit Exhibits And Pavilions (2nd and 3rd Floors)

END OF SESSION 12
 
SESSION 13 SCHEDULE
Tuesday
SESSION 13: OUTPATIENT VASCULAR AND BUSINESS ISSUES
x
1:00 PM - 1:05 PM Midterm Results Of Endovascular Treatment Of Common Femoral Artery Occlusive Disease Performed In An Outpatient Setting: It Works And Why
  Presenter(s):Sam S. Ahn, MD, FACS, MBA  
  View Slides in PDF      
1:06 PM - 1:11 PM Advantages And Limitations Of Same Day Discharge For Patients Undergoing EVAR: When Is It Safely Possible And When Not
  Presenter(s):Maciej L. Dryjski , MD, PhD / Linda Harris, MD  
  View Slides in PDF      
1:12 PM - 1:17 PM Office Based Lower Extremity Endovascular Treatment Is Safe, Effective And Cost-Saving: How To Prevent Operator Conflict Of Interest And Patient Abuse: The NY Times Is Not Always Right
  Presenter(s):Miguel F. Montero-Baker, MD  
  View Slides in PDF      
1:18 PM - 1:23 PM 4-French Infrainguinal Interventions In An Outpatient Setting Are Safer And Effective: What Equipment Is Needed
  Presenter(s):Jos C. van den Berg, MD, PhD  
  View Slides in PDF      
1:24 PM - 1:29 PM With Lower Extremity Revascularization Procedures Increased Cost Does Not Improve Outcomes: What Risk Factors Increase Costs And How Should This Influence Treatment
  Presenter(s):Richard J. Powell, MD  
  View Slides in PDF      
1:30 PM - 1:35 PM Outpatient Vascular (Angio) Centers: Are They Leading To Unethical Vascular Practices And Harming Patients: What Can Be Done About It
  Presenter(s):Stephen M. Bauer, MD  
  View Slides in PDF      
1:36 PM - 1:41 PM Importance Of An Office Based Practice To SVS Members And Vascular Surgeons: How Can The Conflict Of Interest (COI) Issue Be Dealt With Fairly
  Presenter(s):Kim J. Hodgson, MD  
  View Slides in PDF      
1:42 PM - 1:47 PM Assuring Quality Care In An Office Based Setting: Tips And Tricks For Opening An Outpatient Vascular Center And Doing It Right To Avoid Unmonitored And Unnecessary Procedures – As Described In The NY Times
  Presenter(s):Krishna Jain, MD  
  View Slides in PDF      
1:48 PM - 1:53 PM Centers For Amputation Prevention Have Clinical And Financial Advantages And Fill A Need: How To Set One Up And What Is Needed
  Presenter(s):Richard F. Neville, MD  
  View Slides in PDF      
1:54 PM - 2:00 PM Panel Discussion
END OF SESSION 13
 
SESSION 14 SCHEDULE
Tuesday
SESSION 14: NEW TECHNIQUES, CONCEPTS AND UPDATES
x
2:00 PM - 2:05 PM Can Spiral Intermittent Limb Compression Be An Effective Treatment For CLI And Heart Failure
  Presenter(s):Magdiel Trinidad Vasquez, MD  
  View Slides in PDF      
2:06 PM - 2:11 PM Role Of Increased Shear Stress In Leading To Thrombosis: Mechanism And Significance For Vascular Devices And Reconstructions
  Presenter(s):David H. Deaton, MD, FACS  
  View Slides in PDF      
2:12 PM - 2:17 PM Telemedicine For Vascular Surgery: Is It Feasible: What Is Its Status And What Are Its Limitations And Risks
  Presenter(s):Clifford M. Sales, MD, MBA, FACS / Jonathan Levison, MD  
  View Slides in PDF      
2:18 PM - 2:23 PM Impact Of Delay In Treatment On Outcomes For CLI: For AAAs
  Presenter(s):Katariina M. Noronen, MD  
  View Slides in PDF      
2:24 PM - 2:29 PM Pneumatic Compression And Other Tricks For Brachial Access Hemostasis After Large Sheath Insertion
  Presenter(s):Rajiv Parakh, MBBS, MS, FRCS  
  View Slides in PDF      
2:30 PM - 2:35 PM Transradial Access For Renal, Visceral And Lower Extremity Interventions: Equipment Needed, Tips And Tricks
  Presenter(s):Robert A. Lookstein, MD, FSIR, FAHA  
  View Slides in PDF      
2:36 PM - 2:41 PM Horizon And Nexus Endografts: A New Concept For Branch Endografting In The Thoracic And Abdominal Aorta
  Presenter(s):Mario L. Lachat, MD  
  View Slides in PDF      
2:42 PM - 2:47 PM OCT (Optical Coherence Tomography) To Improve Crossing Of CTOs And Treatment By OCT Directed Atherectomy: The Avinger Pantheris Device And Its Results And How They Correlate With Plaque Histology
  Presenter(s):Patrick E. Muck, MD, FACS / John B. Simpson, MD, PhD  
  View Slides in PDF      
2:48 PM - 2:53 PM Status Of Left Atrial Appendage Occlusive Devices To Prevent Strokes: Who Should Get Them
  Presenter(s):Aamir S. Shah, MD / Ali Khoynezhad, MD, PhD  
  View Slides in PDF      
2:54 PM - 2:59 PM Arteries And Grafts On Fire: Value And Limitations Of 18F-FDG PET CT In Diagnosing Arteritis And Graft Infections
  Presenter(s):Hisham Rashid, FRCS, FRCS(Gen)  
  View Slides in PDF      
3:00 PM - 3:05 PM Update On Gaining Arterial Access For EVAR And TEVAR With Challenging Aorto-Iliac Anatomy: Tips And Tricks For Conduits And Direct Aortic Or Common Iliac Sheath Placement
  Presenter(s):Jeffrey P. Carpenter, MD  
  View Slides in PDF      
3:06 PM - 3:20 PM Panel Discussion And Break
Visit Exhibits And Pavilions (2nd and 3rd Floors)

END OF SESSION 14
 
SESSION 15 SCHEDULE
Tuesday
SESSION 15: RENAL AND VISCERAL ARTERY ISSUES
x
RENAL ARTERY ISSUES
3:20 PM - 3:25 PM Current Status Of Renal Artery Stenting In Children And Adults: When Is It The Treatment Of Choice And What Is Its Future
  Presenter(s):Thomas A. Sos, MD  
  View Slides in PDF      
3:26 PM - 3:31 PM IV DSA Is The Best Way To Assess Occlusive Disease Of The Aorta And Its Branches In Children: Embolization May Be Best Treatment For Segmental Renal Artery Stenosis Causing Hypertension
  Presenter(s):Kyung Cho, MD  
  View Slides in PDF      
3:32 PM - 3:37 PM Value Of DEBs To Treat Renal Artery Lesions, Recurrent Lesions And ISR
  Presenter(s):Fabrizio Fanelli, MD, EBIR  
  View Slides in PDF      
3:38 PM - 3:43 PM Open Renal Revascularization Can Salvage Failed Renal PTAs And Stents And Do So Durably: Tips And Tricks For These Operations
  Presenter(s):Thomas C. Bower, MD  
  View Slides in PDF      
3:44 PM - 3:49 PM Acute Renal Artery Occlusions: Causes; How To Treat And How Long After An Acute Occlusion Can Kidneys Be Salvaged With Good Function: Mechanism For Such Salvage After Long Delays
  Presenter(s):Samy S. Nitecki, MD  
  View Slides in PDF      
3:50 PM - 3:55 PM Renal Artery Aneurysms Rarely Rupture EVEN When >2 cm: How Fast Do They Grow: When And How Should They Be Fixed
  Presenter(s):Peter F. Lawrence, MD  
  View Slides in PDF      
VISCERAL ARTERY ISSUES
3:56 PM - 4:01 PM 10-Year Natural History Study Of Splanchnic Aneurysms (Splenic, Hepatic, Gastroduodenal And Mesenteric): When Should They Be Fixed And How
  Presenter(s):Mark Conrad, MD, MMSc  
  View Slides in PDF      
4:02 PM - 4:07 PM Endovascular Approaches To Treatment Of Giant Visceral Aneurysms (Up To 10 cm)
  Presenter(s):Michele Rossi, MD  
  View Slides in PDF      
4:08 PM - 4:13 PM Best Current Treatment For Mesenteric Ischemia: When Endo, When Open, When Hybrid
  Presenter(s):Timur P. Sarac, MD  
  View Slides in PDF      
4:14 PM - 4:19 PM Median Arcuate Ligament Syndrome: How To Diagnose And When And How To Treat Open, Laparoscopic Or Endovascularly: Does Treatment Work And How Should The Celiac Axis Be Managed
  Presenter(s):Alan M. Dietzek, MD, RPVI, FACS / Keith D. Calligaro, MD  
  View Slides in PDF      
4:30 PM - 4:26 PM Panel Discussion
END OF SESSION 15
 
SESSION 16 SCHEDULE
Tuesday
SESSION 16: TOPICS RELATED TO OPEN SURGERY AND THE TREATMENT OF AORTIC COARCTATIONS
x
OPEN SURGERY TOPICS
4:26 PM - 4:31 PM New Improved Techniques For Open TAAA Repair: Better Organ Protection And Using Hybrid (Gore) Stent Graft For Faster Branch Revascularization
  Presenter(s):Yamume Tshomba, MD / Roberto Chiesa, MD / Enrico M. Marone, MD  
  View Slides in PDF      
4:32 PM - 4:37 PM An Important Role For Open Surgery Exists For AAAs In 2015 And It Will In The Future
  Presenter(s):Arno von Ristow, MD  
  View Slides in PDF      
4:38 PM - 4:43 PM Prevention Of Incisional Hernias After Open AAA Repairs Via A Midline Laparotomy Incision By Mesh Augmented Primary Closure (The PRIMAAT Trial): Technique And Material
  Presenter(s):Isabelle van Herzeele, MD, PhD / Frederik Berrevoet, MD / Filip Muysoms, MD  
  View Slides in PDF      
4:44 PM - 4:49 PM The Worst Patients For EVAR Are The Best For A Mini-Laparotomy Open Repair: How Is It Done
  Presenter(s):Francesco Spinelli, MD  
  View Slides in PDF      
4:50 PM - 4:55 PM Newer Innovations And Technical Tips And Tricks For Anterior Spine Exposure And Large Vessel Mobilization: What Vascular Surgeons Need To Know
  Presenter(s):Bauer E. Sumpio, MD, PhD  
  View Slides in PDF      
4:56 PM - 5:01 PM Open Retroperitoneal Exposure Of The Entire Abdominal Aorta And Its Branches Via A Left Retroperitoneal Approach (Video Presentation)
  Presenter(s):William J. Quinones-Baldrich, MD  
  View Slides in PDF      
5:02 PM - 5:07 PM Advantages And Disadvantages Of Hybrid Repair For Thoracoabdominal Aortic Aneurysms (TAAAs): Tips And Tricks For Doing It Right
  Presenter(s):Sebastian E. Debus, MD, PhD  
  View Slides in PDF      
5:08 PM - 5:13 PM Challenges And Results Of Open Repairs Of Residual TAAAs Distal To Prior TEVAR For TBADs
  Presenter(s):Manju Kalra, MBBS  
  View Slides in PDF      
5:14 PM - 5:19 PM Some CLI In Hemodialysis Patients Is Best Treated By Open Bypass Rather Than An Endovascular Procedure: Which Patients With What Anatomy
  Presenter(s):Mark G. Davies, MD  
  View Slides in PDF      
5:20 PM - 5:26 PM Panel Discussion
AORTIC COARCTATION TOPICS
Moderator(s): Hazim J. Safi, MD / Elchanan Bruckheimer, MBBS  
5:26 PM - 5:31 PM DEBATE: For Adult Coarctations And Their Complications When Is Endo OK And When Is Open Surgery Needed: What Are The Best And Safest Procedures
  Presenter(s):Joseph E. Bavaria, MD  
5:32 PM - 5:37 PM DEBATE: Adult Coarctations And Complications Of Previous Coarctation Repairs Are Best Treated Endovascularly But One Must Be Innovative
  Presenter(s):Jan S. Brunkwall, MD, PhD  
  View Slides in PDF      
5:38 PM - 5:43 PM 5-Year Results With Balloon-Expandable Stent-Grafts In The Treatment Of Adult Aortic Coarctations
  Presenter(s):Elchanan Bruckheimer, MBBS  
  View Slides in PDF      
5:44 PM - 5:49 PM TEVAR Treatment Of Patch Aneurysms And Other Complications Of Prior Open Repairs: Advantages, Limitations And Precautions
  Presenter(s):Dittmar Boeckler, MD  
  View Slides in PDF      
5:50 PM - 5:55 PM New Generation Stent-Grafts For Treating Complications Of Aortic Coarctation Repairs: The Landscape Is Changing
  Presenter(s):Colin D. Bicknell, MD, FRCS  
  View Slides in PDF      
5:56 PM - 6:03 PM Panel Discussion

End of Program B

END OF SESSION 16
 
SESSION 17 SCHEDULE
Tuesday
SESSION 17: MANAGEMENT OF PULMONARY EMBOLISM: THE MOMENTUM FOR EFFECTIVE TREATMENT IS REAL – PART 1
Moderators:Michael R. Jaff, DO  
x
7:00 AM - 7:05 AM Introduction To The Symposium
  Presenter(s):Frank J. Veith, MD  
  View Slides in PDF      
7:05 AM - 7:15 AM Welcome And Introduction
  Presenter(s):Michael R. Jaff, DO  
7:15 AM - 7:25 AM The Basics Of Pulmonary Embolism: What Is The Role Of The History, Exam, Biomarkers?
  Presenter(s):Ido Weinberg, MD, MSc  
  View Slides in PDF      
7:25 AM - 7:35 AM The Basics Of Echocardiography For PE: What Must The Vascular Specialist Know, And Is An Emergent Echo Necessary
  Presenter(s):David M. Dudzinski, MD  
  View Slides in PDF      
7:35 AM - 7:50 AM What Is State-Of-The-Art Medical Therapy For PE
  Presenter(s):Geno J. Merli, MD, MACP, FHM, FSVM  
  View Slides in PDF      
7:50 AM - 8:00 AM Intravenous Thrombolytic Therapy For PE: Does It Work Acutely
  Presenter(s):Christopher Kabrhel, MD, MPH  
  View Slides in PDF      
8:00 AM - 8:10 AM Catheter-Directed Thrombolysis For PE: What Are The Long-Term Outcomes
  Presenter(s):Rabih A. Chaer, MD  
  View Slides in PDF      
8:10 AM - 8:25 AM Percutaneous Pharmacomechanical Intervention For PE: Do We Really Know About The Hows And Whens
  Presenter(s):Nils Kucher, MD  
  View Slides in PDF      
8:25 AM - 8:35 AM Lysis For PE - What About The Nuts And Bolts: Heparin, PTT And Fibrinogen Monitoring, And How Do You Know When You Are Done
  Presenter(s):Raghu Kolluri, MD  
  View Slides in PDF      
8:35 AM - 8:45 AM Technical Tips For Pharmacomechanical Intervention For PE: How Do I Do It
  Presenter(s):Jeffrey Y. Wang, MD  
  View Slides in PDF      
Moderator(s): Michael R. Jaff, DO  
8:45 AM - 9:15 AM Case Presentations/Discussion/Questions And Answers
  Panelist(s): Rabih A. Chaer, MD / Christopher Kabrhel, MD, MPH / Raghu Kolluri, MD / Nils Kucher, MD / Geno J. Merli, MD, MACP, FHM, FSVM / Jeffrey Y. Wang, MD / Ido Weinberg, MD, MSc  
  View Slides in PDF      
9:15 AM - 9:45 AM Break – Visit Exhibits And Pavilions (2nd and 3rd Floors)
END OF SESSION 17
 
SESSION 18 SCHEDULE
Tuesday
SESSION 18: MANAGEMENT OF PULMONARY EMBOLISM: THE MOMENTUM FOR EFFECTIVE TREATMENT IS REAL – PART 2
Moderators:Michael R. Jaff, DO  
x
9:45 AM - 9:55 AM PE Without DVT: What Does It Mean And Does It Matter
  Presenter(s):Anil P. Hingorani, MD  
  View Slides in PDF      
9:55 AM - 10:10 AM Percutaneous Thrombolysis And Thromboaspiration: The Impact Of Combination Therapy
  Presenter(s):Narendra N. Khanna, MD, DM, FRCP, FACC  
  View Slides in PDF      
10:10 AM - 10:20 AM Vortex Strategy For Massive PE
  Presenter(s):Christopher J. Kwolek, MD  
  View Slides in PDF      
10:20 AM - 10:30 AM ECMO And Surgical Thromboembolectomy For Massive PE: When, How And Why
  Presenter(s):Nicholas G. Smedira, MD  
  View Slides in PDF      
10:30 AM - 10:45 AM What Is The Modern Algorithm For Management Of Massive And Submassive PE
  Presenter(s):Nils Kucher, MD  
  View Slides in PDF      
10:45 AM - 11:00 AM Vena Cava Filters In PE Treatment: Do We Need To Do This, And If So, When
  Presenter(s):Robert A. Lookstein, MD, FSIR, FAHA  
  View Slides in PDF      
11:00 AM - 11:15 AM And Now For Something Completely Different: Catheter-Directed Thrombolysis In The Pediatric Population
  Presenter(s):Peter H. Lin, MD  
  View Slides in PDF      
11:15 AM - 11:30 AM The Team Approach To PE Management: The Emergence Of National PERT Centers
  Presenter(s):Kenneth Rosenfield, MD  
  View Slides in PDF      
Moderator(s): Michael R. Jaff, DO  
11:30 AM - 11:45 AM Challenging Cases And “PERT” Decisions
  Panelist(s): Anil P. Hingorani, MD / Nils Kucher, MD / Christopher J. Kwolek, MD / Peter H. Lin, MD / Robert A. Lookstein, MD, FSIR, FAHA / Kenneth Rosenfield, MD / Nicholas G. Smedira, MD  
  View Slides in PDF      
11:45 AM - 12:00 PM Questions And Answers
12:00 PM - 1:00 PM Lunch Break – 2nd Floor Promenade
Visit Exhibits And Pavilions (2nd and 3rd Floors)

END OF SESSION 18
 
SESSION 19 SCHEDULE
Tuesday
SESSION 19: RAPID EXPANSION OF OPPORTUNITIES FOR EFFECTIVE TREATMENT OF LARGE VEIN STENOSIS, THROMBOSIS, AND OCCLUSION
x
1:00 PM - 1:05 PM Lower Extremity Venous Occlusive Disease: A Rapidly Progressing Field With Major Opportunities For Improving Clinical Outcomes
  Presenter(s):Peter Gloviczki, MD  
  View Slides in PDF      
1:06 PM - 1:11 PM Large Vein Occlusive Disease: A Global Health Issue In 2015 And Beyond
  Presenter(s):Manj S. Gohel, MD, RCS, FEBVS  
  View Slides in PDF      
1:12 PM - 1:17 PM Quality Of Life Surveys In Patients Undergoing Intervention For Chronic Venous Disease: The Good, The Bad, And The Ugly
  Presenter(s):Cees H.A. Wittens, MD, PhD  
  View Slides in PDF      
1:18 PM - 1:23 PM Non-Thrombotic May-Thurner Syndrome: Defining Pathology Mandating Treatment From Normal Anatomy
  Presenter(s):Brian G. DeRubertis, MD  
  View Slides in PDF      
1:24 PM - 1:29 PM When And How Should Pelvic Venous Compression Syndromes Be Treated
  Presenter(s):David L. Gillespie, MD  
  View Slides in PDF      
1:30 PM - 1:35 PM Treating Iliofemoral DVT In Pregnancy: Anticoagulation Alone Is No Longer Acceptable In Most Patients
  Presenter(s):Anthony J. Comerota, MD, FACS, FACC  
  View Slides in PDF      
1:36 PM - 1:41 PM Role Of Inflammation In DVT: Its Relationship With Thrombosis
  Presenter(s):Thomas W. Wakefield, MD  
  View Slides in PDF      
1:42 PM - 1:47 PM Hemodynamics Of Venous Disease: Toward A Better Understanding And Consensus
  Presenter(s):Byung-Boong Lee, MD  
  View Slides in PDF      
1:48 PM - 1:53 PM Third Party Payment For Venous Interventions: Current Deliberations And Gazing Into The Crystal Ball
  Presenter(s):Sean P. Roddy, MD  
  View Slides in PDF      
1:54 PM - 1:59 PM Panel Discussion
END OF SESSION 19
 
SESSION 20 SCHEDULE
Tuesday
SESSION 20: ENDOVASCULAR INTERVENTIONS AND PHARMACOLOGIC REGIMENS FOR ACUTE LOWER EXTREMITY DVT: NEW EVIDENCE FOR CLINICAL SAFETY AND EFFECTIVENESS
x
2:00 PM - 2:05 PM ATTRACT Study Of rt-PA For Acute DVT: Almost 7 Years And Almost 700 Patients, Almost Done: What Will We Find
  Presenter(s):Anthony J. Comerota, MD, FACS, FACC  
  View Slides in PDF      
2:06 PM - 2:11 PM Acute DVT Should Be Managed With An Aggressive Interventional Approach: Large Experience From South Asia
  Presenter(s):Narendra N. Khanna, MD, DM, FRCP, FACC  
  View Slides in PDF      
2:12 PM - 2:17 PM Thrombolysis For DVT: Predictors Of Success
  Presenter(s):Rabih A. Chaer, MD  
  View Slides in PDF      
2:18 PM - 2:22 PM BERNUTIFUL: A Beautifully Designed Trial To Evaluate Ultrasound-Assisted Thrombolysis For DVT
  Presenter(s):Nils Kucher, MD / Iris Baumgartner, MD  
  View Slides in PDF      
2:23 PM - 2:28 PM How Long To Anticoagulate After DVT: Duplex Imaging Guides Treatment Duration
  Presenter(s):Timothy K. Liem, MD, MBA  
  View Slides in PDF      
2:29 PM - 2:34 PM Understanding The Genetics Of Warfarin Dosing And Implications For Safer Anticoagulant Therapy
  Presenter(s):Karthikeshwar Kasirajan, MD  
  View Slides in PDF      
2:35 PM - 2:40 PM New Oral Anticoagulants For Extending Treatment Of DVT: Do They Alter The Risk/Benefit Ratio
  Presenter(s):Anthony J. Comerota, MD, FACS, FACC  
  View Slides in PDF      
2:41 PM - 2:50 PM Panel Discussion
2:51 PM - 3:15 PM Break – Visit Exhibits And Pavilions (2nd and 3rd Floors)
END OF SESSION 20
 
SESSION 21 SCHEDULE
Tuesday
SESSION 21: NEW DEVICES FOR TREATING LARGE VEIN OCCLUSIVE DISEASE
x
3:16 PM - 3:21 PM The First Comparative Study Of Four Dedicated Stents For The Venous System
  Presenter(s):Rick De Graaf, MD, PhD  
  View Slides in PDF      
3:22 PM - 3:27 PM DEBATE: Marketed Stents Designed For Arteries Are More Than Adequate For Treating Venous Disease
  Presenter(s):Mark J. Garcia, MD  
  View Slides in PDF      
3:28 PM - 3:33 PM DEBATE: Arterial Stents Are Suboptimal In Veins: Newer Stents Designed For The Venous Side Are Mandatory
  Presenter(s):Seshadri Raju, MD  
  View Slides in PDF      
3:34 PM - 3:39 PM Cutting Balloon Angioplasty For Symptomatic Femoropopliteal Vein Stenoses
  Presenter(s):Thomas O. McNamara, MD  
  View Slides in PDF      
3:40 PM - 3:45 PM The Cook Zilver Vena Venous Stent: Update From The VIVO Trial
  Presenter(s):Anthony J. Comerota, MD, FACS, FACC  
  View Slides in PDF      
3:46 PM - 3:51 PM Early Experience With The Veniti VICI Venous Stent And Update On The VIRTUS Trial
  Presenter(s):William A. Marston, MD  
  View Slides in PDF      
3:52 PM - 3:57 PM Rapid Clearance Of Acute Thrombus From The Large Veins: The AngioVac System
  Presenter(s):David J. Dexter, MD  
  View Slides in PDF      
3:58 PM - 4:03 PM Ultrasound-Enhanced Thrombolysis For Older DVT: Update From The ACCESS Study
  Presenter(s):Mark J. Garcia, MD  
  View Slides in PDF      
4:04 PM - 4:09 PM Panel Discussion
END OF SESSION 21
 
SESSION 22 SCHEDULE
Tuesday
SESSION 22: THE INFERIOR VENA CAVA: CHALLENGES AND OPPORTUNITIES
x
4:10 PM - 4:15 PM Surgical Reconstruction Of The Iliocaval Segment: When And How
  Presenter(s):Peter Gloviczki, MD  
  View Slides in PDF      
4:16 PM - 4:21 PM Recanalization Of The Inferior Vena Cava: Technique And Results
  Presenter(s):Erin H. Murphy, MD / Seshadri Raju, MD  
  View Slides in PDF      
4:22 PM - 4:27 PM Advantages Of Robotic Vena Cava Surgery Over Traditional Techniques
  Presenter(s):Samuel R. Money, MD, MBA  
  View Slides in PDF      
4:28 PM - 4:33 PM Acute And Chronic IVC Occlusion: Why It Occurs And Options For Treatment
  Presenter(s):David L. Gillespie, MD  
  View Slides in PDF      
4:34 PM - 4:39 PM Massive DVT And Pulmonary Embolism: Early Institution Of ECMO And Aggressive Anticoagulant Improves Survival
  Presenter(s):Mark G. Davies, MD  
  View Slides in PDF      
4:40 PM - 4:45 PM Embolic Risk Of Percutaneous Thrombectomy And Thrombolysis For DVT: An IVC Filter Is Not Necessary
  Presenter(s):Peter H. Lin, MD  
  View Slides in PDF      
4:46 PM - 4:51 PM Newer, Safer Retrievable IVC Filter Designs Alter Risks And Rewards And Will Expand Applicability Indications
  Presenter(s):Richard G. McWilliams, FRCR, EBIR  
  View Slides in PDF      
4:52 PM - 5:00 PM Panel Discussion

End of Program C

END OF SESSION 22
 
SESSION 23 SCHEDULE
Wednesday
SESSION 23: LOWER EXTREMITY OCCLUSIVE DISEASE MANAGEMENT – HOT TOPICS AND NEW DEVELOPMENTS
x
6:40 AM - 6:45 AM Prosthetic (PTFE) Grafts Are As Good Or Better Than Non-Greater Saphenous Autologous Vein Grafts For Below The Knee (BTK) Bypasses
  Presenter(s):Rabih A. Chaer, MD  
  View Slides in PDF      
6:46 AM - 6:51 AM 12 Commandments To Make BTK Interventions For CLI Succeed
  Presenter(s):Ali Amin, MD, RVT, FACS, FACC  
  View Slides in PDF      
6:52 AM - 6:57 AM What Is The Best Way To Deal Endovascularly With SFA Occlusions To Its Origin
  Presenter(s):George H. Meier III, MD  
  View Slides in PDF      
6:58 AM - 7:03 AM 12-Month Results With The Endovascular Tacking Device (Tack-It) For Treating Flow Limiting Post PTA Dissections: The TOBA Trial
  Presenter(s):David H. Deaton, MD, FACS  
  View Slides in PDF      
7:04 AM - 7:09 AM New Approaches To Limb Salvage In CLI Due To Very Distal Disease: Pedal Loop, Transcollateral And Small Artery Access In The Foot: Techniques, Tips And Tricks
  Presenter(s):Roberto Ferraresi, MD  
  View Slides in PDF      
7:10 AM - 7:15 AM Fast, Cheap Way To Cross Tibial CTOs Antegrade And When It Doesn’t Work, Improved Pedal Access Is Available: Techniques And Equipment
  Presenter(s):Gary M. Ansel, MD  
  View Slides in PDF      
7:16 AM - 7:21 AM Technical Tips, Pitfalls And Midterm Results With Pedal Access Procedures
  Presenter(s):Hosam F. El Sayed, MD  
  View Slides in PDF      
7:22 AM - 7:27 AM How Does Stent Design Influence Results Of SFA Stenting: Advantages And Limitations Of Newer Stents: Supera, Tigris, Biomimics, Etc.
  Presenter(s):Marc Bosiers, MD / Koen Deloose, MD  
  View Slides in PDF      
7:28 AM - 7:33 AM DEBATE: Based On 5-Year Results, The Zilver PTX Stent Is The Treatment Of Choice For SFA Occlusive Disease
  Presenter(s):Michael D. Dake, MD  
  View Slides in PDF      
7:34 AM - 7:39 AM <>DEBATE: Zilver PTX Stents Are Effective For Long Or Calcified SFA Lesions: But All Other SFA Lesions Should Be Treated With Drug Eluting Balloons (DEBs)
  Presenter(s):Thomas Zeller, MD  
  View Slides in PDF      
7:40 AM - 7:46 AM Panel Discussion
END OF SESSION 23
 
SESSION 24 SCHEDULE
Wednesday
SESSION 24: MORE LOWER EXTREMITY HOT TOPICS AND NEW DEVELOPMENTS
x
7:46 AM - 7:51 AM Comparison Of Tibial Bypasses With Saphenous Vein vs. Heparin Bonded PTFE (Propaten): Current Indications For Prosthetic Tibial Bypasses And New Developments For Limb Salvage
  Presenter(s):Richard F. Neville, MD  
  View Slides in PDF      
7:52 AM - 7:57 AM In Patients With Extensive Gangrene From CLI (Rutherford 5 And 6), Limited Vein And Occlusive Disease Of The SFA And Distal Arteries, Endovascular Treatment Of The SFA And A Short Vein Distal Bypass Is The Best Way To Achieve Limb And Patient Survival
  Presenter(s):Francesco Spinelli, MD  
  View Slides in PDF      
7:58 AM - 8:03 AM Below The Ankle And Perimalleolar Occlusive Disease With CLI: Tips And Tricks For Treating It Endovascularly And When They Should Be Used: Hydrodynamic Boost To Re-Enter The Tibial Artery True Lumen And Venous Arterialization
  Presenter(s):Roberto Ferraresi, MD  
  View Slides in PDF      
8:04 AM - 8:09 AM New Tips, Tricks And Devices For Pedal And Other Distal Access Procedures
  Presenter(s):Andrej Schmidt, MD  
  View Slides in PDF      
DRUG ELUTING BALLOONS (DEBS)
8:10 AM - 8:15 AM Importance Of Trial Design And Other Factors In Evaluating The Differing Results With DEBs
  Presenter(s):Kenneth Rosenfield, MD  
  View Slides in PDF      
8:16 AM - 8:21 AM Under What Conditions Should DEBs Be Used Preferentially: Diabetics, Calcified Lesions, Extensive Foot Necrosis: What Does It Take To Make DEBs Work Optimally
  Presenter(s):Francesco Liistro, MD  
  View Slides in PDF      
8:22 AM - 8:27 AM 2-Year Results With The Lutonix (Bard) DEB vs. Uncoated Balloon Angioplasty (POBA): The LEVANT II Trial In The SFA And BTK Lesions
  Presenter(s):Andrej Schmidt, MD / Dierk Scheinert, MD / Kenneth Rosenfield, MD / Marianne Brodmann, MD / Thomas Zeller, MD  
  View Slides in PDF      
8:28 AM - 8:33 AM In Femoropopliteal Stenting Does Drug Elution Make A Difference vs. Uncoated Stents: New Data From The MAJESTIC Trial
  Presenter(s):Stefan Mueller-Huelsbeck, MD  
  View Slides in PDF      
8:34 AM - 8:39 AM Access For BTK Interventions Via Puncture Through Totally Occluded SFAs (With Or Without A Previous Stent): How To Do It
  Presenter(s):Luigi Inglese, MD  
8:40 AM - 8:45 AM What The Surgeon Should NOT Do To Preserve Options For Future Endovascular Therapy And Vice Versa
  Presenter(s):Sigrid Nikol, MD  
  View Slides in PDF      
8:46 AM - 8:52 AM Panel Discussion
END OF SESSION 24
 
SESSION 25 SCHEDULE
Wednesday
SESSION 25: MORE LOWER EXTREMITY NEW DEVELOPMENTS AND HOT TOPICS
x
8:52 AM - 8:57 AM DEBATE: What Percent Of CLI Patients Will Require An Open Surgical Procedure At Some Point In Their Course: An Interventionist's Point Of View
  Presenter(s):Giancarlo Biamino, MD, PhD  
  View Slides in PDF      
8:58 AM - 9:03 AM DEBATE: What Percent Of CLI Patients Will Require An Open Procedure At Some Point In Their Course: An Endovascularly Oriented Vascular Surgeon's Point Of View
  Presenter(s):Joseph L. Mills, MD  
  View Slides in PDF      
9:04 AM - 9:09 AM 2-Year Positive Results With The In.Pact Admiral DEB To Treat SFA And Popliteal Lesions: The In.Pact SFA RCT Shows Better Patency And Decreased Reintervention Rates Compared To POBA
  Presenter(s):Peter A. Schneider, MD / Gunnar Tepe, MD / John R. Laird, MD  
  View Slides in PDF      
9:10 AM - 9:15 AM Value Of The In.Pact DEB To Treat Long TASC C And D Lesions: From The In.Pact SFA Trial Long Lesion Cohort
  Presenter(s):Gunnar Tepe, MD  
  View Slides in PDF      
9:16 AM - 9:21 AM Critical Analysis Of The LEVANT II And In.Pact SFA RCTs Of DEBs vs. POBA: What Are The Take Home Messages
  Presenter(s):Thomas Zeller, MD  
  View Slides in PDF      
9:22 AM - 9:27 AM Update On The Status Of Drug Eluting Balloons In The US Currently – And What Is Coming
  Presenter(s):Edward Y. Woo, MD  
  View Slides in PDF      
TREATMENT OF LEG AND FOOT ARTERY OCCLUSIVE DISEASE
9:28 AM - 9:33 AM Foot Artery Disease In CLI: Innocent Bystander Or Leading Villain: When Should It Be Treated; When Should It Not Be Treated; And When Can It Not Be Treated: Some Patent Arteries In Leg And Foot Are Not Seen On DSA: How They Can Be Visualized
  Presenter(s):Roberto Ferraresi, MD  
  View Slides in PDF      
9:34 AM - 9:39 AM Future Of Pedal Access And Interventions: What Are Its Limits And Potential: Can It Be Achieved With Duplex Guidance And Can It Be Used For Atherectomy (With The Diamond Back Device): Technical Tips
  Presenter(s):Jihad A. Mustapha, MD  
  View Slides in PDF      
9:40 AM - 9:45 AM DEBs And Drug Eluting Stents (DESs) For BTK Arteries: Where Are We And What Is The Future
  Presenter(s):Konstantinos Katsanos, MSc, MD, PhD, EBIR  
  View Slides in PDF      
9:46 AM - 9:51 AM Novel Hybrid Technique For Treating Complex Disease Involving CFA, SFA And Tibial Disease: Distal Access, Retrograde Wire Passage To A Common Femoral Arteriotomy Facilitates Complex Prograde Endovascular Treatments
  Presenter(s):Joshua D. Adams, MD / Claudio J. Schonholz, MD  
  View Slides in PDF      
9:52 AM - 9:59 AM Panel Discussion
9:59 AM - 10:12 AM Break – Visit Exhibits And Pavilions (2nd and 3rd Floors)
END OF SESSION 25
 
SESSION 26 SCHEDULE
Wednesday
SESSION 26: MORE LOWER EXTREMITY NEW DEVELOPMENTS AND HOT TOPICS
x
10:12 AM - 10:17 AM DEBATE: An Endovascular First Approach To All CLI Patients Results In Better Limb Salvage: Based On Long-Term Follow-Up Of A Single Vascular Surgical Center
  Presenter(s):Ramon L. Varcoe, MD  
  View Slides in PDF      
10:18 AM - 10:23 AM DEBATE: Not So: Some CLI Patients Are Still Best Treated First By An Open Bypass: Which Ones And An Endovascular First Policy Can Harm Such Patients
  Presenter(s):Michael S. Conte, MD  
  View Slides in PDF      
10:24 AM - 10:29 AM Consequences Of An “Endovascular First Policy For All CLI Patients”: They Are Real – Especially With TASC C And D Lesions
  Presenter(s):Ross Milner, MD  
  View Slides in PDF      
10:30 AM - 10:35 AM Consequences Of Failed Tibial Angioplasty: How Often Is The Distal Target Vessel Altered Or Symptoms Increased: Open Bypass As The Initial Treatment Is Better For CLI Patients With TASC D Lesions
  Presenter(s):Marc L. Schermerhorn, MD  
  View Slides in PDF      
10:36 AM - 10:41 AM Endovascular Treatments For TASC C And D Lesions Have Improved And Justifies Their Use With Such Lesions: Do Results Support This Use
  Presenter(s):Gary M. Ansel, MD  
  View Slides in PDF      
10:42 AM - 10:47 AM 5-Year Results With The Supera Interwoven Stent Are Better Than Other Bare Metal Stents (BMSs) And DEBs In A Propensity Matched Comparison
  Presenter(s):Andrej Schmidt, MD / Dierk Scheinert, MD / Sabine Steiner, MD  
  View Slides in PDF      
10:48 AM - 10:53 AM 3-Year Results From The US IDE Trial With The Supera Stent: How Does The Deployment Technique Influence Midterm Patency
  Presenter(s):Lawrence A. Garcia, MD  
  View Slides in PDF      
10:54 AM - 10:59 AM Real World Experience With The Supera Stent For Long Challenging SFA/Pop Lesions: Deployment Tips And Mode Of Failure
  Presenter(s):D. Christopher Metzger, MD   
  View Slides in PDF      
11:00 AM - 11:05 AM 1-2-Year Good Results With The Xience Prime Balloon Expandable Everolimus DES For Long BTK Lesions Are Good: From The DESTINY 2 Trial
  Presenter(s):Marc Bosiers, MD / Patrick Peeters, MD  
  View Slides in PDF      
11:06 AM - 11:12 AM Panel Discussion
NEW DEVELOPMENTS IN DEBS
Moderator(s): Peter A. Schneider, MD / Darren B. Schneider, MD  
11:12 AM - 11:17 AM Role Of DEBs For Infrainguinal Lesions (SFA/Pop/BTK) In 2015 And The Future: What Is It And What Will It Be In Primary And Recurrent Lesions And ISR
  Presenter(s):Giancarlo Biamino, MD, PhD  
  View Slides in PDF      
11:18 AM - 11:23 AM DEBATE: Why We Should Stay Away From DEBs For BTK Interventions
  Presenter(s):Erich Minar, MD  
  View Slides in PDF      
11:24 AM - 11:29 AM DEBATE: DEBs For BTK Lesions Have A Bright Future: Why The In.Pact Deep Trial Did Not Work And Lessons Learned That Should Make DEBs Effective BTK Including In Crural Arteries
  Presenter(s):Francesco Liistro, MD  
  View Slides in PDF      
11:30 AM - 11:35 AM Ongoing Trials Of Drug Delivery Techniques And Improved Stents For BTK Arteries: The Future Is Bright
  Presenter(s):Andrej Schmidt, MD / Dierk Scheinert, MD  
  View Slides in PDF      
11:36 AM - 11:41 AM Late Patency And Limb Salvage Results After Plantar And Pedal Loop PTAs For CLI: How Do They Differ In Patients With Gangrene And Ulceration And Those With Rest Pain
  Presenter(s):Roberto Ferraresi, MD  
  View Slides in PDF      
11:42 AM - 11:47 AM Infrainguinal Artery Calcification In Fem/Pop And Tibial Arteries: What Is Its Location And Nature And How Does It Impact On Endovascular Treatments In The Thigh, Leg And Foot
  Presenter(s):Jihad A. Mustapha, MD  
  View Slides in PDF      
11:48 AM - 11:53 AM Meta-Analysis Of Results With Venous Arterialization For Limb Salvage: When Does It Work And Why: Properly Done It Offers A Hope For Limb Salvage In Otherwise Hopeless Circumstances
  Presenter(s):Pramook Mutirangura, FRCS (Edinburgh)  
  View Slides in PDF      
11:54 AM - 12:00 PM Panel Discussion
12:00 PM - 1:00 PM Lunch Break – 2nd Floor Promenade
Visit Exhibits And Pavilions (2nd and 3rd Floors)

END OF SESSION 26
 
SESSION 27 SCHEDULE
Wednesday
SESSION 27: LOWER EXTREMITY NEW DEVELOPMENTS RELATED TO TREATMENT OF IN STENT RESTENOSIS (ISR)
x
1:00 PM - 1:05 PM How Can ISR Be Classified And What Is Currently The Best Treatment For Each Class
  Presenter(s):Peter A. Schneider, MD  
  View Slides in PDF      
1:06 PM - 1:11 PM The Spectranetics Excimer Laser Plus Balloon Angioplasty Is The Best Treatment For ISR: Based On The EXCITE-ISR Trial: Should The Balloon Be A DEB
  Presenter(s):Craig M. Walker, MD / D. Christopher Metzger, MD   
  View Slides in PDF      
1:12 PM - 1:17 PM Atherectomy (Silverhawk) Plus DEB Is The Best Treatment For ISR And Is Cost Effective: Based On The DEFINITIVE AR Trial
  Presenter(s):Thomas Zeller, MD / Gunnar Tepe, MD  
  View Slides in PDF      
1:18 PM - 1:23 PM Viabahn Relining Is Usually The Best Treatment For ISR: Based On Updated 2-Year Results Of The RELINE Trial: When Is It Not The Best
  Presenter(s):Patrick Peeters, MD / Marc Bosiers, MD / Koen Deloose, MD  
  View Slides in PDF      
1:24 PM - 1:29 PM Viabahn Stent-Grafts Are Good Treatment For ISR: When Are They The Best: What Is The Pattern Of Failure And What Can Be Done To Prevent It
  Presenter(s):Johannes Lammer, MD  
  View Slides in PDF      
1:30 PM - 1:35 PM DEB With The Cotavance Balloon vs. POBA For ISR: Good 1-Year Results: The COPA CABANA Trial
  Presenter(s):Gunnar Tepe, MD  
  View Slides in PDF      
1:36 PM - 1:41 PM Panel Discussion
END OF SESSION 27
 
SESSION 28 SCHEDULE
Wednesday
SESSION 28: NEW DEVELOPMENTS IN LOWER EXTREMITY STENT-GRAFTS, POPLITEAL ANEURYSMS AND OTHER CLI TOPICS OF INTEREST
x
1:42 PM - 1:47 PM Emergency Treatment Of Vascular Injuries With Stent-Grafts (Covered Stents): Which Stent-Graft For Which Injuries And Other Tips And Tricks In Their Use
  Presenter(s):Maria Antonella Ruffino, MD  
  View Slides in PDF      
1:48 PM - 1:53 PM What Is The Best Current Treatment For Long SFA Occlusions: BMSs, DESs, DEBs, Atherectomy And PTA Or Viabahn Stent-Grafts
  Presenter(s):Johannes Lammer, MD  
  View Slides in PDF      
1:54 PM - 1:59 PM 3-Year Results With Heparin Bonded Viabahn Stent-Grafts To Treat Long SFA Occlusions
  Presenter(s):Michel M.P. Reijnen, MD, PhD  
  View Slides in PDF      
2:00 PM - 2:05 PM Heparin Bonding Probably Does Not Improve Results with PTFE Stent-Grafts Or Open PTFE Bypasses
  Presenter(s):Jonathan D. Beard, ChM, MEd, FRCS  
  View Slides in PDF      
POPLITEAL ANEURYSM HOT TOPICS (SEE ALSO SESSION 85)
2:06 PM - 2:11 PM Endoluminal Bypasses With Stent-Grafts For Thrombosed Popliteal Aneurysms: When Can It Work And How To Do It
  Presenter(s):Giovanni Pratesi, MD  
  View Slides in PDF      
2:12 PM - 2:17 PM DEBATE: Most Popliteal Aneurysms Should Be Treated Endovascularly: What Are The Exceptions and What Is Their Proportion
  Presenter(s):Irwin V. Mohan, MBBS, MD, FRCS, FEBVS, FRACS  
  View Slides in PDF      
2:18 PM - 2:23 PM DEBATE: Not So: Endovascular Repair Of Popliteal Aneurysms May Not Be As Good As It’s Cracked Up To Be – Especially In Certain Circumstances: Open Repair Via A Posterior Approach Is Best For Most
  Presenter(s):Martin Bjorck, MD, PhD  
  View Slides in PDF      
2:24 PM - 2:29 PM Endovascular Stent-Graft Repair Is The Best Treatment For Most Popliteal Aneurysms: What Are The Exceptions
  Presenter(s):Franco Grego, MD  
  View Slides in PDF      
2:30 PM - 2:35 PM Open vs. Endo Repair For Popliteal Aneurysms: Which Is Best: From A Real World National Italian Registry
  Presenter(s):Walter Dorigo, MD  
  View Slides in PDF      
2:36 PM - 2:41 PM Surveillance Duplex Ultrasound Is Not Reliable For Predicting Stent-Graft Failure After Popliteal Aneurysm Repair But Is Reliable For Predicting Failure Of SFA Stent-Grafts For Occlusive Disease
  Presenter(s):Keith D. Calligaro, MD / Matthew J. Dougherty, MD  
  View Slides in PDF      
OTHER LOWER EXTREMITY TOPICS OF INTEREST
Moderator(s): Joseph L. Mills, MD / Patrick J. Lamparello, MD  
2:48 PM - 2:53 PM Value Of Prostaglandins In CLI For Diabetics And Non-Diabetics: Beneficial Effects Can Be Documented By Flow Measurements
  Presenter(s):Afshin Assadian, MD  
  View Slides in PDF      
2:54 PM - 2:59 PM Myths Concerning Pedal Bypasses: Their Bad Reputation Is Undeserved: With Them And Pedal Loop Endovascular Techniques No Patient With CLI Should Be Untreatable
  Presenter(s):Hisham Rashid, FRCS, FRCS(Gen)  
  View Slides in PDF      
3:00 PM - 3:05 PM Failure Modes For Pedal Access Endovascular Interventions
  Presenter(s):Rabih A. Chaer, MD  
  View Slides in PDF      
3:06 PM - 3:11 PM Impact Of Nitinol Stent Oversizing On Outcomes Of Fempop Interventions: How Should Optimal Stent Size Be Determined
  Presenter(s):Nicolas A. Diehm, MD  
  View Slides in PDF      
3:12 PM - 3:17 PM Distal (Pedal) Bypasses vs. PTAs For The Treatment Of Tibial And Pedal Occlusive Lesions: Pros And Cons Of Each
  Presenter(s):Hany Zayed, MD  
  View Slides in PDF      
3:18 PM - 3:23 PM Panel Discussion
3:23 PM - 3:33 PM Break – Visit Exhibits And Pavilions (2nd and 3rd Floors)
END OF SESSION 28
 
SESSION 29 SCHEDULE
Wednesday
SESSION 29: ADVANCES IN THE TREATMENT OF ACUTE LIMB ISCHEMIA (ALI) AND INTERMITTENT CLAUDICATION (IC)
x
ACUTE LIMB ISCHEMIA (SEE ALSO SESSION 62)
3:33 PM - 3:38 PM DEBATE: All Patients With Acute Limb Ischemia (ALI) Should Be Treated Endovascularly: A Strategy For Doing So – Including Mechanical Thrombectomy: Which Device Is Currently Best
  Presenter(s):Ali Amin, MD, RVT, FACS, FACC  
  View Slides in PDF      
3:39 PM - 3:44 PM DEBATE: Some Patients With ALI Need Open Surgical Techniques: Who Are They And Why Are The Open Techniques Needed And Beneficial
  Presenter(s):Joseph L. Mills, MD  
  View Slides in PDF      
3:45 PM - 3:50 PM Update On Thrombosuction For ALI: What Are The Best Techniques: How To Do It And What Are The Results
  Presenter(s):Athanasios Katsargyris, MD / Eric L.G. Verhoeven, MD, PhD  
  View Slides in PDF      
3:51 PM - 3:56 PM Intraoperative Venous Drainage Through A Hemodialysis System Can Be A Limb And Life Saving Technique For Patients With Late Stage ALI And Reperfusion Injury: How To Do It
  Presenter(s):Pramook Mutirangura, FRCS (Edinburgh)  
  View Slides in PDF      
NEW DEVELOPMENTS IN THE MANAGEMENT OF INTERMITTENT CLAUDICATION (IC) AND OTHER CONDITIONS
3:57 PM - 4:02 PM DEBATE: How Should Most Patients With IC Be Treated: An Interventional Cardiologist’s View
  Presenter(s):William A. Gray, MD  
  View Slides in PDF      
4:03 PM - 4:08 PM DEBATE: How Should Most Patients With IC Be Treated: A Vascular Surgeon’s View
  Presenter(s):Frank B. Pomposelli, MD  
  View Slides in PDF      
4:09 PM - 4:14 PM With Supervised Exercise For IC When Is Stenting Needed: Never? Rarely?
  Presenter(s):Konstantinos Katsanos, MSc, MD, PhD, EBIR  
  View Slides in PDF      
4:15 PM - 4:20 PM Patients With IC Should Have A Trial Of Exercise Treatment And Be Informed About Risks And Benefits Before They Are Treated Interventionally
  Presenter(s):Jonathan D. Beard, ChM, MEd, FRCS  
  View Slides in PDF      
4:21 PM - 4:26 PM Use Of Electronic Devices Like Fitbits To Improve IC Treatment
  Presenter(s):Robyn A. Macsata, MD  
  View Slides in PDF      
4:27 PM - 4:32 PM New Automated Device For Rapid Percutaneous Insertion Of Femoral Artery Sheath In Emergent Situations
  Presenter(s):Rajabrata Sarkar, MD, PhD  
  View Slides in PDF      
4:33 PM - 4:39 PM Panel Discussion
END OF SESSION 29
 
SESSION 30 SCHEDULE
Wednesday
SESSION 30: CLI AND THE ANGIOSOME CONCEPT; REOPERATIONS AND REINTERVENTION; OTHER NEW CONCEPTS AND TECHNIQUES
x
4:39 PM - 4:44 PM DEBATE: The Angiosome Concept Has Been Proven Helpful With Open Surgical And Endovascular Treatments Of CLI With Gangrenous Or Ulcerated Lesions
  Presenter(s):Richard F. Neville, MD  
  View Slides in PDF      
4:45 PM - 4:50 PM DEBATE: The Angiosome Concept Has Not Been Proven Helpful In The Treatment Of CLI With Gangrenous Or Ulcerated Lesions
  Presenter(s):Bauer E. Sumpio, MD, PhD  
  View Slides in PDF      
4:51 PM - 4:56 PM Angiosome Targeted Revascularization Is More Important With Endovascular Repair Than Bypass Surgery
  Presenter(s):Maarit Venermo, MD, PhD  
  View Slides in PDF      
4:57 PM - 5:02 PM Critique Of The Angiosome Concept: It Is Not Simple: Outcomes Depend More On The Distribution System In The Foot Than Angiosomes
  Presenter(s):Roberto Ferraresi, MD  
  View Slides in PDF      
5:03 PM - 5:08 PM Is The Angiosome Concept Worthwhile And How Should It Be Used
  Presenter(s):Peter A. Schneider, MD  
  View Slides in PDF      
5:09 PM - 5:14 PM Update On The Angiosome Concept: It’s Not All It’s Cracked Up To Be: What Other Factors Are More Important
  Presenter(s):Hisham Rashid, FRCS, FRCS(Gen)  
  View Slides in PDF      
5:15 PM - 5:20 PM The Angiosome Concept Is Not Necessary To Achieve Limb Salvage With Ischemic Gangrenous Foot Lesions
  Presenter(s):Ignacio Escotto, MD  
  View Slides in PDF      
5:21 PM - 5:26 PM Angiosomes Of The Foot Have Tremendous Variability As Indicated By Laser-Assisted Indocyanine Green Imaging Using The SPY SYSTEM
  Presenter(s):Werner Lang, MD  
  View Slides in PDF      
5:27 PM - 5:32 PM The Importance Of Reoperation Or Reintervention When A Primary Procedure For CLI Fails And The Limb Is Rethreatened: 1, 2, 3, 4 And More Procedures Can Be Worthwhile: A Vascular Surgeon’s View
  Presenter(s):Evan C. Lipsitz, MD  
  View Slides in PDF      
NEW CONCEPTS AND TECHNIQUES
5:33 PM - 5:38 PM Vorapaxar - A New PAR-1 Receptor Blocker, Improves Cardiovascular And Limb Outcomes In PAD Patients: The FDA Agrees
  Presenter(s):Anthony J. Comerota, MD, FACS, FACC  
  View Slides in PDF      
5:39 PM - 5:44 PM When And How Should Distal Embolic Protection Devices Be Used With Lower Extremity Interventions
  Presenter(s):D. Christopher Metzger, MD   
  View Slides in PDF      
5:45 PM - 5:55 PM Panel Discussion

End of Program D

END OF SESSION 30
 
SESSION 31 SCHEDULE
Wednesday
SESSION 31: NATURAL HISTORY, MEDICAL TREATMENTS AND ANTI-ATHEROSCLEROTIC MEDICATIONS
x
6:45 AM - 6:50 AM Is Metabolic Syndrome A Marker Of Adverse Outcomes After Vascular Procedures: What Can Be Done To Improve The Situation
  Presenter(s):Alan Dardik, MD, PhD  
  View Slides in PDF      
6:51 AM - 6:56 AM Cilostazol (Pletal) Is An Underutilized Medication In Vascular Patients: It Can Promote Patency And Decrease Amputations After Arterial Revascularizations: What Is Optimal Timing And Dosing For Its Use
  Presenter(s):Todd R. Vogel, MD, MPH  
  View Slides in PDF      
6:57 AM - 7:03 AM How Should Beta Blockers Be Used In Vascular Patients Undergoing Procedures: Use And Overuse Can Harm Patients And Their Use Should Not Be A Quality Metric
  Presenter(s):Michael C. Stoner, MD  
  View Slides in PDF      
7:04 AM - 7:09 AM How Do Patient Risk Factors And Antiplatelet Medications Influence Myocardial Ischemia And Infarction In Patients Undergoing Open Arterial Operations: What Can Be Done To Decrease These Adverse Events
  Presenter(s):Caron B. Rockman, MD / Jeffrey S. Berger, MD, MS, FAHA, FACC   
  View Slides in PDF      
7:10 AM - 7:15 AM Smoking, Cholesterol, Obesity And BP: The Big 4 Modifiable Causes Of Vascular Disease: Fix Them And Live Forever: What Is Optimal Statin Usage
  Presenter(s):Richard Bulbulia, MA, MD, FRCS  
  View Slides in PDF      
7:16 AM - 7:21 AM What Is Happening With The AHA Cholesterol Guidelines: Should We Measure Serum Cholesterol: How Low Should The LDL Be Pushed To And Can It Get There
  Presenter(s):Jeffrey S. Berger, MD, MS, FAHA, FACC   
  View Slides in PDF      
7:22 AM - 7:27 AM Status Of Cholesterol Lowering Drug Zetia (Ezetimbe) And Its Combination With Statins (Vytorin): Do They Help To Prevent Cardiovascular Events More Than Statins Alone: Who Should Be On Them: The IMPROVE –IT Trial
  Presenter(s):Don Poldermans, MD  
  View Slides in PDF      
7:28 AM - 7:33 AM Status Of The New Cholesterol Lowering Drugs: The PCSK 9 Inhibitors (Evolucumab [Amgen] And Alirocumab [Sanofi]): Do They Decrease Cardiovascular Events: How Are They Given; What Are Their Downsides; What Will Their Role Be And When Will They Be Available
  Presenter(s):Ron Waksman, MD  
  View Slides in PDF      
7:34 AM - 7:39 AM Statins And Dual Antiplatelet Drugs Reduce Amputations: What Is The Evidence
  Presenter(s):Konstantinos Katsanos, MSc, MD, PhD, EBIR  
  View Slides in PDF      
7:40 AM - 7:48 AM Panel Discussion
END OF SESSION 31
 
SESSION 32 SCHEDULE
Wednesday
SESSION 32: RENAL DENERVATION AND OTHER TREATMENTS FOR RESISTANT HYPERTENSION: BLACK BOX WARNINGS; KEY CAROTID TOPIC
x
7:48 AM - 7:53 AM Current Status Of Catheter Based Renal Radiofrequency Denervation For Hypertension: Where Is It Going
  Presenter(s):Horst Sievert, MD  
  View Slides in PDF      
7:54 AM - 7:59 AM Why The Renal Denervation RCTs Have Not Shown A Positive Effect: Does The Treatment Concept Have A Future
  Presenter(s):Michael R. Jaff, DO / Krishna J. Rocha-Singh, MD  
  View Slides in PDF      
8:00 AM - 8:05 AM What Is The Future For Renal Denervation: What Are Its Assets Beyond Lowering BP: Will It Become A Mainstream Treatment
  Presenter(s):Melvin D. Lobo, MBChB, PhD, FRCP  
  View Slides in PDF      
8:06 AM - 8:11 AM Does Surgical Renal Denervation Work: Why Does It Fail Long-Term: Is There A Bright Future For Renal Denervation
  Presenter(s):Juan C. Parodi, MD  
  View Slides in PDF      
8:12 AM - 8:17 AM Newer Methods To Achieve Renal Denervation: Can Catheter Based Ultrasound (Surround Sound) Be Effective And Safe For Lowering BP, For Treating Heart Failure (The RETREAT Trial): What About Catheter Chemical Denervation With Alcohol And DW 2013: How Are They Delivered
  Presenter(s):Horst Sievert, MD  
  View Slides in PDF      
OTHER TREATMENTS FOR RESISTANT HYPERTENSION
8:18 AM - 8:23 AM Update On Chronic Carotid Sinus Stimulation With An Implantable Device To Treat Resistant Hypertension
  Presenter(s):Fred A. Weaver, MD  
  View Slides in PDF      
8:24 AM - 8:29 AM Treatment Of Resistant Hypertension By The ROX AV Coupling Device: An Endovascular Technique To Create An Iliac A-V Fistula: Technique, Results And Risks
  Presenter(s):David H. Deaton, MD, FACS / Paul A. Sobotka, MD  
  View Slides in PDF      
8:30 AM - 8:35 AM Vascular Specialists Ignore Black Box Warnings About Certain Drugs And Their Optimal Usage Resulting In Poor Patient Care: What Can Be Done About It
  Presenter(s):Karthikeshwar Kasirajan, MD  
  View Slides in PDF      
KEY CAROTID TOPIC
8:36 AM - 8:41 AM What Is Best Medical Treatment (BMRx) For Patients With Carotid Disease
  Presenter(s):J. David Spence, MD  
  View Slides in PDF      
8:42 AM - 8:49 AM Panel Discussion
END OF SESSION 32
 
SESSION 33 SCHEDULE
Wednesday
SESSION 33: TREATMENT AND PREVENTION OF COMPLICATIONS; ENDOTENSION AND ENDOLEAKS
x
8:49 AM - 8:54 AM Value Of Measuring Troponins Before And After Open Vascular Operations: When And How Does It Help In Patient Management
  Presenter(s):Caron B. Rockman, MD / Ramon Berguer, MD, PhD  
  View Slides in PDF      
8:55 AM - 9:00 AM Open And Endo Rescue Procedures When The Initial Procedure Goes Awry Or Has A Complication: Tips And Tricks For Getting Out Of Trouble
  Presenter(s):Michael B. Silva, Jr., MD  
  View Slides in PDF      
9:01 AM - 9:06 AM Is Endotension Still A Reality With Modern Vascular Imaging: What Conditions Can Mimic It
  Presenter(s):Jacques Busquet, MD  
  View Slides in PDF      
9:07 AM - 9:12 AM Strategies For Managing A Patient With A Growing AAA Sac After EVAR But No Apparent Endoleak: Open Or Laparoscopic, Fenestrated Cuff Or Relining Or Observe
  Presenter(s):Michael P. Jenkins, MBBS, BSc, MS, FRCS, FEBVS  
  View Slides in PDF      
ENDOLEAKS
9:13 AM - 9:18 AM Better Imaging Of Endoleaks (Type I) With Contrast MRI Permits Better Diagnosis And Treatment Leading To Better Outcomes
  Presenter(s):Frans L. Moll, MD, PhD  
  View Slides in PDF      
9:19 AM - 9:24 AM Aneurysm Sac Filling: A New Endovascular Technique To Eliminate Any Kind Of Endoleak
  Presenter(s):Michael J. Jacobs, MD  
  View Slides in PDF      
9:25 AM - 9:30 AM Partial Conversion To Treat Persistent Type 2 Endoleaks: When And How To Do It
  Presenter(s):Nicola Mangialardi, MD / Sonia Ronchey, MD, PhD  
  View Slides in PDF      
9:31 AM - 9:36 AM Diagnosis And Treatment Of Endoleaks With Nellix Endografts (EVAS): Much Is Different
  Presenter(s):Fabio Verzini, MD, PhD  
  View Slides in PDF      
9:37 AM - 9:42 AM Type 2 Endoleak Embolization By Laser-Assisted Transendograft Micropuncture: How To Do It And Results
  Presenter(s):Mark W. Mewissen, MD  
  View Slides in PDF      
9:43 AM - 9:48 AM Keys To Success With Embolic Treatment Of Complex Recalcitrant Type 2 Endoleaks After EVAR
  Presenter(s):Martin R. Back, MD  
  View Slides in PDF      
9:49 AM - 9:54 AM DEBATE: Fenestrated Cuffs Are The Best Way To Treat Persistent Type 1A Endoleaks After EVAR
  Presenter(s):Timothy A.M. Chuter, DM  
  View Slides in PDF      
9:55 AM - 10:00 AM DEBATE: Not So: Chimney Techniques Are The Best Way To Treat Persistent Type 1A Endoleaks After EVAR
  Presenter(s):Konstantinos P. Donas, MD  
  View Slides in PDF      
10:01 AM - 10:08 AM Panel Discussion
10:08 AM - 10:20 AM Break – Visit Exhibits And Pavilions (2nd and 3rd Floors)
END OF SESSION 33
 
SESSION 34 SCHEDULE
Wednesday
SESSION 34: HISTORY, MEDICAL/SURGICAL TOPICS AND IMPORTANT ISSUES
x
10:20 AM - 10:25 AM What Did Leonardo da Vinci Know About Atherosclerosis Before William Harvey
  Presenter(s):Christopher K. Zarins, MD  
  View Slides in PDF      
10:26 AM - 10:31 AM The First Published Report On CAS In 1977: An Interesting Story: How Was It Received
  Presenter(s):Klaus D. Mathias, MD  
  View Slides in PDF      
MEDICAL/SURGICAL TOPICS
10:32 AM - 10:37 AM Tests For The Hypercoaguable State Are Overused And Unnecessary In Most Vascular Patients: When Are They Needed And Helpful
  Presenter(s):Elna M. Masuda, MD  
  View Slides in PDF      
10:38 AM - 10:43 AM Atherosclerotic Plaque Regression: Is It Now A Reality: How Can It Occur: And What Are The Expectations For The Future
  Presenter(s):Ralph G. DePalma, MD  
  View Slides in PDF      
10:44 AM - 10:49 AM Value Of Frailty Indices In Vascular Surgical Procedures: What Are They And How Can They Be Helpful
  Presenter(s):Gregory L. Moneta, MD  
  View Slides in PDF      
10:50 AM - 10:55 AM Tips And Tricks In The Management Of Pediatric Vascular Trauma
  Presenter(s):Meryl E. Davis, FRCS / George Hamilton, MD, FRCS  
  View Slides in PDF      
10:56 AM - 11:01 AM Panel Discussion
IMPORTANT ISSUES
Moderator(s): Ramon Berguer, MD, PhD / Enrico Ascher, MD  
11:01 AM - 11:06 AM How Can Vascular Surgeons Reconcile Work And Family Responsibilities And Time Commitments And Succeed With Both
  Presenter(s):Marshall E. Benjamin, MD  
  View Slides in PDF      
11:07 AM - 11:12 AM Patient Benefit From Meetings Of The Vascular Community For Education, Innovation And Evidence With Active Collaboration Of CME And Industry Regulatory Bodies
  Presenter(s):Roger M. Greenhalgh, MD  
  View Slides in PDF      
11:13 AM - 11:18 AM Current Status Of MOC For Vascular Surgeons: Why Vascular Surgeons Should Join The Cardiologists To Resist The Existing Onerous Requirements
  Presenter(s):John F. Eidt, MD  
  View Slides in PDF      
11:19 AM - 11:24 AM Variability In Operating Time For The Same Procedure By Different Vascular Surgeons: How Does It Correlate With Outcomes: Do Slow Surgeons Get Better Or Worse Results
  Presenter(s):Jack L. Cronenwett, MD  
  View Slides in PDF      
11:25 AM - 11:30 AM How Should Academic Activity Be Rated And Rewarded: Should There Be Academic RVUs To Define And Quantitate Academic Activity And Productivity: How To Set Up Such A System
  Presenter(s):Mark G. Davies, MD / Alan B. Lumsden, MD, FACS  
  View Slides in PDF      
11:31 AM - 11:36 AM Lessons Learned From 2 Disasters: 9-11 And Superstorm Sandy
  Presenter(s):Mark A. Adelman, MD  
  View Slides in PDF      
11:37 AM - 11:42 AM Why Should Vascular Surgeons Get An MBA Or Other Advanced Degree
  Presenter(s):Robert B. McLafferty, MD  
  View Slides in PDF      
11:43 AM - 11:48 AM What Is The Value Of Vascular And Endovascular Societies: What Should They Do For Us And Our Specialty: Which Ones Should We Join And Why
  Presenter(s):Donald B. Reid, MD  
  View Slides in PDF      
11:49 AM - 11:59 AM Panel Discussion
12:00 PM - 1:00 PM Lunch Break – 2nd Floor Promenade
Visit Exhibits And Pavilions (2nd and 3rd Floors)

END OF SESSION 34
 
SESSION 35 SCHEDULE
Wednesday
SESSION 35: ISSUES, ETHICS, HEALTH CARE REFORM AND THE AFFORDABLE CARE ACT (ACA)
x
1:00 PM - 1:05 PM The Importance Of Dynasties In Vascular Surgery: Why They Develop And Why They Fall
  Presenter(s):Jerry Goldstone, MD, FACS, FRCSEd  
  View Slides in PDF      
1:06 PM - 1:11 PM An Ethicist Looks At Overuse Of Procedures And Admissions By Doctors And Hospitals: Why Our Health Care System Incentivizes Such Overuse In Every Institution
  Presenter(s):James W. Jones, MD, PhD, MHA  
  View Slides in PDF      
1:12 PM - 1:17 PM The Battle Of Quality vs. Quantity In Hospital Administration: Quantity Wins All Too Often
  Presenter(s):Clifford M. Sales, MD, MBA, FACS  
  View Slides in PDF      
1:18 PM - 1:23 PM How Patients (And Their Medical Doctors) Should Be Aware Of Unnecessary Tests And Procedures On Their Veins And Arteries: Such Procedural Overuse Can Harm Patients And Increase Health Care Costs
  Presenter(s):Russell H. Samson, MD, RVT, FACS  
  View Slides in PDF      
1:24 PM - 1:29 PM How To Survive In An ACO-ACA Environment: Is Our Health Care System Crumbling
  Presenter(s):Bruce A. Perler, MD, MBA  
  View Slides in PDF      
1:30 PM - 1:35 PM What Is Happening With The Device Tax Component Of The ACA: What Are The Detrimental Effects Of The ACA On Industry
  Presenter(s):Nicky James / Pete R. Yonkman / Kem Hawkins, MBA  
  View Slides in PDF      
1:36 PM - 1:41 PM The Negative Impact Of The ACA On The Country And Health Care Is Worse Than We Thought It Would Be
  Presenter(s):Clifford J. Buckley, MD  
  View Slides in PDF      
1:42 PM - 1:47 PM There Are Some Good Parts To The ACA That Should Be Preserved: How Can That Be Done
  Presenter(s):Timothy F. Kresowik, MD  
  View Slides in PDF      
1:48 PM - 1:53 PM Perils Of The ACA For Patients: Health Care Exchanges Or Short Changes
  Presenter(s):James H. Black, III, MD  
  View Slides in PDF      
1:54 PM - 1:59 PM Perspectives On Consolidation In The Health Care Industry: What Is Good And What Is Bad: How Can We Physicians Cope
  Presenter(s):Michael R. Jaff, DO  
  View Slides in PDF      
2:00 PM - 2:05 PM Medical Decision Making Should Be Shared With The Patient Especially With Vascular Patients: It Can Improve Care
  Presenter(s):Dirk T. Ubbink, MD, PhD  
  View Slides in PDF      
2:06 PM - 2:11 PM It Is An Imperfect World For Everyone – But Especially For Physicians And Super-Especially For Vascular Surgeons/Specialists
  Presenter(s):David H. Deaton, MD, FACS  
  View Slides in PDF      
2:12 PM - 2:20 PM Panel Discussion
END OF SESSION 35
 
SESSION 36 SCHEDULE
Wednesday
SESSION 36: ACOs, GOVERNING BODIES (BOARDS/RRC), INDEPENDENCE, EDUCATION, REIMBURSEMENTS, TRAINING, SIMULATION
x
2:20 PM - 2:25 PM Strategies To Allow Us To Confront The Changing Health Care System And ACOs
  Presenter(s):John H. Furtek, BS, RT(r)  
  View Slides in PDF      
2:26 PM - 2:31 PM Why ACOs Have Not And Will Not Decrease Health Spending In Cardiovascular Care
  Presenter(s):Philip P. Goodney, MD, MS  
  View Slides in PDF      
2:32 PM - 2:37 PM Is The RRC-S (Residency Review Committee-Surgery) Working Well For Vascular Surgery: Should We Have An Independent RRC-VS
  Presenter(s):Ronald L. Dalman, MD  
  View Slides in PDF      
2:38 PM - 2:43 PM Current Impact Of The 0+5 Vascular Surgery Residency Programs: Should Vascular Surgery Now Become An Independent Specialty As It Is In Most Other Civilized Countries
  Presenter(s):John F. Eidt, MD  
  View Slides in PDF      
2:44 PM - 2:49 PM The Need For Continuing Evolution And Recognition Of Vascular Surgery As An Independent Specialty
  Presenter(s):James C. Stanley, MD  
  View Slides in PDF      
2:50 PM - 2:55 PM Role Of Our Vascular Journals In Dealing With Political, Training And Governance Issues Facing Vascular Surgery
  Presenter(s):Timothy M. Sullivan, MD  
  View Slides in PDF      
2:56 PM - 3:01 PM Update On 0+5 Vascular Residencies: Numbers, Levels Of Resident Satisfaction And Incidence Of Dropouts
  Presenter(s):Murray L. Shames, MD  
  View Slides in PDF      
3:02 PM - 3:07 PM Comparison Of Knowledge Base, Surgical Skills And Other Characteristics Of 5+2 And 0+5 Vascular Surgery Residents
  Presenter(s):Robyn A. Macsata, MD  
  View Slides in PDF      
3:08 PM - 3:13 PM Importance Of Promoting The Careers Of Junior Faculty Vascular Surgeons (As Well As Residents And Fellows): A System For Doing It
  Presenter(s):Karl A. Illig, MD / John F. Eidt, MD  
  View Slides in PDF      
3:14 PM - 3:19 PM Panel Discussion
REIMBURSEMENT ISSUES
Moderator(s): Ramon Berguer, MD, PhD / Kim J. Hodgson, MD  
3:19 PM - 3:24 PM Update On Coding And Reimbursement Issues For Vascular Surgery: Now, In 2016 And Beyond
  Presenter(s):Sean P. Roddy, MD  
  View Slides in PDF      
3:25 PM - 3:30 PM Financial Impact Of The ACA To Date And In The Future: What Will It Mean To Vascular Surgeons
  Presenter(s):Robert M. Zwolak, MD, PhD  
  View Slides in PDF      
SIMULATION ISSUES
3:31 PM - 3:36 PM How To Shift The Learning Curve For Vascular Surgery From The Patient To A Model: The Vascular International Training Course Helps To Do This
  Presenter(s):Hans-Henning Eckstein, MD, PhD  
  View Slides in PDF      
3:37 PM - 3:42 PM Advantages In Patient Specific Simulation For EVAR For Elective And Ruptured AAAs
  Presenter(s):Isabelle van Herzeele, MD, PhD / Mario L. Lachat, MD  
  View Slides in PDF      
3:43 PM - 3:48 PM The Introduction Of New Technology For Treating Vascular Lesions May Lead To Unnecessary Adverse Events: Many Of These Can Be Avoided By Simulation And Team Training
  Presenter(s):Colin D. Bicknell, MD, FRCS  
  View Slides in PDF      
3:49 PM - 4:00 PM Panel Discussion And Break
Visit Exhibits And Pavilions (2nd and 3rd Floors)

END OF SESSION 36
 
SESSION 37 SCHEDULE
Wednesday
SESSION 37: VASCULAR CARE, MALPRACTICE LAW, CONTRACTS, COSTS, REIMBURSEMENT AND THE FDA
x
4:00 PM - 4:05 PM The Indications And Results For EVAR Differ Widely In Different Regions: What Is The Reason
  Presenter(s):Barend M.E. Mees, MD, PhD  
  View Slides in PDF      
4:06 PM - 4:11 PM Health Care Literacy In Vascular Patients Is Inadequate: Do We Need Better Ways To Inform Patients
  Presenter(s):Olivier H.J. Koning, MD, PhD  
  View Slides in PDF      
4:12 PM - 4:17 PM What Is The Patient’s Compensation System Law: Where Is It In Effect; How Will It Help End The Malpractice Problem, Help Patients And Doctors To Be Treated Fairly And Cut Health Care Costs
  Presenter(s):O. William Brown, MD, JD  
  View Slides in PDF      
4:18 PM - 4:23 PM How Vascular Surgeons And Specialists Should Negotiate Contracts With Hospitals, Employers Or Partners: Tips And Tricks
  Presenter(s):Hillel Presser, Esq., MBA  
  View Slides in PDF      
4:24 PM - 4:29 PM Vascular Surgery Patients Readmissions: What Can And Cannot Be Modified And Why Financial Penalties For Many Of Them Are Unfair
  Presenter(s):Peter Henke, MD  
  View Slides in PDF      
4:30 PM - 4:35 PM How To Make EVAR More Cost Effective And Profitable For Hospitals In Today’s Health Care Environment
  Presenter(s):W. Charles Sternbergh III, MD  
  View Slides in PDF      
4:36 PM - 4:41 PM Tips And Tricks On How Vascular Surgeons Can Fairly Maximize Collections And Income In A Practice Or An Academic Setting
  Presenter(s):Alan M. Graham, MD  
  View Slides in PDF      
4:42 PM - 4:47 PM What The FDA Is Doing To Facilitate Access To New Devices Rapidly And With Assured Safety And Effectiveness – In Both The Civilian And Military Spheres
  Presenter(s):Kenneth J. Cavanaugh, Jr., PhD / J. Pablo Morales, MD / Brian Pullin, MD  
  View Slides in PDF      
4:48 PM - 4:53 PM When Do I Need A Physician Sponsored Investigative Device Exemption (PSIDE) And How Do I Get It
  Presenter(s):Dorothy B. Abel, BSBME  
  View Slides in PDF      
4:54 PM - 4:59 PM Tips And Tricks To Make A PSIDE Affordable
  Presenter(s):Carlos H. Timaran, MD  
  View Slides in PDF      
5:00 PM - 5:06 PM Panel Discussion
END OF SESSION 37
 
SESSION 38 SCHEDULE
Wednesday
SESSION 38: ISSUES: PUBLISHING MDs’ RESULTS; RESEARCH TIPS; EVIDENCE BASED MEDICINE; RCTs; GUIDELINES; ACA; DISHONEST WITNESSES; VQIs AND SOCIETIES
x
5:06 PM - 5:11 PM Preferential Funding For Primary Care vs. Specialty Care And Penalties For Readmissions (As Promoted In The ACA) Are Bad For Patients And Society And Will Not Decrease Costs
  Presenter(s):Bruce A. Perler, MD, MBA  
  View Slides in PDF      
5:12 PM - 5:17 PM Publishing Vascular Surgeons’ Mortality Results In The Public Press Can Be A Disaster For The Surgeon And Bad For Patient Care: The UK Experience
  Presenter(s):Ian Loftus, MD  
  View Slides in PDF      
5:18 PM - 5:23 PM Issues In Planning And Interpreting Small Trials: How To Make Their Data Meaningful
  Presenter(s):Charles C. Miller, PhD  
  View Slides in PDF      
5:24 PM - 5:29 PM How To Get Access To Population Based Datasets
  Presenter(s):Todd R. Vogel, MD, MPH  
  View Slides in PDF      
5:30 PM - 5:35 PM The Tyranny Of p Values: The Importance Of Knowing The Details And Flaws In The Holy Grail Of RCTs
  Presenter(s):Jerry Goldstone, MD, FACS, FRCSEd  
  View Slides in PDF      
5:36 PM - 5:41 PM The New SVS Practice Guidelines For Lower Extremity Occlusive Disease: Key Take Home Messages And How They Prevent Over Usage Of SFA Stents
  Presenter(s):Frank B. Pomposelli, MD / Michael S. Conte, MD  
  View Slides in PDF      
5:42 PM - 5:47 PM Validity Of The New SVS Lower Extremity Threatened Limb Classification System: The WIFI System (Wound Ischemia And Foot Infection): It Allows Prediction Of Poor Outcomes With CLI Treatment
  Presenter(s):Marc L. Schermerhorn, MD / Joseph L. Mills, MD  
  View Slides in PDF      
5:48 PM - 5:53 PM What To Do When Physician Expert Witnesses Provide False Testimony Against You
  Presenter(s):O. William Brown, MD, JD  
  View Slides in PDF      
5:54 PM - 5:59 PM VQI In A Community Hospital: How It Succeeded In Improving Vascular Care And Resolving Harmful Turf Issues
  Presenter(s):Tej M. Singh, MD, MBA  
  View Slides in PDF      
6:00 PM - 6:05 PM DEBATE: Positive Value Of VQI Initiatives
  Presenter(s):Larry W. Kraiss, MD  
  View Slides in PDF      
6:06 PM - 6:11 PM DEBATE: Limitations And Possible Downsides Of VQI Initiatives
  Presenter(s):Kenneth Ouriel, MD, MBA  
  View Slides in PDF      
6:12 PM - 6:17 PM How Vascular Societies Should Prevent Risk Averse Behavior Of Surgeons And Gaming The System For The Benefit Of Surgeons And To The Detriment Of Patients: Do The Societies Do It Well
  Presenter(s):Jonathan D. Beard, ChM, MEd, FRCS  
  View Slides in PDF      
6:18 PM - 6:25 PM Panel Discussion

End of Program E

END OF SESSION 38
 
SESSION 39 SCHEDULE
Wednesday
SESSION 39: MORE NEW DEVELOPMENTS RELATING TO THORACIC AORTA AND AORTIC DISSECTIONS
x
6:45 AM - 6:50 AM How Often Are Additional Procedures (Open Or Endo) Required After An Open Ascending Aortic Repair Of A Type A Aortic Dissection (TAAD)
  Presenter(s):Ross Milner, MD  
  View Slides in PDF      
6:57 AM - 7:02 AM Open Retrograde Access To Branch Arteries As A Bailout For Failed Antegrade Access During F/BEVAR
  Presenter(s):Eric L.G. Verhoeven, MD, PhD  
  View Slides in PDF      
7:03 AM - 7:08 AM Total Arch Replacement For Aortic Dissections: Value Of Frozen Elephant Trunk Procedures With EVITA, Jotec Or Thoraflex Hybrid (Vascutek) Grafts
  Presenter(s):Aamir S. Shah, MD / Ali Khoynezhad, MD, PhD  
  View Slides in PDF      
7:15 AM - 7:20 AM DEBATE: Branched Grafts Are The Best Endovascular Method To Treat Arch Aneurysms And TAAAs: Parallel Grafts Have Disadvantages
  Presenter(s):Stephan Haulon, MD  
  View Slides in PDF      
7:21 AM - 7:26 AM DEBATE: Disadvantages Of Off-The-Shelf And Patient Specific Branched Grafts: Parallel Grafts Are Better Solutions
  Presenter(s):Armando C. Lobato, MD, PhD  
  View Slides in PDF      
7:27 AM - 7:32 AM Pitfalls In F/BEVAR And How To Deal With Them
  Presenter(s):Götz M. Richter, MD, PhD  
  View Slides in PDF      
7:33 AM - 7:38 AM PET CT With 18F-FDG Can Predict Late Aortic Complications After TEVAR For TBADs
  Presenter(s):Natzi Sakalihasan, MD, PhD  
  View Slides in PDF      
7:39 AM - 7:44 AM Influence Of Respiratory And Cardiac Induced Movement On Precise Aortic Arch Endograft Deployment
  Presenter(s):Geert Willem H. Schurink, MD, PhD  
  View Slides in PDF      
7:45 AM - 7:51 AM Panel Discussion
6:51 PM - 6:56 AM Clinical Outcomes Of TBADs In Patients With Connective Tissue Diseases (Marfans, Loeys-Dietz, Etc.) Are Worse Than In Those Without
  Presenter(s):Richard G.J. Gibbs, FRCS  
  View Slides in PDF      
7:09 PM - 7:14 PM MR Elastography To Characterize The Aortic Wall: Implications For The Design And Sizing Of Ascending Aortic Devices
  Presenter(s):Rachel E. Clough, MD, PhD  
  View Slides in PDF      
END OF SESSION 39
 
SESSION 40 SCHEDULE
Wednesday
SESSION 40: MORE TOPICS RELATING TO THE ASCENDING AORTA, THE ARCH AND PARALLEL GRAFTS
x
7:52 AM - 7:57 AM Further Experience With Longer Follow-Up On Arch Chimney Grafts: When Do They Work And Pitfalls To Avoid So They Do Not Fail
  Presenter(s):Nicola Mangialardi, MD / Sonia Ronchey, MD, PhD  
  View Slides in PDF      
7:58 AM - 8:03 AM In Vitro Analysis Of Parallel Grafts: How They Work And Why They Fail: New Lessons Learned
  Presenter(s):Jan D. Blankensteijn, MD  
  View Slides in PDF      
8:04 AM - 8:09 AM Tips And Tricks To Facilitate Successful Use Of Branched Endografts And Pitfalls To Avoid
  Presenter(s):Martin J. Austermann, MD  
  View Slides in PDF      
8:10 AM - 8:15 AM Use Of The VORTEC Technique – A Clampless, Sutureless Anastomosis Using An Endograft Connector To Revascularize The Supra-Aortic Branches Simplifies Hybrid Arch Repairs: Technique And Results
  Presenter(s):Zoran Rancic, MD, PhD / Mario L. Lachat, MD  
  View Slides in PDF      
8:16 AM - 8:21 AM Single Innominate Chimney Grafts: When Is It A Good Choice And When Is It Not
  Presenter(s):Boonprasit Kritpracha, MD  
  View Slides in PDF      
8:22 AM - 8:27 AM Various Cardiac Access Routes To Treat Ascending Aortic And Arch Lesions: Advantages And Limitations
  Presenter(s):Tilo Kölbel, MD, PhD  
  View Slides in PDF      
8:28 AM - 8:33 AM Redo Procedures After TEVAR: Why Needed; Tips, Tricks And Results; Value Of A Self-Expanding Extra Large Stent (Jotec E-XL)
  Presenter(s):Germano Melissano, MD / Roberto Chiesa, MD  
  View Slides in PDF      
8:34 AM - 8:39 AM Retrograde Aortic Dissection After TEVAR: Incidence, Risk Factors, Precautions And Treatment
  Presenter(s):Joseph S. Coselli, MD / Ourania Preventza, MD  
  View Slides in PDF      
8:40 AM - 8:46 AM Panel Discussion
END OF SESSION 40
 
SESSION 41 SCHEDULE
Wednesday
SESSION 41: MORE TOPICS RELATED TO FENESTRATED, BRANCHED AND PARALLEL GRAFTS; JUXTARENAL AAAs AND TAAAs
x
8:46 AM - 8:51 AM Optimal Choice Of Bridging Stent-Grafts For F/BEVAR: What Is Available And Which Is Best
  Presenter(s):Richard G. McWilliams, FRCR, EBIR  
  View Slides in PDF      
8:52 AM - 8:57 AM 3 Or 4 FEVAR vs. Standard FEVAR With 2 Fenestrations And A Scallop For The SMA: Advantages, Limitations And Differing Results
  Presenter(s):Athanasios Katsargyris, MD / Eric L.G. Verhoeven, MD, PhD  
  View Slides in PDF      
8:58 AM - 9:03 AM How To Avoid Brachial Or Axillary Access With Complex AAA Repairs: Tips And Tricks
  Presenter(s):Joshua D. Adams, MD / Claudio J. Schonholz, MD  
  View Slides in PDF      
9:04 AM - 9:09 AM DEBATE: EVAR With Short (8-15 mm) Necks Are Best Treated With Standard EVAR Using Newer Endograft Devices
  Presenter(s):Hence J.M. Verhagen, MD, PhD  
  View Slides in PDF      
9:10 AM - 9:15 AM DEBATE: EVAR With Short (8-15 mm) Necks Are Best Treated By FEVAR
  Presenter(s):Matthew J. Eagleton, MD  
  View Slides in PDF      
9:16 AM - 9:21 AM Strategies And Techniques To Treat Short Proximal Neck AAAs
  Presenter(s):Giovanni Torsello, MD  
  View Slides in PDF      
9:22 AM - 9:28 AM Panel Discussion
Moderator(s): Jason T. Lee, MD / Stephan Haulon, MD  
9:28 AM - 9:33 AM DEBATE: Endovascular Methods Are Now The Best Treatment For Most TAAAs
  Presenter(s):Timothy A.M. Chuter, DM  
  View Slides in PDF      
9:34 AM - 9:39 AM DEBATE: Not So: Open Repair Is Still The Best Treatment For Many (Possibly Most) TAAAs
  Presenter(s):Hazim J. Safi, MD  
  View Slides in PDF      
9:40 AM - 9:45 AM Eight Simple Markers That Can Suggest The Presence Of A Thoracic Aneurysm
  Presenter(s):John A. Elefteriades, MD  
  View Slides in PDF      
9:46 AM - 9:51 AM With complicated TBADs, Are The Hard Indications For Treatment (Rupture And Malperfusion) Associated With Higher Mortality And Morbidity Than The Soft Indications (Pain And Persistent Hypertension)
  Presenter(s):Matt M. Thompson, MD  
  View Slides in PDF      
9:52 AM - 9:57 AM Update On Tips And Tricks For Treating Arterial Complications Of Ehlers-Danlos Syndrome, Marfan’s And Other Connective tissue Disorders: Endografts Can Be Valuable
  Presenter(s):James H. Black, III, MD  
  View Slides in PDF      
9:58 AM - 10:03 AM Accurate Placement Of Thoracic Endografts Parallel To The Aortic Arch By Controlling Device Angulation Improves Outcomes: Techniques For Doing So
  Presenter(s):Ali Azizzadeh, MD  
  View Slides in PDF      
10:04 AM - 10:09 AM Purse-String Temporary Closure Of Femoral Access Sites During Complex EVARs (B/FEVAR) To Decrease Limb And Spinal Cord Ischemia
  Presenter(s):Athanasios Katsargyris, MD / Eric L.G. Verhoeven, MD, PhD  
  View Slides in PDF      
10:10 AM - 10:15 AM How To Identify Healthy Aorta To Land The Ends Of Aortic Endografts With Complex AAAs: Is It Always Necessary To Do So
  Presenter(s):Matthew J. Eagleton, MD  
  View Slides in PDF      
10:16 AM - 10:23 AM Panel Discussion
10:23 AM - 10:38 AM Break – Visit Exhibits And Pavilions (2nd and 3rd Floors)
END OF SESSION 41
 
SESSION 42 SCHEDULE
Wednesday
SESSION 42: UPDATE ON THE STATUS OF MULTILAYER FLOW MODULATING (MLFM) STENTS FOR THE TREATMENT OF AORTIC ANEURYSMS AND DISSECTIONS
x
10:38 AM - 10:43 AM The MLFM Stent Is A Better Treatment For TAAAs Than F/BEVAR, Parallel Grafts, Hybrid Repairs And Full Open Repair And Here Is The Data
  Presenter(s):Sherif Sultan, MD, FRCS, EBQS-VASC  
  View Slides in PDF      
10:44 AM - 10:49 AM 4-Year Experience With MLFM Stents For The Treatment Of Complex Aortic Aneurysms: When They Do Not Work
  Presenter(s):Thomas Larzon, MD, PhD  
  View Slides in PDF      
10:50 AM - 10:55 AM 4-Year Results Of The MLFM Stent For The Treatment Of Complex Aortic Aneurysms: From The French Registry
  Presenter(s):Claude D. Vaislic, MD  
  View Slides in PDF      
10:56 AM - 11:01 AM Why I Am Still Somewhat Skeptical
  Presenter(s):Mark F. Fillinger, MD  
  View Slides in PDF      
11:02 AM - 11:07 AM For What Aortic Lesions Is The MLFM Stent An Effective Treatment: Tips And Tricks To Make It Work
  Presenter(s):Erno Remsey-Semmelweis, MD  
  View Slides in PDF      
11:08 AM - 11:13 AM When Is The MLFM Stent An Effective Treatment Of Arch And Ascending Aortic Aneurysms And When Is It Not: A Partly Positive View And Experience
  Presenter(s):Ralf R. Kolvenbach, MD  
  View Slides in PDF      
11:14 AM - 11:19 AM Treatment Of Aortic Dissection And Complex TAAAs With The MLFM Stent: Experience In More Than 30 Patients
  Presenter(s):Victor S. Costache, MD, PhD  
  View Slides in PDF      
11:20 AM - 11:25 AM Update On The MLFM Stent For Treatment Of Complex Aortic Aneurysms: Is Its Star Rising
  Presenter(s):Frans L. Moll, MD, PhD  
  View Slides in PDF      
11:26 AM - 11:31 AM Role Of Multilayer Uncovered Stents For The Successful Treatment Of TAAAs: The Concept Works: When And How
  Presenter(s):Qingsheng Lu, MD / Zaiping Jing, MD  
  View Slides in PDF      
11:32 AM - 11:37 AM Is The MLFM Stent A Valid Treatment In High Risk 80- And 90-Year Olds With Paravisceral And TAAAs
  Presenter(s):Arno von Ristow, MD  
  View Slides in PDF      
11:38 AM - 11:43 AM The MLFM Stent Has A Role In The Treatment Of Complex Aortic Aneurysms: What Is It And What More Do We Need To Know
  Presenter(s):Christos D. Liapis, MD  
  View Slides in PDF      
11:44 AM - 11:49 AM Histopathological Findings In Patients And Animals After Implantation Of MLFM Stents: Characteristics Of Endothelialization And Thrombus Formation
  Presenter(s):Antoine Alves, Dr.  
  View Slides in PDF      
11:50 AM - 12:00 PM Panel Discussion
Visit Exhibits And Pavilions (2nd and 3rd Floors)

END OF SESSION 42
 
SESSION 43 SCHEDULE
Wednesday
SESSION 43: MORE TOPICS RELATED TO AAAs, THE ABDOMINAL AORTA AND EVAR
x
1:00 PM - 1:05 PM Comparative Changes In Aortic Neck Morphology After EVAR And Open AAA Repair: Is Open Repair Really That Good: From The DREAM Trial
  Presenter(s):Jan D. Blankensteijn, MD  
  View Slides in PDF      
1:06 PM - 1:11 PM EVAR Strategy To Deal With A Proximal Neck Over 35 mm In Diameter
  Presenter(s):Jacques Busquet, MD  
  View Slides in PDF      
1:12 PM - 1:17 PM Patterns Of Rupture Of AAAs After EVAR: How Does It Differ From Rupture Patterns In Untreated AAAs
  Presenter(s):Markus K. Furrer, MD  
  View Slides in PDF      
1:18 PM - 1:23 PM Differences In AAA Size At Rupture Between Patients Treated By EVAR And Those Not So Treated
  Presenter(s):James May, MD, MS, FRACS, FACS  
  View Slides in PDF      
1:24 PM - 1:29 PM Progress In 18F-FDG Uptake On PET CT And Other Markers In Predicting AAA Rupture Risk
  Presenter(s):Natzi Sakalihasan, MD, PhD  
  View Slides in PDF      
1:30 PM - 1:35 PM Current Indications For Repairing Small AAAs (<5 cm) By EVAR; By Open Repair: Has Anything Changed
  Presenter(s):Ronald M. Fairman, MD  
  View Slides in PDF      
1:36 PM - 1:42 PM Panel Discussion
END OF SESSION 43
 
SESSION 44 SCHEDULE
Wednesday
SESSION 44: RECORDED LIVE COMPLEX ENDOVASCULAR CASES: COMPLICATIONS WITH SOLUTIONS
x
1:42 PM - 1:54 PM Single Session Pharmacomechanical Venous Thrombolysis
  Presenter(s):Gerard J. O'Sullivan, MD  
  View Slides in PDF      
1:54 PM - 2:06 PM Stent Graft-Induced New Entry (SINE) After TEVAR For Stanford Type B Aortic Dissection
  Presenter(s):Donald D. Lee, MD  
  View Slides in PDF      
2:06 PM - 2:18 PM Extensive Aorto-Iliac Occlusive Disease: A Modified CERAB Technique
  Presenter(s):Andrew Holden, MBChB  
  View Slides in PDF      
2:18 PM - 2:30 PM Hydrodynamic Boost: A Novel Re-Entry Technique In Distal BTK Vessel: When And How To Do It
  Presenter(s):Roberto Ferraresi, MD  
  View Slides in PDF      
2:30 PM - 2:42 PM CLI Patient Following 2 Failed Bypass Surgery Procedures Who Was Told The Next Step Would Be Amputation
  Presenter(s):Thomas Zeller, MD  
  View Slides in PDF      
2:42 PM - 2:54 PM Endovascular Techniques To Restore The Femoral Artery After Failed Bypass
  Presenter(s):Andrej Schmidt, MD  
  View Slides in PDF      
2:54 PM - 3:02 PM General Discussion
3:02 PM - 3:17 PM Break – Visit Exhibits And Pavilions (2nd and 3rd Floors)
END OF SESSION 44
 
SESSION 45 SCHEDULE
Wednesday
SESSION 45: INNOVATIVE TECHNIQUES FOR CHALLENGING PERIPHERAL LESIONS
x
3:17 PM - 3:25 PM Latest Techniques For Aortoiliac Reconstruction Of TASC C And D Lesions: Are Covered Stents The Solution
  Presenter(s):Koen Deloose, MD  
  View Slides in PDF      
3:25 PM - 3:37 PM Recorded Case: Chimney Reconstruction Of A Complete Aortoiliac Occlusion (Leriche Syndrome)
  Presenter(s):Peter C.J. Goverde, MD / Andrej Schmidt, MD  
  View Slides in PDF      
3:37 PM - 3:45 PM Patient Specific Approaches For Femoropopliteal Lesions: Stents, Atherectomy And Drug-Eluting Devices
  Presenter(s):D. Christopher Metzger, MD   
  View Slides in PDF      
3:45 PM - 3:57 PM Recorded Case: Recanalization Of A Severely Calcified SFA Occlusion With Interwoven Nitinol Stents
  Presenter(s):Andrej Schmidt, MD / M. Ulrich, MD  
3:57 PM - 4:05 PM The Angiosome Concept For BTK Interventions: How to Translate It Into Clinical Practice
  Presenter(s):Giancarlo Biamino, MD, PhD  
  View Slides in PDF      
4:05 PM - 4:17 PM Recorded Case: Recanalization Of A Tibioperoneal Trunc Occlusion With DES Via Retrograde Peroneal Access
  Presenter(s):Andrej Schmidt, MD / C. Piorkowski, MD  
4:17 PM - 4:25 PM Current And Future Concepts To Improve Outcome Of BTK-Interventions In CLI
  Presenter(s):Ramon L. Varcoe, MD  
  View Slides in PDF      
4:25 PM - 4:37 PM Panel Discussion
END OF SESSION 45
 
SESSION 46 SCHEDULE
Wednesday
SESSION 46: MORE TOPICS RELATED TO AAAs, THE AORTA AND EVAR
x
4:37 PM - 4:42 PM How To Manage EVAR With Small Distal Aortas: When Are Bifurcated Grafts OK And When Is An Aorto-Uni-Iliac Device Needed
  Presenter(s):David J. Minion, MD  
  View Slides in PDF      
4:43 PM - 4:48 PM Screening For AAAs In Women: When Should They Be Screened And When Should They Not Be
  Presenter(s):Andrew N. Nicolaides, MS, FRCS / Mohsen Chabok, MD, MSc  
  View Slides in PDF      
4:49 PM - 4:54 PM Is EVAR Good Treatment For Young (<60) AAA Patients: When Is Open Repair The Best Option
  Presenter(s):Thomas L. Forbes, MD  
  View Slides in PDF      
4:55 PM - 5:00 PM DEBATE: Off-Label Use Of EVAR Devices May Have Satisfactory Early Outcomes, But Long-Term Outcomes Are Guarded
  Presenter(s):Ali F. AbuRahma, MD  
  View Slides in PDF      
5:01 PM - 5:06 PM DEBATE: Not So: Off-Label Use Of EVAR Devices Is Sometimes Justified And Does Not Yield Higher Long-Term Failure Rates If Certain Requirements Are Fulfilled
  Presenter(s):B. Patrice Mwipatayi, FRACS  
  View Slides in PDF      
5:07 PM - 5:12 PM What Has Changed Since Our Oft Quoted 2011 Circulation Article: I Now Believe Some Off-Label Use Of EVAR Devices Is Justified And Safe
  Presenter(s):Andres Schanzer, MD  
  View Slides in PDF      
5:13 PM - 5:19 PM Panel Discussion
Moderator(s): Thomas L. Forbes, MD / Ali F. AbuRahma, MD  
5:19 PM - 5:24 PM Has EVAR Led To A Decrease In AAA Rupture Over The Last 2 Decades Or Has It Just Led To More Unnecessary AAA Repairs
  Presenter(s):James May, MD, MS, FRACS, FACS  
  View Slides in PDF      
5:25 PM - 5:30 PM The Iliac Seal Zone In EVAR: Its Dynamics And Clinical Consequences
  Presenter(s):Hence J.M. Verhagen, MD, PhD  
  View Slides in PDF      
5:31 PM - 5:36 PM Diminished Sexual Function In AAA Patients Occurs After EVAR As Well As Open Repair
  Presenter(s):Jan S. Brunkwall, MD, PhD  
  View Slides in PDF      
5:37 PM - 5:42 PM Are Newer EVAR Devices Better Than The Previous Ones: Do They Produce Better Results Or Are They Just Easier To Use
  Presenter(s):Marc R.H.M. van Sambeek, MD, PhD  
  View Slides in PDF      
5:43 PM - 5:48 PM Patient Reported Quality Of Life (QOL) Measures After Open And Endo AAA Repair: Which Is Better
  Presenter(s):Robert J. Hinchliffe, MD  
  View Slides in PDF      
5:49 PM - 5:55 PM Panel Discussion

End of Program F

END OF SESSION 46
 
SESSION 47 SCHEDULE
Thursday
SESSION 47: NEW TECHNIQUES, TECHNOLOGY AND CONCEPTS
x
6:45 AM - 6:50 AM Implantable Microtechnology To Remotely Monitor Bypass Function
  Presenter(s):Richard F. Neville, MD  
  View Slides in PDF      
6:51 AM - 6:56 AM MR Based 3D Imaging In Peripheral Vascular Interventions: A Way To Reduce Radiation Exposure
  Presenter(s):Jos C. van den Berg, MD, PhD  
  View Slides in PDF      
6:57 AM - 7:02 AM Innovative Approaches To Cell Therapy For CLI And Bold MRI To Measure Calf Perfusion To Monitor Its Effects
  Presenter(s):Bijan Modarai, PhD, FRCS  
  View Slides in PDF      
7:03 AM - 7:08 AM Percussion Crossing Device (The Piculet Hammer) To Facilitate Crossing Heavily Calcified CTOs
  Presenter(s):Max Amor, MD  
  View Slides in PDF      
7:09 AM - 7:14 AM Shockwave Lithoplasty: A Balloon That Transmits Shockwaves To Crack Heavily Calcified Lesions And Then Dilate Them (PTA)
  Presenter(s):Andrew Holden, MBChB / Marianne Brodmann, MD  
  View Slides in PDF      
7:15 AM - 7:20 AM Variable Curve Directable Guide Sheath From Aptus To Facilitate Other Challenging Endovascular Procedures
  Presenter(s):Joshua D. Adams, MD / Claudio J. Schonholz, MD  
  View Slides in PDF      
7:21 AM - 7:26 AM What Has Anatomy And Pathology Taught Us About Renal Denervation: Where Are The Nerves That Need To Be Destroyed And What Damage Can Radiofrequency Do To The Renal Artery
  Presenter(s):Renu Virmani, MD  
  View Slides in PDF      
7:27 AM - 7:32 AM Human Tissue Engineered Arterial Grafts Are Finally Working As Lower Extremity Bypasses And Dialysis Access: Why And Prospects For The Future
  Presenter(s):Jeffrey H. Lawson, MD, PhD  
  View Slides in PDF      
7:33 AM - 7:38 AM What Is New In Better Balloon Angioplasty Catheters: Can They Inflate In A Curved Configuration
  Presenter(s):Timothy A.M. Chuter, DM  
  View Slides in PDF      
7:39 AM - 7:44 AM Value Of 3D Printing To Create A Vascular Phantom To Facilitate And Improve Complex AAA Repairs
  Presenter(s):Benjamin W. Starnes, MD  
  View Slides in PDF      
7:45 AM - 7:50 AM How To Non-Invasively Measure Blood Flow And Lesion Significance In Coronary Arteries With CTA: Fractional Flow Reserve (FFR) Is Valuable There: Will It Be In Other Arterial Beds And How Will It Work
  Presenter(s):Christopher K. Zarins, MD  
  View Slides in PDF      
7:51 AM - 7:58 AM Panel Discussion
END OF SESSION 47
 
SESSION 48 SCHEDULE
Thursday
SESSION 48: ADVANCES IN BRANCHED AND FENESTRATED EVAR (F/BEVAR) AND PARALLEL GRAFTS FOR LESIONS NEAR TO OR IN THE VISCERAL AORTA
x
7:58 AM - 8:03 AM How Durable Are F/B Endografts For Various Aortic Lesions Including TAAAs
  Presenter(s):Tara M. Mastracci, MD  
  View Slides in PDF      
8:04 AM - 8:09 AM How Durable Are Parallel Grafts (Chimney And Periscope Grafts) For Various Aortic Lesions Including TAAAs
  Presenter(s):Mario L. Lachat, MD  
  View Slides in PDF      
8:10 AM - 8:15 AM Parallel Grafts (Chimneys, Etc.) Do Work As Proven By The PERICLES Registry: Midterm Results With A Variety Of Devices
  Presenter(s):Konstantinos P. Donas, MD / Jason T. Lee, MD  
  View Slides in PDF      
8:16 AM - 8:21 AM Parallel Grafts Are Valuable Even If F/BEVAR Is Available
  Presenter(s):Frank J. Criado, MD, FACS, FSVM  
  View Slides in PDF      
8:22 AM - 8:27 AM Status Of Sandwich Grafts For Aneurysms Involving The Visceral Segment: What Are The Midterm Results – Single Center And Multicenter
  Presenter(s):Armando C. Lobato, MD, PhD  
  View Slides in PDF      
8:28 AM - 8:33 AM Sandwich (Parallel) Grafts Work For TAAAs: How Much Oversizing Of The Main Endograft And Overlap Of The Branch Grafts Are Required
  Presenter(s):Ralf R. Kolvenbach, MD  
  View Slides in PDF      
8:34 AM - 8:39 AM Failure Modes Of Chimney And Other Parallel Grafts And How They May Be Overcome
  Presenter(s):Claude Mialhe, MD  
  View Slides in PDF      
8:40 AM - 8:45 AM Inner Branched Endografts: A Better Solution For F/BEVAR Than Other Configurations For Treating Visceral Aortic Segment Lesions
  Presenter(s):Marcelo Ferreira, MD  
  View Slides in PDF      
8:46 AM - 8:51 AM Role Of Off-The-Shelf Fenestrated And Branched Grafts For Treating AAAs Involving The Visceral Segment Of The Aorta (Cook P-Branch And T-Branch) Devices: What Percent Of Patients Are Suitable
  Presenter(s):Mark A. Farber, MD  
  View Slides in PDF      
8:52 AM - 8:57 AM Patient Specific And Off-The-Shelf Devices Will Not Suffice For Many Patients With AAAs Involving The Visceral Aortic Segment: What Is The Solution
  Presenter(s):David J. Minion, MD  
  View Slides in PDF      
8:58 AM - 9:05 AM Panel Discussion
9:05 AM - 9:20 AM Break – Visit Exhibits And Pavilions (2nd and 3rd Floors)
END OF SESSION 48
 
SESSION 49 SCHEDULE
Thursday
SESSION 49: MORE TOPICS RELATED TO F/BEVAR AND PARALLEL GRAFTS FOR TREATMENT OF AAAs AND TAAAs
x
MORE ON THORACOABDOMINAL ANEURYSMS (TAAAS)
9:20 AM - 9:25 AM For Which TAAA Patient Is No Repair The Best Option: Better Than A B/FEVAR
  Presenter(s):Gustavo S. Oderich, MD, FACS  
  View Slides in PDF      
9:26 AM - 9:31 AM For Which TAAA Patient Is An Open Repair The Right Option: In What Type Of Institution
  Presenter(s):Richard P. Cambria, MD  
  View Slides in PDF      
9:32 AM - 9:37 AM For Which TAAA Patient Is A F/BEVAR The Best Option: In What Type Of Institution
  Presenter(s):Stephan Haulon, MD  
  View Slides in PDF      
9:38 AM - 9:43 AM In Which TAAA Patient Is A Parallel Graft Procedure With All Chimney And Periscope Grafts Or A Partially Hybrid Procedure The Best Treatment: What Are The Disadvantages Or Limitations
  Presenter(s):Mario L. Lachat, MD  
  View Slides in PDF      
9:44 AM - 9:49 AM In Which TAAA Patient Is A Sandwich Graft The Best Option: Advantages, Disadvantages And Limitations
  Presenter(s):Armando C. Lobato, MD, PhD  
  View Slides in PDF      
9:50 AM - 9:55 AM How To Detect And Best Manage Complications Of F/BEVAR: They Are Part Of The Game
  Presenter(s):Luis A. Sanchez, MD  
  View Slides in PDF      
9:56 AM - 10:01 AM Update On The French Countrywide Comparison Of Open Repair vs. F/BEVAR For The Treatment Of AAAs Involving The Visceral Aortic Segment: New 4-Year Results
  Presenter(s):Jean-Pierre Becquemin, MD, FRCS  
  View Slides in PDF      
10:02 AM - 10:10 AM Panel Discussion
Moderator(s): Evan C. Lipsitz, MD / ShenMing Wang, MD, PhD  
10:11 AM - 10:16 AM Staged Hybrid Repair Of Extensive TAAA Especially Those Associated With Aortic Dissections: Another Option With Advantages
  Presenter(s):Gilbert R. Upchurch, Jr., MD  
  View Slides in PDF      
10:17 AM - 10:22 AM A New Manifold Branched Endograft Device For Treating TAAAs And Other Complex Aortic Lesions: Concept, Advantages, Initial Clinical Experience Under A PSIDE
  Presenter(s):Patrick W. Kelly, MD  
  View Slides in PDF      
10:23 AM - 10:28 AM Tips And Tricks To Facilitate Upper Extremity Access For F/BEVAR And Parallel Graft Insertion And How To Avoid Complications
  Presenter(s):Carlos H. Timaran, MD  
  View Slides in PDF      
10:29 AM - 10:34 AM How Physicians Can Modify Gore C3 Devices To Facilitate F/BEVAR In Urgent TAAAs And Pararenal AAAs: Midterm Clinical Results
  Presenter(s):Wayne W. Zhang, MD  
  View Slides in PDF      
10:35 AM - 10:40 AM Can Parallel Graft EVAR Work In A Community Hospital Setting: Advantages And Limitations
  Presenter(s):Jeffrey Y. Wang, MD  
  View Slides in PDF      
10:41 AM - 10:46 AM Advances In Fenestrated And Branched Endografts To Simplify Their Use And Improve Results Including Methods To Minimize Lower Extremity Ischemia With Prolonged Sheath Insertion
  Presenter(s):Gustavo S. Oderich, MD, FACS  
  View Slides in PDF      
10:47 AM - 10:52 AM Midterm Results Following Hybrid (Octopus) Repair Of Complex TAAAs With And Without CT Disorders: It Is Still An Option In Experienced Centers
  Presenter(s):Sebastian E. Debus, MD, PhD  
  View Slides in PDF      
10:53 AM - 11:00 AM Panel Discussion
END OF SESSION 49
 
SESSION 50 SCHEDULE
Thursday
SESSION 50: IN TRIBUTE TO OUR MILITARY: TOPICS RELATED TO MILITARY TRAUMA AND VASCULAR SURGERY (7 And 10-MINUTE TALKS)
x
11:00 AM - 11:07 AM Long-Term Results Of Vascular Injuries And Repairs After The Lebanon-Israel War
  Presenter(s):Samy S. Nitecki, MD  
  View Slides in PDF      
11:08 AM - 11:15 AM Implementation Of A Vascular Trauma Course For Military And Civilian Surgeons In Germany: Important For Dealing With Combat And Terror Situations
  Presenter(s):Michael Engelhardt, MD / Afshin Assadian, MD  
  View Slides in PDF      
11:16 AM - 11:23 AM Novel Off-The-Shelf Conduits For Use With Military Vascular Injuries: The Humacyte Graft
  Presenter(s):Todd E. Rasmussen, MD, FACS  
  View Slides in PDF      
11:24 AM - 11:34 AM Medical Lessons From War: Turning Past Data Into Future Decisions And Guidelines
  Presenter(s):Eric Elster, MD  
  View Slides in PDF      
11:35 AM - 11:50 AM A Serious And Possible Limiting Problem With Visual Impairment From Protracted Space Flights: Increased Intracranial Pressure As A Possible Cause And What Can Be Done About It
  Presenter(s):Lee M. Morin, MD, PhD  
  View Slides in PDF      
11:50 AM - 12:00 PM Panel Discussion
12:00 PM - 1:00 PM Lunch Break – 2nd Floor Promenade
Visit Exhibits And Pavilions (2nd and 3rd Floors)

END OF SESSION 50
 
SESSION 51 SCHEDULE
Thursday
SESSION 51: NEW DEVELOPMENTS IN THE MANAGEMENT OF RUPTURED AAAs (RAAAs): IT’S STILL CONTROVERSIAL
x
THE RAAA CONTROVERSY
1:00 PM - 1:05 PM Level 1 Evidence (IMPROVE Trial, Etc.) Shows That EVAR Has No Survival Advantage Over Open Repair For RAAAs: The Outcome Of Treatment Depends On Bad Neck Anatomy More Than Treatment Method
  Presenter(s):Janet T. Powell, MD, PhD / Robert J. Hinchliffe, MD  
  View Slides in PDF      
1:06 PM - 1:11 PM Open Repair Is As Good As EVAR For RAAAs: The AJAX Trial Proves It
  Presenter(s):Willem Wisselink, MD  
  View Slides in PDF      
1:12 PM - 1:17 PM The IMPROVE And Other RCTs Reach A Misleading Main Conclusion – EVAR Has A Lower Mortality Than Open Repair For RAAAs If It Can Be Done
  Presenter(s):Frank J. Veith, MD / Martin Malina, MD, PhD  
  View Slides in PDF      
1:18 PM - 1:23 PM The Main Conclusions Of IMPROVE AJAX And ECAR - RCTs Comparing EVAR And Open Repair For RAAAs Are Incorrect: The Proof: 100% Of RAAAs Can Be Treated By EVAR Or Chimney EVAR With Low Early Mortality And Turn Down Rates
  Presenter(s):Thomas Larzon, MD, PhD / Dieter O. Mayer, MD / Mario L. Lachat, MD / Johnny Steuer, MD, PhD  
  View Slides in PDF      
1:24 PM - 1:29 PM With RAAAs, Patients With Hostile Neck Anatomy Do Not Have Worse Outcomes Than Those With Favorable Anatomy: Our Data Differs From Those In The IMPROVE Trial
  Presenter(s):Marc R.H.M. van Sambeek, MD, PhD  
  View Slides in PDF      
1:30 PM - 1:35 PM DEBATE: Midterm Re-Interventions And Survival Is No Better After EVAR For RAAAs Than After Open Repair
  Presenter(s):Willem Wisselink, MD  
  View Slides in PDF      
1:36 PM - 1:41 PM DEBATE: Midterm And Late Survival And Quality Of Life After EVAR For RAAAs Are Better Than After Open Repair
  Presenter(s):Dieter O. Mayer, MD / Zoran Rancic, MD, PhD / Mario L. Lachat, MD  
  View Slides in PDF      
1:42 PM - 1:47 PM Improving Nationwide Care For RAAAs: Lessons From The US And The UK: The Proportion Of Patients Reaching The Hospital But Not Treated Invasively (The Turn Down Rate) Is Shocking!
  Presenter(s):Matt M. Thompson, MD  
  View Slides in PDF      
1:48 PM - 1:53 PM Late Breaking (1-Year) Results From The IMPROVE Trial Shows That An EVAR Strategy May Be Better In Some Ways Than Open Repair For RAAAs
  Presenter(s):Robert J. Hinchliffe, MD / Janet T. Powell, MD, PhD  
  View Slides in PDF      
1:54 PM - 2:00 PM Panel Discussion
END OF SESSION 51
 
SESSION 52 SCHEDULE
Thursday
SESSION 52: MORE TOPICS RELATED TO RAAAs AND TAAAs
x
RAAA RELATED TOPICS
2:00 PM - 2:05 PM Asthma And The Drugs Used In Its Treatment Increases The Rupture Risk Of AAAs
  Presenter(s):Jes S. Lindholt, MD  
  View Slides in PDF      
2:06 PM - 2:11 PM What Are The Risk Factors For AAA Expansion And Rupture: Do Statins Help
  Presenter(s):Janet T. Powell, MD, PhD  
  View Slides in PDF      
2:12 PM - 2:17 PM Which Patients With RAAAs Benefit The Most From EVAR: Tips And Tricks For Doing It Well
  Presenter(s):Manish Mehta, MD, MPH  
  View Slides in PDF      
2:18 PM - 2:23 PM Acute Renal Failure Is More Common After Open Repair For RAAAs Than After EVAR
  Presenter(s):Jonathan R. Boyle, MD, FRCS  
  View Slides in PDF      
2:24 PM - 2:29 PM Nellix Endografts Can Be Used Effectively To Treat RAAAs: Tips, Tricks, Advantages And Limitations
  Presenter(s):Michel M.P. Reijnen, MD, PhD  
  View Slides in PDF      
2:30 PM - 2:35 PM Emergency EVAR Should Be The New And Best Standard Of Care For RAAAs: Why
  Presenter(s):Hans-Henning Eckstein, MD, PhD  
  View Slides in PDF      
2:36 PM - 2:41 PM Open Repair Of RAAAs Is A Bad Option And Here Is Why
  Presenter(s):Sherif Sultan, MD, FRCS, EBQS-VASC  
  View Slides in PDF      
TAAA RELATED TOPICS
2:42 PM - 2:47 PM A New Preloaded Wire System To Simplify TAAA Branched Endograft Repairs
  Presenter(s):Timothy A. Resch, MD, PhD  
  View Slides in PDF      
2:48 PM - 2:53 PM What Is The Role Of Open Surgery For TAAAs And Thoracic Aneurysms In 2015 And Beyond
  Presenter(s):Michael J. Jacobs, MD  
  View Slides in PDF      
2:54 PM - 3:00 PM Panel Discussion
3:00 PM - 3:10 PM Break – Visit Exhibits And Pavilions (2nd and 3rd Floors)
END OF SESSION 52
 
SESSION 53 SCHEDULE
Thursday
SESSION 53: VASCULAR ROBOTICS AND GUIDANCE SYSTEMS
x
3:10 PM - 3:15 PM Progress In The Hansen Magellan Robot Technology For Catheter/Sheath Guidance: Results And How It Improves Procedural Success And Safety To The Patient And Operator
  Presenter(s):Nicholas J.W. Cheshire, MD  
  View Slides in PDF      
3:16 PM - 3:21 PM The Magellan Robot System Is Valuable For FEVAR, Carotid And Embolization Procedures
  Presenter(s):Miss Celia Riga, BSc, MBBS, MD, FRCS / Colin D. Bicknell, MD, FRCS  
  View Slides in PDF      
3:22 PM - 3:27 PM Benefits From The Magellan Robotic Navigation With 3D Imaging: It Really Helps With Complex Endovascular Procedures
  Presenter(s):Alan B. Lumsden, MD, FACS  
3:28 PM - 3:33 PM Lessons Learned From The Magellan Robot Catheter/Sheath Guidance System: Advantages And Limitation: When Is It Valuable And When Is It Essential
  Presenter(s):Barry T. Katzen, MD  
  View Slides in PDF      
3:34 PM - 3:39 PM What The ROVER Registry Tells Us About The Magellan Robot System And How It Has Facilitated Endo Procedures That Have Failed Standard Manual Attempts
  Presenter(s):Jean Bismuth, MD  
  View Slides in PDF      
3:40 PM - 3:45 PM How The Magellan Robotic System Helps In A Vascular Practice: And How It Improves Results And Efficiency
  Presenter(s):Joseph J. Ricotta II, MD, MS  
  View Slides in PDF      
3:46 PM - 3:51 PM The Magellan Robotic System Has Distinct Advantages In Performing Difficult Embolization Procedures: What Are They
  Presenter(s):Patrick E. Muck, MD, FACS  
  View Slides in PDF      
3:52 PM - 3:57 PM Robotic Aortic Surgery May Be A Failed Experiment But Robotically Directed Catheters Have A Bright Future In Vascular Surgery: Why
  Presenter(s):Hans M.E. Coveliers, MD, MBA  
  View Slides in PDF      
3:58 PM - 4:03 PM Duplex Guidance For Endovascular Interventions In Patients With Renal Insufficiency: Tips And Tricks To Make It Work
  Presenter(s):Natalie A. Marks, MD, RPVI, RVT / Enrico Ascher, MD / Anil P. Hingorani, MD  
  View Slides in PDF      
4:04 PM - 4:10 PM Panel Discussion
END OF SESSION 53
 
SESSION 54 SCHEDULE
Thursday
SESSION 54: MORE CONTROVERSIES, UPDATES AND NEW CONCEPTS – FENESTRATION IN TBADs; EVAS FOR EVAR; PRE-EVAR EMBOLIZATION; TRAINING TRAUMA SURGEONS, ETC.
x
FENESTRATION IN TBAD
4:10 PM - 4:15 PM A New Concept For Treating TBAD After TEVAR By Extensive Fenestration To Equalize True And False Lumen Pressures: And A special New Instrument To Do It Endovascularly: Theory, Technique, Results
  Presenter(s):Juan C. Parodi, MD / Ramon Berguer, MD, PhD  
  View Slides in PDF      
4:16 PM - 4:21 PM Role Of Fenestration For TBAD In The TEVAR Era: Management Of TBAD Patients Is Not Simple: Fenestration Is An Important Option For Some Patients: When And How To Do It
  Presenter(s):David M. Williams, MD  
  View Slides in PDF      
4:22 PM - 4:27 PM Cheese Wire Technique To Eliminate An Aortic Dissection Flap In Chronic TBAD Patient: When Needed; Advantages And Limitations
  Presenter(s):Ronald L. Dalman, MD  
  View Slides in PDF      
4:28 PM - 4:33 PM An Endovascular Flap Cutting Device To Fenestrate Chronic TBADs: When Is It Needed
  Presenter(s):Jean-Marc Alsac, MD, PhD  
  View Slides in PDF      
4:34 PM - 4:39 PM Possible Long-Term Disadvantages Of A Suprarenal Bare Stent With AAA EVAR Endografts
  Presenter(s):Claude Mialhe, MD  
  View Slides in PDF      
4:40 PM - 4:45 PM DEBATE: EVAS (Endovascular Aneurysm Sealing) With The Nellix Device Is A Game Changer For Endo AAA Repair
  Presenter(s):Matt M. Thompson, MD  
  View Slides in PDF      
4:46 PM - 4:51 PM DEBATE: EVAS With The Nellix Device Is Not A Game Changer For Endo AAA Repair
  Presenter(s):Hence J.M. Verhagen, MD, PhD  
  View Slides in PDF      
4:52 PM - 4:58 PM Panel Discussion
Moderator(s): Michel Makaroun, MD / John B. Chang, MD   
4:59 PM - 5:04 PM Clinical Significance In Macrophage Types And Changes In Macrophage Types With Vascular Disease
  Presenter(s):John P. Fletcher, MD  
  View Slides in PDF      
5:05 PM - 5:10 PM New Approach To Median Arcuate Ligament Syndrome: Transthoracic Ligament Release And Mesenteric Revascularization: When Should It Be Done (Diagnosis), Technique And Results
  Presenter(s):Enrique Criado, MD, FACS  
  View Slides in PDF      
VALUE OF PRE-EVAR BRANCH EMBOLIZATION
5:11 PM - 5:16 PM DEBATE: AAA Branch (Lumbar And IMA) Before EVAR Is Seldom Worth The Effort And Has Downsides
  Presenter(s):Richard G. McWilliams, FRCR, EBIR  
  View Slides in PDF      
5:17 PM - 5:22 PM DEBATE: Branch Coil Embolization During EVAR Is Worthwhile And Decreases Type 2 Endoleaks: When Should It Be Done
  Presenter(s):Dominique Fabre, MD  
  View Slides in PDF      
5:23 PM - 5:28 PM AAA Branch Embolization Before EVAR: Does It Have Value And When Should It Be Done
  Presenter(s):Franco Grego, MD  
  View Slides in PDF      
TRAINING TRAUMA SURGEONS
5:29 PM - 5:34 PM DEBATE: Why Trauma Surgeons Should Be Trained In Vascular And Endovascular Techniques
  Presenter(s):Charles J. Fox, MD, FACS  
  View Slides in PDF      
5:35 PM - 5:40 PM DEBATE: Nonsense: We Don’t Train Trauma Surgeons To Do Procedures For Head Trauma And Should Not Train Them To Do Vascular And Endovascular Procedures
  Presenter(s):Mark A. Adelman, MD  
  View Slides in PDF      
5:41 PM - 5:46 PM I Have Changed My Mind: Chimney Grafts And Other Parallel Grafts Have A Role In The Era Of Fenestrated And Branched Endografts: What Is This Role
  Presenter(s):Martin Malina, MD, PhD  
  View Slides in PDF      
5:47 PM - 5:55 PM Panel Discussion

End of Program G

END OF SESSION 54
 
SESSION 55 SCHEDULE
Thursday
SESSION 55: NEW OR IMPROVED DEVICES FOR EVAR AND JUXTARENAL AAA REPAIR (4 1/2-MINUTE TALKS
x
6:45 AM - 6:50 AM Aorfix Endograft With The New IntelliFlex Delivery System For EVAR: Technique And Advantages
  Presenter(s):Andrew Holden, MBChB  
  View Slides in PDF      
6:50 AM - 6:55 AM Aorfix Endograft For EVAR: Interim Results Of The ARCHYTAS Post Market Registry Experience With On-Label And Off-Label Use Of The Graft With Unfavorable Anatomy
  Presenter(s):Vicente Riambau, MD, PhD  
  View Slides in PDF      
6:55 AM - 7:00 AM Aorfix Endograft For EVAR: 3-Year Results Of PYTHAGORAS Pivotal PMA Trial In Standard And Angulated Neck AAAs
  Presenter(s):Mark F. Fillinger, MD  
  View Slides in PDF      
7:00 AM - 7:05 AM Gore C3 Excluder Endograft With C3 Delivery System Which Allows Graft Repositioning: Advantages And Experience In >200 AAA Patients
  Presenter(s):Athanasios Katsargyris, MD / Eric L.G. Verhoeven, MD, PhD  
  View Slides in PDF      
7:05 AM - 7:10 AM Gore Excluder Endograft For EVAR: 10-Year Experience Demonstrates Endograft Durability
  Presenter(s):Giovanni Pratesi, MD  
  View Slides in PDF      
7:10 AM - 7:15 AM Gore Conformable CEXC Excluder Endograft For EVAR: The Angle Of The Proximal Graft Body Can Be Actively Changed To Conform To AAA Neck Angulation: How Does It Work And Early Results
  Presenter(s):Marc R.H.M. van Sambeek, MD, PhD / Dittmar Boeckler, MD / Hence J.M. Verhagen, MD, PhD  
  View Slides in PDF      
7:15 AM - 7:20 AM Cordis Incraft Endograft For EVAR 4-Year Experience: Advantages And European Trial Results
  Presenter(s):Giovanni Torsello, MD  
  View Slides in PDF      
7:20 AM - 7:31 AM Panel Discussion
Moderator(s): ShenMing Wang, MD, PhD / James F. McKinsey, MD  
7:31 AM - 7:36 AM Fenestrated Anaconda Endograft (Vascutek) For Juxtarenal AAA Repairs And Type 1A Endoleaks: Advantages And European Multicenter Results To Date
  Presenter(s):Donald B. Reid, MD / Clark J. Zeebregts, MD, PhD / Afshin Assadian, MD  
  View Slides in PDF      
7:36 AM - 7:41 AM Anaconda ONE-LOK Endograft (Vascutek) For EVAR: Technical Advantages And 1 Year US Results
  Presenter(s):Christopher J. Kwolek, MD  
  View Slides in PDF      
7:41 AM - 7:46 AM Newly Modified Medtronic Endurant (EVO) Endograft: Initial Clinical Experience And Advantages
  Presenter(s):Gilbert R. Upchurch, Jr., MD  
  View Slides in PDF      
7:46 AM - 7:51 AM Ovation Endograft From TriVascular For EVAR: Advantages And Tips And Tricks For Use
  Presenter(s):David J. Minion, MD  
  View Slides in PDF      
7:51 AM - 7:56 AM Ovation Endograft From TriVascular: The Real World European Experience And Advantages
  Presenter(s):Patrick Peeters, MD  
  View Slides in PDF      
7:56 AM - 8:01 AM Ovation Prime Endograft From TriVascular: Midterm Results And Advantages
  Presenter(s):Carlo Setacci, MD / Francesco Setacci, MD  
  View Slides in PDF      
8:01 AM - 8:12 AM Panel Discussion
END OF SESSION 55
 
SESSION 56 SCHEDULE
Thursday
SESSION 56: MORE NEW OR IMPROVED DEVICES FOR EVAR
x
8:12 AM - 8:17 AM Aorfix Endograft Can Be Effective In Badly Angled AAA Necks: Tips And Tricks To Make It Work And When It Will Not
  Presenter(s):Mahmoud B. Malas, MD, MHS  
  View Slides in PDF      
8:18 AM - 8:23 AM Treovance Endograft (Bolton Medical) For EVAR: Experience To Date And Advantages
  Presenter(s):Matthew J. Eagleton, MD  
  View Slides in PDF      
8:24 AM - 8:29 AM New Cook Zenith Alpha Endograft System For EVAR: Why It Is Better
  Presenter(s):Eric L.G. Verhoeven, MD, PhD  
  View Slides in PDF      
8:30 AM - 8:35 AM Nellix Endograft System From Endologix For Endovascular Aneurysm Sealing (EVAS): Clinical Experience To Date: Type 1A Endoleaks Can Occur And Can Cause Rupture But They Can Be Detected And Fixed: How To Do So
  Presenter(s):Dittmar Boeckler, MD  
  View Slides in PDF      
8:36 AM - 8:41 AM Nellix Endograft System For EVAS: Key Points From The Global Registry And How To Prevent, Diagnose And Treat Type IA Endoleaks
  Presenter(s):Andrew Holden, MBChB / Jean-Paul de Vries, MD, PhD  
  View Slides in PDF      
8:42 AM - 8:47 AM Nellix Endograft System For EVAS: What Are The Anatomic Restrictions: Can Chimney Grafts Be Used With It: How To Detect And Fix Gutter Endoleaks
  Presenter(s):Ian Loftus, MD  
  View Slides in PDF      
8:48 AM - 8:53 AM In Vitro Model Shows That Sac And Gutter Sealing Is Achieved With Chimney Graft And The Nellix Device If Certain Conditions Are Fulfilled
  Presenter(s):Jan D. Blankensteijn, MD  
  View Slides in PDF      
8:54 AM - 8:59 AM How The Nellix Device Can Be Used To Treat AAAs With Iliac Aneurysms: Tips And Tricks
  Presenter(s):Dainis K. Krievins, MD  
  View Slides in PDF      
9:00 AM - 9:05 AM Gore Excluder Iliac Branched Endograft Device For Hypogastric Revascularization: The Initial European Experience: Advantages And Limitations
  Presenter(s):Michel M.P. Reijnen, MD, PhD  
  View Slides in PDF      
9:06 AM - 9:11 AM 1-Year US Results Of Gore Iliac Branched Endograft: Advantages And Limitations
  Presenter(s):Darren B. Schneider, MD  
  View Slides in PDF      
9:12 AM - 9:17 AM Cook Iliac Branched Device For Hypogastric Revascularization: Advantages And Long-Term Durability: Failure Rates And Contraindications
  Presenter(s):Fabio Verzini, MD, PhD  
  View Slides in PDF      
9:18 AM - 9:25 AM Panel Discussion
9:25 AM - 9:40 AM Break - Visit Exhibits And Pavilions (2nd and 3rd Floors)
END OF SESSION 56
 
SESSION 57 SCHEDULE
Thursday
SESSION 57: NEW OR IMPROVED DEVICES FOR TEVAR OR BRANCHED EVAR FOR TAAAs
x
9:40 AM - 9:45 AM The Bolton Ascending Aortic Endovascular Endograft Device: Technical Aspects, Advantages And Limitations
  Presenter(s):Carlos E. Donayre, MD / Rodney A. White, MD  
  View Slides in PDF      
9:46 AM - 9:51 AM Bolton Relay Endograft System For TEVAR: Technical Description, Unique Advantages And Clinical Experience To Date
  Presenter(s):Vicente Riambau, MD, PhD  
  View Slides in PDF      
9:52 AM - 9:57 AM Bolton Aortic Arch Endograft Device: Technical Description, Advantages And Clinical Results
  Presenter(s):W. Anthony Lee, MD  
  View Slides in PDF      
9:58 AM - 10:03 AM Proximal Scalloped Endografts (Bolton) For TEVAR To Maintain Left Subclavian Flow: Advantages, Limitations And Midterm Results
  Presenter(s):Michael P. Jenkins, MBBS, BSc, MS, FRCS, FEBVS  
  View Slides in PDF      
10:04 AM - 10:09 AM Advantages Of The Bolton Relay TEVAR Device With A Proximal Scallop: Can It Serve As An Off-The-Shelf Device
  Presenter(s):Jean-Marc Alsac, MD, PhD  
  View Slides in PDF      
10:10 AM - 10:15 AM Gore Conformable TAG (CTAG) Device For TEVAR: 2-Year Multicenter Trial Results
  Presenter(s):William D. Jordan, Jr., MD  
  View Slides in PDF      
10:16 AM - 10:21 AM Value Of Hybrid Repairs Of Aortic Arch Lesions With And Without The Gore Hybrid Graft: Its Advantages
  Presenter(s):Grayson H. Wheatley, MD  
  View Slides in PDF      
10:22 AM - 10:27 AM Cook Zenith Low Profile Alpha Endograft System For TEVAR: Advantages And Clinical Results
  Presenter(s):Germano Melissano, MD  
  View Slides in PDF      
10:28 AM - 10:33 AM Cook Zenith Alpha Endograft Device For TEVAR: Advantages And Clinical Experience
  Presenter(s):Jean-Pierre Becquemin, MD, FRCS  
  View Slides in PDF      
10:34 AM - 10:39 AM Cook T-Branch Off-The-Shelf Branched Endograft System For TAAAs: Extending Its Applicability
  Presenter(s):Marcelo Ferreira, MD  
  View Slides in PDF      
10:40 AM - 10:49 AM Panel Discussion
END OF SESSION 57
 
SESSION 58 SCHEDULE
Thursday
SESSION 58: NEW THORACIC AORTIC AND TAAA DEVICES
x
10:50 AM - 10:55 AM Are New Endograft Devices For TEVAR Solving The Problems That Occurred With The Older Systems: What Does The Future Hold
  Presenter(s):Clifford J. Buckley, MD  
  View Slides in PDF      
10:56 AM - 11:01 AM The Value And Limitations Of The New Lower Profile Devices For TEVAR
  Presenter(s):Giovanni Torsello, MD  
  View Slides in PDF      
11:02 AM - 11:07 AM A New Simplified Endovascular Graft For TAAAs: It Needs Only A Single Measurement: Neck Diameter For Planning And Graft Selection
  Presenter(s):Juan C. Parodi, MD  
  View Slides in PDF      
11:08 AM - 11:13 AM Update On The Zenith TX2-LP Endograft System For Treatment Of Blunt Thoracic Aortic Injuries: Advantages, Limitations And Results
  Presenter(s):Benjamin W. Starnes, MD  
  View Slides in PDF      
11:14 AM - 11:19 AM For Treating Ischemic Complications Of TBADs, The Petticoat Concept Using A Proximal Bolton Relay Or E-Vita (Jotec) TEVAR And Distal Jotec E-XL Bare Stent Is Valuable But 50% Of Patients Also Require Aortic Branch Stents: Clinical Results
  Presenter(s):Burkhart Zipfel, MD, PhD  
  View Slides in PDF      
LEFT SUBCLAVIAN ARTERY REVASCULARIZATION
11:20 AM - 11:25 AM Laser In Situ Fenestration Is The Best Way To Preserve LSA Flow When Its Origin Must Be Covered: Techniques, Limitations And Midterm Results
  Presenter(s):Jean M. Panneton, MD  
  View Slides in PDF      
BRANCHED TEVAR
11:26 AM - 11:31 AM The Medtronic Branched TEVAR Endograft – The Valiant Mona LSA System: Technique, Advantages And Results
  Presenter(s):Frank R. Arko, MD / Eric E. Roselli, MD  
  View Slides in PDF      
11:32 AM - 11:37 AM Gore Branched Endograft For Treating Arch Lesions: Technique, Early Results With The LSA And Future Potential For Treating Other Arch Branches
  Presenter(s):Michael D. Dake, MD  
  View Slides in PDF      
11:38 AM - 11:43 AM Will The Benefits Of LSA Branched TEVAR Devices Justify The Costs
  Presenter(s):Frank J. Criado, MD, FACS, FSVM  
  View Slides in PDF      
11:44 AM - 11:49 AM New Developments In In Situ Fenestration: How Can It Be Made To Work In Complex Aortic And Arch Endografting
  Presenter(s):Bjõrn Sonesson, MD, PhD  
  View Slides in PDF      
11:50 AM - 12:00 PM Panel Discussion
12:00 PM - 1:00 PM Lunch Break – 2nd Floor Promenade
Visit Exhibits And Pavilions (2nd and 3rd Floors)

END OF SESSION 58
 
SESSION 59 SCHEDULE
Thursday
SESSION 59: NEW DEVICES FOR TREATMENT OF LOWER EXTREMITY DISEASE
x
PROSTHETIC ARTERIAL GRAFTS
1:00 PM - 1:05 PM 1-Year Results Of The FINAST RCT Comparing The Fusion Bioline Heparin Coated Prosthetic Graft vs. A Standard PTFE Graft For Femoropopliteal Bypasses: The Fusion Graft Had Better Patency And Less Suture Line Bleeding
  Presenter(s):Alan B. Lumsden, MD, FACS  
  View Slides in PDF      
1:06 PM - 1:11 PM Update On The Advantages Of Spiral Flow Prosthetic Grafts In Decreasing Intimal Hyperplasia After Bypasses
  Presenter(s):Sebastian E. Debus, MD, PhD / Christian A. Behrendt, MD / Hosam F. El Sayed, MD  
  View Slides in PDF      
1:12 PM - 1:17 PM Are Propaten-Bonded PTFE Arterial Fempop Grafts Cost Effective: How Well Does Their Improved Patency Persist
  Presenter(s):Jes S. Lindholt, MD  
  View Slides in PDF      
1:18 PM - 1:23 PM Interesting Uses For The Gore Hybrid PTFE Graft Which Combines A Covered Self-Expanding Stent At One End With A Standard Vascular Graft At The Other End: Advantages And Limitations
  Presenter(s):Edward Y. Woo, MD  
  View Slides in PDF      
ENDOVASCULAR INNOVATIONS
1:24 PM - 1:29 PM Present Status Of Drug Eluting Devices In Tibial Artery Endovascular Treatments
  Presenter(s):Mark G. Davies, MD  
  View Slides in PDF      
1:30 PM - 1:35 PM The Value Of DEBs In Infrapopliteal Arteries Is Promising: Why The In.Pact Deep Trial Failed To Show A Benefit And What Is Being Done To Make DEBs Work Better In Leg Arteries
  Presenter(s):Andrej Schmidt, MD  
  View Slides in PDF      
1:36 PM - 1:41 PM A New Concept For Local Drug Delivery To Arteries Using The Bullfrog Catheter Technology From Mercator
  Presenter(s):Andrej Schmidt, MD / Dierk Scheinert, MD  
  View Slides in PDF      
1:42 PM - 1:47 PM Update On The Chocolate PTA Balloon: Mode Of Action, Advantages And Clinical Results
  Presenter(s):Jihad A. Mustapha, MD  
  View Slides in PDF      
1:48 PM - 1:53 PM Value Of Bioabsorbable Antibiotic Impregnated Beads In Treating Vascular Graft Infections
  Presenter(s):Rabih A. Chaer, MD  
  View Slides in PDF      
1:54 PM - 2:00 PM Panel Discussion
END OF SESSION 59
 
SESSION 60 SCHEDULE
Thursday
SESSION 60: NEW STENT AND STENT-GRAFT DEVICES AND CONCEPTS
x
BIODEGRADABLE STENTS
2:00 PM - 2:05 PM The ABSORB III Trial Results: The Pivotal US Approval Randomized Trial Of Bioabsorbable Scaffolds vs. Metallic Drug-Eluting Stents In Coronary Artery Disease
  Presenter(s):Gregg W. Stone, MD  
  View Slides in PDF      
2:06 PM - 2:11 PM How Well Do Biodegradable Stents Work In The Coronary Arteries: Where Are They Going In Other Arteries – Especially Smaller Ones
  Presenter(s):Ron Waksman, MD  
  View Slides in PDF      
2:12 PM - 2:17 PM 1-Year Experience With Drug Eluting (Everolimus) Bioabsorbable Stents (ABSORB BVS From Abbott) In The BTK Arteries Including The Tibials
  Presenter(s):Ramon L. Varcoe, MD  
  View Slides in PDF      
2:18 PM - 2:23 PM The ESPRIT Bioabsorbable DES In The SFA: 2-Year Results Are Promising
  Presenter(s):Johannes Lammer, MD  
  View Slides in PDF      
2:24 PM - 2:29 PM Rethinking Stent Designs And Techniques For Use In The SFA: What Does The Future Hold
  Presenter(s):Brian G. DeRubertis, MD  
  View Slides in PDF      
2:30 PM - 2:42 PM Panel Discussion
Moderator(s): Giancarlo Biamino, MD, PhD / Firas F. Mussa, MD  
2:43 PM - 2:48 PM New Nitinol Stents (Like SMART CONTROL From Cordis) In The SFA: Are They Better Than The Old Ones For Patency And Effectiveness – Especially For More Complex Lesions
  Presenter(s):Daniel G. Clair, MD  
  View Slides in PDF      
2:49 PM - 2:54 PM Pulsar Nitinol Stent In Combination With Other Adjunctive Techniques (DEBs, Scoring Balloons, Debulking Devices): 12-Month Results Of The BIOFLEX Registry Are Promising
  Presenter(s):Michael K.W. Lichtenberg, MD  
  View Slides in PDF      
2:55 PM - 3:00 PM >1 Year Experience With The Unique Two Component Gore Tigris Stent In The SFA And Popliteal Artery: What Are Its Unique Advantages And Limitations
  Presenter(s):Andrej Schmidt, MD  
  View Slides in PDF      
3:01 PM - 3:06 PM Self-Expanding Thin Strut Nitinol Stents (Pulsar) Plus DEBs: 2-Year Results From The DEBAS Trial Are Promising
  Presenter(s):B. Patrice Mwipatayi, FRACS  
  View Slides in PDF      
3:07 PM - 3:12 PM A Long Self-Expanding Bare Metal Stent (EverFlex From Covidien) Can Be Effective In Treating Complex Fempop Lesions: 3-Year Results From The DURABILITY II Trial
  Presenter(s):Jon S. Matsumura, MD / Krishna J. Rocha-Singh, MD  
  View Slides in PDF      
3:13 PM - 3:18 PM Silent Infection Of Endografts: How Can It Be Detected And What Is Its Significance
  Presenter(s):Werner Lang, MD  
  View Slides in PDF      
3:19 PM - 3:26 PM Panel Discussion
3:26 PM - 3:40 PM Break - Visit Exhibits And Pavilions (2nd and 3rd Floors)
END OF SESSION 60
 
SESSION 61 SCHEDULE
Thursday
SESSION 61: PREVENTING AND TREATING MIGRATION AND ENDOLEAKS: UPDATE ON HELI-FX ENDOANCHORS
x
3:40 PM - 3:45 PM How Effective Is Embolization (With Coils And Onyx) For Otherwise Untreatable Proximal Type 1 Endoleaks After EVAR: Techniques, Midterm Outcomes, Pitfalls And Patient Selection
  Presenter(s):Robert A. Morgan, MD  
  View Slides in PDF      
3:46 PM - 3:51 PM When Do Aptus EndoAnchors Work In EVAR And When Don’t They: Update On ANCHOR Registry: Do EndoAnchors Prevent Type 1A Endoleaks
  Presenter(s):William D. Jordan, Jr., MD  
  View Slides in PDF      
3:52 PM - 3:57 PM Can EndoAnchors Fix Early And Late Type 1A Endoleaks: Do They Prevent Migration
  Presenter(s):Jean-Paul de Vries, MD, PhD  
  View Slides in PDF      
3:58 PM - 4:03 PM Treatment Of Endograft Migration With Type 1A Endoleak With Chimney Grafts: Technical Tips And Results
  Presenter(s):Ignacio Escotto, MD  
  View Slides in PDF      
4:04 PM - 4:09 PM EndoAnchors Can Increase EVAR Durability: Comparison Of Matched Patients With And Without EndoAnchors
  Presenter(s):Bart E. Muhs, MD, PhD  
  View Slides in PDF      
4:10 PM - 4:15 PM Do EndoAnchors Stop Or Delay AAA Neck Dilatation After EVAR
  Presenter(s):Apostolos K. Tassiopoulos, MD  
  View Slides in PDF      
WITH TEVAR
4:16 PM - 4:21 PM Tips And Tricks For EndoAnchor Use During TEVAR: When Are They Indicated
  Presenter(s):Grayson H. Wheatley, MD  
  View Slides in PDF      
4:22 PM - 4:27 PM Technique Of EndoAnchor Placement During TEVAR: Indications And Results
  Presenter(s):Jean M. Panneton, MD  
  View Slides in PDF      
4:28 PM - 4:33 PM Use Of EndoAnchors To Seal Gutter Endoleaks After Parallel Grafts With TEVAR And EVAR: Technical Consideration And How To Place Them
  Presenter(s):Zvonimir Krajcer, MD, FACC  
  View Slides in PDF      
4:34 PM - 4:39 PM Value Of EndoAnchors In Complex TEVARs And F/B EVARs: Indications And Technical Tips
  Presenter(s):Piotr M. Kasprzak, MD  
  View Slides in PDF      
4:40 PM - 4:47 PM Panel Discussion
END OF SESSION 61
 
SESSION 62 SCHEDULE
Thursday
SESSION 62: NEW DEVICES AND CONCEPTS FOR EMBOLIZATION, THROMBECTOMY AND THROMBOLYSIS
x
4:48 PM - 4:53 PM POD Coils From Penumbra: A New Better Coil Embolization Device Which Fixes Coils To Vessel Wall And Permits Tighter Packing: Technical Aspects And Clinical Experience
  Presenter(s):Frank R. Arko, MD  
  View Slides in PDF      
4:54 PM - 4:59 PM Clinical Experience With PODCOIL Embolization In The ACE Multicenter Study
  Presenter(s):Claudio J. Schonholz, MD  
  View Slides in PDF      
CATHETER THROMBECTOMY AND THROMBOLYSIS (SEE ALSO SESSION 29)
5:00 PM - 5:05 PM Indigo Catheter Thrombectomy System From Penumbra: A Novel Endovascular Way To Remove Clot From Medium-Sized And Small Arteries: What Makes It Different And Better And Multicenter Clinical Results From The PRISM Trial
  Presenter(s):James F. Benenati, MD  
  View Slides in PDF      
5:06 PM - 5:11 PM Advantages Of The Indigo Thrombectomy Device For Treating ALI: How Does It Work And Why Does It Get Fresh And Old Clot Out More Effectively Than Other Systems
  Presenter(s):Patrick E. Muck, MD, FACS  
  View Slides in PDF      
5:12 PM - 5:17 PM The Indigo Thrombectomy System Reduces The Need For Thrombolytics And Decreases The Risk And Cost Of Treatment For ALI
  Presenter(s):Frank R. Arko, MD  
  View Slides in PDF      
5:18 PM - 5:23 PM When Thrombosis Complicates Retrograde Access For Complex Lower Extremity Interventions, Intra-Thrombus Bolus ReoPro And Catheter Aspiration Can Be Helpful: Technical Tips And Tricks
  Presenter(s):Thomas O. McNamara, MD  
5:24 PM - 5:29 PM How To Decrease Bleeding Associated With Catheter Directed Thrombolysis And Improve Clot Lysis And Safety With A Microbubble Technique: Technical Aspects And Results
  Presenter(s):Kak Khee Yeung, MD, PhD  
  View Slides in PDF      
5:30 PM - 5:35 PM There Is No Advantage To Giving Heparin With Intra-arterial Thrombolysis: How To Prevent Clot Formation On Catheters And Sheaths
  Presenter(s):Martin Bjorck, MD, PhD  
  View Slides in PDF      
5:36 PM - 5:44 PM Panel Discussion

End of Program H

END OF SESSION 62
 
SESSION 63 SCHEDULE
Thursday
SESSION 63: VENOUS CLINICAL EXAMINATION AND HEMODYNAMICS
x
7:30 AM - 7:31 AM Introduction To Veins At VEITH
  Presenter(s):Jose I. Almeida, MD, RVT, RPVI, FACS  
7:31 AM - 7:36 AM Establishing The Treatment Plan With CEAP & VCSS
  Presenter(s):Jose I. Almeida, MD, RVT, RPVI, FACS  
  View Slides in PDF      
7:37 AM - 7:42 AM Outcome Assessment Of CVD
  Presenter(s):Lowell S. Kabnick, MD, RPhS, FACS, FACPh  
  View Slides in PDF      
7:43 AM - 7:48 AM Identifying Reflux Pathways With Duplex Ultrasound Mapping
  Presenter(s):Neil M. Khilnani, MD  
  View Slides in PDF      
7:49 AM - 7:54 AM Symptoms Of Chronic Venous Disease: Definition And Significance
  Presenter(s):Raghu Kolluri, MD  
  View Slides in PDF      
7:55 AM - 8:00 AM Veins: Beginning Or End Of Circulation: Differences In Physiology And Pathology
  Presenter(s):Seshadri Raju, MD  
  View Slides in PDF      
8:01 AM - 8:06 AM Air Plethysmography For Beginners
  Presenter(s):Andrew N. Nicolaides, MS, FRCS  
  View Slides in PDF      
8:07 AM - 8:12 AM Hemodynamic Approach On Superficial Venous Reflux (ASVAL): Does It Work
  Presenter(s):Sylvain Chastanet, MD  
  View Slides in PDF      
8:13 AM - 8:18 AM Hemodynamic Approach On Superficial Venous Reflux (CHIVA): Does It Work
  Presenter(s):Paolo Zamboni, MD  
  View Slides in PDF      
8:19 AM - 8:24 AM A New Look At Venous Hemodynamics: Measuring Reflux And Venous Outflow Obstruction
  Presenter(s):Andrew N. Nicolaides, MS, FRCS  
  View Slides in PDF      
8:25 AM - 8:30 AM Panel Discussion
END OF SESSION 63
 
SESSION 64 SCHEDULE
Thursday
SESSION 64: VENOUS IMAGING TECHNIQUES
x
8:31 AM - 8:36 AM Duplex Mapping: Tweaking The Buttons For Image Optimization
  Presenter(s):Jan M. Sloves, RVT  
  View Slides in PDF      
8:37 AM - 8:42 AM How To Recognize Variants On The Venous Duplex Exam
  Presenter(s):Neil M. Khilnani, MD  
  View Slides in PDF      
8:43 AM - 8:48 AM Reflux Exam In The Standing Position: Why Is This Still Controversial
  Presenter(s):Mark H. Meissner, MD  
  View Slides in PDF      
8:49 AM - 8:54 AM The Argument Against Routine Duplex Ultrasound After Truncal Ablation: An Evidence-Based Cost-Benefit Analysis
  Presenter(s):Thomas F. O'Donnell, Jr., MD  
  View Slides in PDF      
8:55 AM - 9:00 AM Vein Diameter Is Not The Key For Stratifying Interventional Strategies For Superficial Venous Disease
  Presenter(s):Alun H. Davies, MA, DM, DSc, FRCS, FHEA, FEBVS, FACPh  
  View Slides in PDF      
9:01 AM - 9:06 AM The Use Of Wound Planimetry To Guide Decisions About Superficial And Perforator Ablations
  Presenter(s):Peter F. Lawrence, MD  
  View Slides in PDF      
9:07 AM - 9:12 AM C1 Disease And Truncal Incompetence: To Ablate Or Not To Ablate
  Presenter(s):Jose I. Almeida, MD, RVT, RPVI, FACS  
  View Slides in PDF      
9:13 AM - 9:18 AM Panel Discussion
END OF SESSION 64
 
SESSION 65 SCHEDULE
Thursday
SESSION 65: SUPERFICIAL VEIN TREATMENT STRATEGIES AND TECHNIQUES
x
9:19 AM - 9:24 AM Staged Phlebectomy: Why
  Presenter(s):Jean Luc Gerard, MD  
  View Slides in PDF      
9:25 AM - 9:30 AM Concomitant Treatment Of Truncal Reflux And Varicosed Tributaries Is The Gold Standard
  Presenter(s):Alun H. Davies, MA, DM, DSc, FRCS, FHEA, FEBVS, FACPh  
  View Slides in PDF      
9:31 AM - 9:36 AM Lessons Learned: RF Ablation
  Presenter(s):Mark S. Whiteley, MS, FRCS  
  View Slides in PDF      
9:37 AM - 9:42 AM Lessons Learned: Laser Ablation
  Presenter(s):Jean Luc Gerard, MD  
  View Slides in PDF      
9:43 AM - 9:48 AM Lessons Learned: MOCA Ablation
  Presenter(s):Steve Elias, MD  
  View Slides in PDF      
9:49 AM - 9:54 AM Step By Step: Cyanoacrylate Embolic Adhesive
  Presenter(s):Ian J. Franklin, Mr, MS, FRCS (Gen Surg)  
  View Slides in PDF      
9:55 AM - 10:00 AM Step By Step: Proprietary Foam
  Presenter(s):Kathleen D. Gibson, MD  
  View Slides in PDF      
10:01 AM - 10:06 AM Step By Step: Phlebectomy
  Presenter(s):Lowell S. Kabnick, MD, RPhS, FACS, FACPh  
  View Slides in PDF      
10:07 AM - 10:12 AM Cyanocrylate Adhesive: More Than One Product Available: Is There A Difference
  Presenter(s):Ian J. Franklin, Mr, MS, FRCS (Gen Surg)  
  View Slides in PDF      
10:13 AM - 10:18 AM A Strategy For Treatment Of Complex And Extensive Venous Burden
  Presenter(s):Barrie A. Price, Mr, MD, MS, FRCS  
  View Slides in PDF      
10:19 AM - 10:24 AM Superficial Reflux With Obstructed Deep Veins: When And When Not To Treat
  Presenter(s):Manj S. Gohel, MD, RCS, FEBVS  
  View Slides in PDF      
10:25 AM - 10:30 AM Incidence, Causes, And Treatment Of Recurrent Varicose Veins Following Endovenous Thermal Ablation
  Presenter(s):Edward G. Mackay, MD  
  View Slides in PDF      
10:31 AM - 10:36 AM Will The 1920nm Laser Be The Best
  Presenter(s):Lowell S. Kabnick, MD, RPhS, FACS, FACPh  
  View Slides in PDF      
10:37 AM - 10:42 AM Concomitant Truncal Venous Incompetence And Lymphedema: To Ablate Or Not To Ablate
  Presenter(s):Paul Pittaluga, MD  
  View Slides in PDF      
10:43 AM - 10:48 AM Reflux Extending To The Ankle: When And How To Treat
  Presenter(s):Steve Elias, MD  
  View Slides in PDF      
10:49 AM - 10:54 AM Panel Discussion
END OF SESSION 65
 
SESSION 66 SCHEDULE
Thursday
SESSION 66: VENOUS SOCIETAL AND GOVERNANCE
x
10:55 AM - 11:00 AM 25 Years Of IAC-VL And Still No Link To Reimbursement: Should I Continue Spending Money To Re-Accredit
  Presenter(s):Mark H. Meissner, MD  
  View Slides in PDF      
11:01 AM - 11:06 AM IAC Vein Center: Importance And Update
  Presenter(s):Alan M. Dietzek, MD, RPVI, FACS  
  View Slides in PDF      
11:07 AM - 11:12 AM How To Deal With LCDs
  Presenter(s):Harold J. Welch, MD  
  View Slides in PDF      
11:13 AM - 11:18 AM Medicare Policy, Payments And Pitfalls
  Presenter(s):Harold J. Welch, MD  
  View Slides in PDF      
11:19 AM - 11:24 AM How Should Reflux Testing Be Performed According To IAC-VL
  Presenter(s):Ellen D. Dillavou, MD  
  View Slides in PDF      
11:25 AM - 11:30 AM Outpatient Interventions: Are Controls Needed
  Presenter(s):Paul J. Gagne, MD, FSIR, FACR  
  View Slides in PDF      
11:31 AM - 11:36 AM Update On The SVS-PSO VQI Venous Registry
  Presenter(s):Jose I. Almeida, MD, RVT, RPVI, FACS  
  View Slides in PDF      
11:37 AM - 11:42 AM What Is The Future Of Venous Reimbursement
  Presenter(s):Glenn Jacobowitz, MD  
  View Slides in PDF      
11:43 AM - 11:48 AM Non-Thermal Devices Are Available For Truncal Ablation: How To Implement In Practice Without Dedicated CPT Codes
  Presenter(s):Steve Elias, MD  
  View Slides in PDF      
11:49 AM - 11:54 AM A National Coverage Determination Policy Is Needed
  Presenter(s):Lowell S. Kabnick, MD, RPhS, FACS, FACPh  
  View Slides in PDF      
11:55 AM - 12:00 PM Economic Forecast And Recommendations For Venous Intervention
  Presenter(s):Peter F. Lawrence, MD  
  View Slides in PDF      
12:00 PM - 12:59 PM Lunch Break – 2nd Floor Promenade
Visit Exhibits And Pavilions (2nd and 3rd Floors)

END OF SESSION 66
 
SESSION 67 SCHEDULE
Thursday
SESSION 67: EXAMINING THE EVIDENCE
x
1:00 PM - 1:05 PM C6 Disease: Is Superficial Surgery A Cost Benefit
  Presenter(s):Thomas F. O'Donnell, Jr., MD  
  View Slides in PDF      
1:06 PM - 1:11 PM C6 Disease: When To Ablate A Refluxing Saphenous Vein
  Presenter(s):Brajesh K. Lal, MD  
  View Slides in PDF      
1:12 PM - 1:17 PM C5 Or C6 With Arterial Claudication: Which Comes First
  Presenter(s):Marc A. Passman, MD  
  View Slides in PDF      
1:18 PM - 1:23 PM C6: Treat Central Venous Occlusion First
  Presenter(s):Lowell S. Kabnick, MD, RPhS, FACS, FACPh  
  View Slides in PDF      
1:24 PM - 1:29 PM Perforator Ablation For C3 Or C4
  Presenter(s):John Blebea, MD, MBA  
  View Slides in PDF      
1:30 PM - 1:35 PM Is Accessory Saphenous Vein Ablation Experimental
  Presenter(s):Elna M. Masuda, MD  
  View Slides in PDF      
1:36 PM - 1:41 PM Is C2 Disease Progressive
  Presenter(s):Mark H. Meissner, MD  
  View Slides in PDF      
1:42 PM - 1:47 PM Why Graduated Compression Is An Insurance Requirement
  Presenter(s):Fedor Lurie, MD, PhD  
  View Slides in PDF      
1:48 PM - 1:53 PM Panel Discussion
END OF SESSION 67
 
SESSION 68 SCHEDULE
Thursday
SESSION 68: MORE USEFUL SUPERFICAL VEIN INFORMATION
x
1:54 PM - 1:59 PM Is The Saphenous Vein Sacred
  Presenter(s):Paul Pittaluga, MD  
  View Slides in PDF      
2:00 PM - 2:05 PM Sclerotherapy Pearls
  Presenter(s):Neil M. Khilnani, MD  
  View Slides in PDF      
2:06 PM - 2:11 PM Should You Use Foam For Telangiectasia Or Reticular Veins: Where Is The Evidence
  Presenter(s):Ellen D. Dillavou, MD  
  View Slides in PDF      
2:12 PM - 2:17 PM Neurological Complications Of Sclerotherapy For Varicose Veins
  Presenter(s):Edward G. Mackay, MD  
  View Slides in PDF      
2:18 PM - 2:23 PM Why Not Use Homemade Foam For The GSV
  Presenter(s):Lowell S. Kabnick, MD, RPhS, FACS, FACPh  
  View Slides in PDF      
2:24 PM - 2:29 PM Laser Or Ohmic Devices For Telangiectasia: When And Why
  Presenter(s):Ian J. Franklin, Mr, MS, FRCS (Gen Surg)  
  View Slides in PDF      
2:30 PM - 2:35 PM Superficial Vein Thrombophlebitis: To Treat Or Not To Treat
  Presenter(s):Dawn M. Coleman, MD  
  View Slides in PDF      
2:36 PM - 2:41 PM SVT In The Pregnant Patient
  Presenter(s):Joann Lohr, MD  
  View Slides in PDF      
2:42 PM - 2:47 PM Panel Discussion
END OF SESSION 68
 
SESSION 69 SCHEDULE
Thursday
SESSION 69: SUPERFICIAL VENOUS ABLATION, COMPRESSION AND RESEARCH
x
2:48 PM - 2:53 PM How To Properly Design And Interpret Clinical Trials
  Presenter(s):Thomas W. Wakefield, MD  
  View Slides in PDF      
2:54 PM - 2:59 PM Thermal Ablation On Anticoagulated Patients: Is It Safe And Effective
  Presenter(s):Glenn Jacobowitz, MD  
  View Slides in PDF      
3:00 PM - 3:05 PM VeClose Randomized Clinical Trial: 12-Month Follow-Up Results - VenaSeal vs. RFT (ClosureFast)
  Presenter(s):Kathleen D. Gibson, MD  
  View Slides in PDF      
3:06 PM - 3:12 PM Complete Varicose Vein Surgery Improves VCSS: Advantages Of Ablation Plus Transilluminated Powered Phlebectomy (TIPP)
  Presenter(s):Thomas W. Wakefield, MD  
  View Slides in PDF      
3:13 PM - 3:18 PM Biological Differences And Similarities Between 147nm And 1920nm On The Vein Wall: Using Immunocytochemistry
  Presenter(s):Mark S. Whiteley, MS, FRCS  
  View Slides in PDF      
3:19 PM - 3:24 PM Varithena: Summary Phase 3 Trials
  Presenter(s):Lowell S. Kabnick, MD, RPhS, FACS, FACPh  
  View Slides in PDF      
3:25 PM - 3:30 PM The SECURE Trial: Update On Perforator Ablation
  Presenter(s):Mark A. Adelman, MD  
  View Slides in PDF      
3:31 PM - 3:36 PM Endovenous Thermal Ablation RCTs: Do We Know Enough
  Presenter(s):Peter Gloviczki, MD  
  View Slides in PDF      
3:37 PM - 3:42 PM Can Real World Experience Contradict RCTs (e.g., ESCHAR Trial)
  Presenter(s):Alfred M. Obermayer, MD  
  View Slides in PDF      
3:43 PM - 3:48 PM Shocking: All Companies' Graduated Compression Measurements Are Not The Same
  Presenter(s):John Blebea, MD, MBA  
  View Slides in PDF      
3:49 PM - 3:54 PM What To Do When Stockings Fail To Control Swelling
  Presenter(s):Mark H. Meissner, MD  
  View Slides in PDF      
3:55 PM - 4:00 PM What Does Compression Add To Thermal Ablation
  Presenter(s):Todd Berland, MD  
  View Slides in PDF      
4:01 PM - 4:06 PM What Is Short-Stretch Compression And Why Is That Important For Vascular Surgeons
  Presenter(s):Fedor Lurie, MD, PhD  
  View Slides in PDF      
4:07 PM - 4:12 PM Panel Discussion
END OF SESSION 69
 
SESSION 70 SCHEDULE
Thursday
SESSION 70: VENOUS PRACTICE MANAGEMENT
x
4:13 PM - 4:18 PM Five Things Your Office Manager Should Be Doing
  Presenter(s):Barrie A. Price, Mr, MD, MS, FRCS  
  View Slides in PDF      
4:19 PM - 4:24 PM Venous EMR Trials And Tribulations
  Presenter(s):Edward G. Mackay, MD  
  View Slides in PDF      
4:25 PM - 4:30 PM Marketing Your Vein Practice
  Presenter(s):Mark S. Whiteley, MS, FRCS  
  View Slides in PDF      
4:31 PM - 4:36 PM Optimizing Patient Throughput And Increasing Patient Satisfaction: Lean Six Sigma
  Presenter(s):Christopher M. Banoub, MPA  
  View Slides in PDF      
4:37 PM - 4:42 PM Practice Building Tips For Venous Specialists
  Presenter(s):Edward G. Mackay, MD  
  View Slides in PDF      
4:43 PM - 4:48 PM How To Get Vascular Surgeons Engaged In Venous Disease
  Presenter(s):Peter F. Lawrence, MD  
  View Slides in PDF      
4:49 PM - 5:00 PM Panel Discussion

End of Program I

END OF SESSION 70
 
SESSION 71 SCHEDULE
Thursday
SESSION 71: THE OPENING OF A NEW ERA: STROKE TRIALS AND EVIDENCE
Moderators:TBD / TBD  
x
8:00 AM - 8:05 AM Introduction
 
8:06 AM - 8:16 AM Stroke Demographics And Epidemiology
 
8:17 AM - 8:27 AM Recent Negative NEJM Trials: What Did We Learn
 
8:28 AM - 8:38 AM MR CLEAN
 
8:39 AM - 8:49 AM ESCAPE
 
8:50 AM - 9:00 AM SWIFT PRIME
 
9:01 AM - 9:11 AM Innovative Endovascular Therapy: From Trials To Practice
 
9:12 AM - 9:22 AM REVASCAT
 
9:23 AM - 9:33 AM THERAPY
 
9:34 AM - 9:44 AM Evidence Shared By Trials
 
9:45 AM - 9:55 AM Important Differences In Trials
 
9:56 AM - 10:05 AM Panel Discussion
10:05 AM - 10:25 AM Break – Visit Exhibits And Pavilions (2nd and 3rd Floors)
END OF SESSION 71
 
SESSION 72 SCHEDULE
Thursday
SESSION 72: TRIAGE STRATEGIES THAT NEED TO BE ADDRESSED
Moderators:TBD / TBD  
x
10:26 AM - 10:36 AM Prior To The ER And Transport Issues
 
10:37 AM - 10:47 AM Emergency Room Issues And Solutions
 
10:48 AM - 10:58 AM Telestroke Implementation And Problems
 
10:59 AM - 11:09 AM Data: We Should Require Documenting Time Points: AKA Cardiology
 
11:10 AM - 11:20 AM DEBATE: Cardiologists Can Do This: Why I Agree
  Presenter(s):L. Nelson Hopkins, MD  
11:21 AM - 11:31 AM DEBATE: Interventional Neuro Specialists Are Plentiful And The Appropriate Standard Of Care
 
11:32 AM - 11:42 AM Stroke Care Organization: Rural vs. City
 
11:43 AM - 11:53 AM Wake Up Strokes: Do We Have Any Data Or Not
 
11:54 AM - 12:04 PM Panel Discussion
LUNCHEON PROGRAM: NEW FRONTIERS IN BRAIN HEMORRHAGE EVACUATION
Moderator(s): TBD / TBD  
12:05 PM - 12:17 PM The Rationale For Minimally Invasive Surgery For The Evacuation Of Intracranial Hemorrhage
 
12:18 PM - 12:30 PM Minimally Invasive Access Surgery For Intracerebral Hemorrhage: Early Results And Future Directions
 
12:31 PM - 12:43 PM Minimally Invasive Surgery With Apollo: Experience To Date And Next Steps
 
12:44 PM - 12:59 PM Panel Discussion
END OF SESSION 72
 
SESSION 73 SCHEDULE
Thursday
SESSION 73: LUNCHEON PROGRAM: NEW FRONTIERS IN BRAIN HEMORRHAGE EVACUATION
Moderators:TBD
x
12:05 PM - 1:00 PM Please see the bottom of Session 72 for the Multidisciplinary Acute Stroke Management at AIMsymposium Luncheon Program.
END OF SESSION 73
 
SESSION 74 SCHEDULE
Thursday
SESSION 74: PATIENT SELECTION AND STATE-OF-THE-ART IMAGING
Moderators:TBD / TBD  
x
1:00 PM - 1:10 PM Basics Of Imaging For Stroke And The Latest Tools
 
1:11 PM - 1:21 PM Clinical Triage Basics
 
1:22 PM - 1:33 PM CT/CTA Is The Standard And All I Need
 
1:33 PM - 1:43 PM Perfusion Is A Necessity For Best Practice And I Can Prove It
 
1:44 PM - 1:54 PM Size Of The Core And The Physiology Of Progression: My Pearls
 
1:55 PM - 2:05 PM Collateral Imaging At Its Best
 
END OF SESSION 74
 
SESSION 75 SCHEDULE
Thursday
SESSION 75: HEMORRHAGIC STROKE
Moderators:TBD / TBD  
x
2:06 PM - 2:16 PM Intraparenchymal Hemorrhage: When To Decompress
 
2:17 PM - 2:27 PM Imaging Of Parenchymal Clots: Signs That Make You Worry
 
2:28 PM - 2:38 PM Aneurysm Therapy: Is There A Science Behind Which Aneurysms Will Grow And Rupture
 
2:39 PM - 2:49 PM Small Aneurysms: Coil Or Stent – Theory And Logic Behind My Decisions
  Presenter(s):Philip M. Meyers, MD  
2:50 PM - 3:00 PM Wide Neck Aneurysms: New Devices And Strategies
 
3:01 PM - 3:11 PM Flow Diversion: Next Generation Ideas
 
3:12 PM - 3:22 PM Managing Complications Of Aneurysm Therapy
 
3:23 PM - 3:33 PM AVM Treatment Options And Why
 
3:34 PM - 3:44 PM Dural Fistula: Venous Approaches
  Presenter(s):Guilherme Dabus, MD  
3:45 PM - 3:55 PM Dural Sinus Stenosis: When And Why I Treat
 
3:56 PM - 4:06 PM Direct Radial, Carotid And Venous Access
 
END OF SESSION 75
 
SESSION 76 SCHEDULE
Thursday
SESSION 76: LATEST SCIENCE, LITERATURE AND NEWEST DEVICES
Moderators:TBD / TBD  
x
4:07 PM - 4:17 PM Suction Thrombectomy: Lessons Learned
 
4:18 PM - 4:28 PM Stent Retrievers Are The Standard Of Care: The Evidence
 
4:29 PM - 4:39 PM Treating Stroke After The Time Window Closes: Physiology And Practical Issues
  Presenter(s):Colin P. Derdeyn, MD  
4:40 PM - 4:50 PM Posterior Circulation Ischemia: Is There A Role For Thrombectomy
 
4:51 PM - 5:01 PM Posterior Circulation Stroke: Strategies
 
5:02 PM - 5:12 PM Economics Of Stroke Therapy
 
5:13 PM - 5:23 PM Comprehensive Stroke Centers: Is It Going To Be Required For Treatment
 
5:24 PM - 5:30 PM Panel Discussion
End of Program J

END OF SESSION 76
 
SESSION 77 SCHEDULE
Friday
SESSION 77: NEW TECHNIQUES, TECHNOLOGIES, CONCEPTS – CAROTID RELATED
x
6:39 AM - 6:45 AM Atherosclerotic Plaque Regression: Is It Now A Reality: How Can It Occur: And What Are The Expectations For The Future
  Presenter(s):Kosmas I. Paraskevas, MD  
6:46 AM - 6:51 AM Current Optimal Methods To Evaluate Plaque Instability With Asymptomatic Carotid Stenosis (ACS)
  Presenter(s):Clark J. Zeebregts, MD, PhD  
  View Slides in PDF      
6:52 AM - 6:57 AM Juxtaluminal Black Area (JBA) On Duplex Determines Stroke Risk In ACS Patients: How To Determine And Quantitate It: Can It Be Changed: What Other Factors Quantitate Risk
  Presenter(s):Andrew N. Nicolaides, MS, FRCS / Stavros Kakkos, MD, PhD  
  View Slides in PDF      
6:58 AM - 7:03 AM DEBATE: Patch Closure After CEA Should Be Used Most Of The Time: The Level 1 Evidence Shows It